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CHAPTER	  1:	  INTRODUCTION	  TO	  GENERAL	  FE-­‐S	  CLUSTER	  BIOGENESIS	  
PATHWAYS	  
1.0	  Prelude	  Iron	   sulfur	   (Fe-­‐S)	   clusters	   are	   essential	   cofactors	   found	   in	   a	   variety	   of	   proteins	  throughout	  all	  forms	  of	  life.	  Proteins	  that	  bind	  Fe-­‐S	  clusters	  are	  termed	  “Fe-­‐S	  proteins”	  and	  they	   have	   been	   identified	   in	   many	   fundamental	   biochemical	   pathways.	   Despite	   their	  importance,	  I	  remember	  that	  when	  I	  first	  started	  working	  in	  Dr.	  Tim	  Stemmler’s	  research	  lab	  in	  October	  2012,	  I	  had	  never	  heard	  of	  an	  “Fe-­‐S	  cluster”.	  After	  several	  years	  of	  working	  in	  this	   field,	  however,	   I	   finally	  appreciate	   the	  significance	  of	   this	  essential	  and	  ubiquitous	  cofactor.	  During	  my	  first	  year	  researching	  Fe-­‐S	  cluster	  synthesis,	  I	  was	  astonished	  to	  learn	  that	   key	   enzymes	   from	   my	   introductory	   biology	   courses	   such	   as	   DNA	   polymerase	   III,	  aconitase,	  and	  succinate	  dehydrogenase	  all	  utilize	  Fe-­‐S	  clusters.	  In	  fact,	  Fe-­‐S	  clusters	  are	  so	  fundamental	   to	   life	   that	   there	   are	   relatively	   few	   human	   diseases	   related	   to	   Fe-­‐S	   cluster	  formation	  because	  dysfunctional	  Fe-­‐S	  cluster	  biogenesis	   is	  usually	   incompatible	  with	   life.	  Despite	  the	  huge	  variety	  of	  proteins	  requiring	  Fe-­‐S	  clusters,	  there	  are	  a	  limited	  number	  of	  pathway	  in	  eukaryotes	  that	  accommodates	  all	  cellular	  Fe-­‐S	  proteins.	  The	  major	  pathway	  is	  called	  the	  “Iron	  Sulfur	  Cluster”	  pathway,	  or	  “ISC”,	  and	  it	  is	  localized	  to	  the	  mitochondria	  in	  eukaryotes.	  The	  ISC	  pathway	  is	  the	  focus	  of	  my	  dissertation.	  My	  original	  project	   focused	  on	   identifying	  mechanistic	  details	  of	  a	  key	   ISC	  protein	  from	  Saccharomyces	  cerevisiae	   involved	  in	  Fe-­‐S	  cluster	  formation,	  Isu1.	  Over	  the	  4	  years	  I	  worked	  in	  the	  lab,	  the	  aims	  and	  scope	  of	  my	  project	  would	  change	  dramatically.	  In	  fact,	  my	  research	   proposal	   from	   Spring	   2013	   barely	   resembles	   the	   project	   I	   would	   ultimately	  pursue.	  In	  order	  to	  understand	  the	  various	  aspects	  of	  my	  work,	  however,	  you	  must	  first	  be	  familiar	  with	  the	  background	  of	  the	  field.	  This	  first	  chapter	  describes	  the	  current	  status	  of	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the	  field.	  This	  chapter	  is	  adapted	  from	  a	  review	  article	  I	  co-­‐authored	  on	  the	  topic;	  and	  the	  material	  included	  in	  this	  chapter	  from	  that	  review	  were	  written	  entirely	  by	  myself.	  Material	  from	  this	  review	  article	   that	   is	  not	  relevant	   to	  Fe-­‐S	  cluster	  biogenesis	  has	  been	  excluded.	  The	  reference	  for	  this	  article	  is:	  	  Barupala,	  D.	  P.;	  Dzul,	  S.	  P.;	  Riggs-­‐Gelasco,	  P.	  J.;	  Stemmler,	  T.	  L.	  Archives	  of	  biochemistry	  and	  
biophysics	  2016,	  592,	  60.	  
1.1	  Introduction	  After	  heme,	   Iron-­‐sulfur	   (Fe-­‐S)	   clusters	  are	   the	  second	  major	   form	  of	   complex	   iron	  cofactors	   found	   in	   biology.	   Due	   to	   the	   high	   abundance	   of	   iron	   and	   sulfur	   on	   the	   earth’s	  surface,	  and	  the	  easy	  association	  of	  these	  atoms	  under	  anaerobic	  conditions,	  Fe-­‐S	  clusters	  likely	  developed	  early	  in	  evolution	  before	  the	  earth’s	  transition	  to	  an	  aerobic	  atmosphere.	  Consequently,	   these	   cofactors	   are	   ubiquitous	   in	   all	   organisms	   and	   play	   a	   role	   in	   almost	  every	   biological	   pathway.	   Here	  we	   provide	   an	   overview	   of	   the	   structure,	   formation,	   and	  function	  of	  Fe-­‐S	  cluster	  cofactors.	  	  
1.2	  Fe-­‐S	  Cluster	  Structure	  In	   many	   ways,	   Fe-­‐S	   clusters	   are	   simpler	   than	   heme.	   While	   heme	   is	   a	   mixture	   of	  organic	   (protoporphyrin)	   and	   inorganic	   (iron)	   components,	   Fe-­‐S	   clusters	   are	   strictly	  inorganic.	   Iron	   atoms	   in	   biological	   Fe-­‐S	   clusters	   interact	   directly	   with	   protein	   residues,	  with	   sulfur	  atoms	  bridging	   the	  neighboring	   iron	  atoms.	  Fe-­‐S	   clusters	  exist	   in	  a	  variety	  of	  configurations	  depending	  on	  their	  respective	  number	  of	   iron	  and	  sulfur	  atoms.	  The	  three	  most	  common	  forms	  (2Fe-­‐2S,	  3Fe-­‐4S	  and	  4Fe-­‐4S)	  are	  illustrated	  in	  1.1.	  More	  complex	  Fe-­‐S	  clusters	   have	   also	   been	   observed,	   including	   the	   7Fe-­‐8S	   and	   8Fe-­‐8S	   clusters	   identified	   in	  ferredoxins	  from	  Desulfovibrio	  africanus.1	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The	  Fe	  atoms	  within	  the	  Fe-­‐S	  cluster	  can	  exist	  in	  either	  ferric	  or	  ferrous	  forms	  and	  cycling	  between	  these	  redox	  states	  allows	  the	  transfer	  of	  electrons	  for	  redox	  reactions.	  The	  tendency	   of	   the	   oxidized	   Fe-­‐S	   cluster	   to	   gain	   an	   electron	   is	   termed	   the	   “reduction	  potential”.	  By	  convention,	  this	  potential	  is	  expressed	  in	  comparison	  to	  a	  reference	  standard	  hydrogen	  electrode,	  which	   is	  assigned	  a	  potential	  of	  0	  V.	  Depending	  on	  Fe-­‐S	  cluster	   type,	  interactions	  with	  neighboring	  amino	  acids,	   and	  solvent	  accessibility,	   a	   single	  Fe-­‐S	   cluster	  can	   carry	   up	   to	   two	   electrons	   with	   a	   reduction	   potential	   spanning	   ~1000	   mV.2	   This	  remarkable	  range	  of	  accessible	  reduction	  potentials	  can	  largely	  explain	  the	  biological	  utility	  of	  the	  Fe-­‐S	  cluster.	  	  Fe-­‐S	   clusters	   do	   not	   exist	   freely	   but	   are	   intimately	   connected	   to	   their	   apoprotein	  partner.	  Free	  iron	  forms	  an	  insoluble	  complex	  when	  bound	  to	  sulfide,	  so	  the	  protein	  plays	  a	  critical	  role	  in	  solubilizing	  the	  Fe-­‐S	  unit.	  Fe-­‐S	  proteins	  usually	  bind	  their	  corresponding	  Fe-­‐S	   cofactor	   via	   ionic	   interactions	  between	   cysteine	   thiols	   and	   iron	   in	   the	  Fe-­‐S	   cofactor.	   In	  some	  cases,	  Fe-­‐S	  clusters	  are	  alternatively	  ligated	  via	  histidine	  residues.	  Subsets	  of	  2Fe2S	  clusters,	  such	  as	  those	  found	  in	  Rieske	  proteins	  (see	  section	  3.5),	  are	  coordinated	  by	  two	  cysteine	   and	   two	   histidines	   (Cys2His2)3	   and	   a	   common	   coordination	   theme	   of	   proteins	  involved	  in	  Fe-­‐S	  cluster	  biogenesis	  is	  Cys3His1	  coordination.4	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Figure	   1.1:	   Structure	   for	   the	  3	  most	   common	   forms	  of	  Fe-­‐S	  Cluster:	  2Fe-­‐2S,	  3Fe-­‐4S,	   and	  4Fe-­‐4S.	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1.3	  General	  Fe-­‐S	  Cluster	  Biogenesis	  Pathways	  Production	  of	  Fe-­‐S	  clusters	  must	  be	  highly	  regulated	  to	  prevent	  unwanted	  reactions	  of	  both	  free	  iron	  and	  sulfur.	  Similar	  to	  heme-­‐proteins,	  Fe-­‐S	  proteins	  are	  synthesized	  in	  their	  
apo-­‐state	   and	   obtain	   their	   Fe-­‐S	   cluster	   cofactor	   from	   a	   dedicated	   Fe-­‐S	   cluster	   formation	  pathway.	  At	  present,	   there	  are	   three	  known	  general	  pathways	   for	  Fe-­‐S	  cluster	   formation:	  the	   iron	   sulfur	   cluster	   (ISC),	   cytosolic	   iron	   sulfur	   assembly	   (CIA),	   and	   sulfur	   assimilation	  (SUF)	   pathways.	   These	   three	   pathways	   provide	   Fe-­‐S	   clusters	   for	   the	   majority	   of	   Fe-­‐S	  proteins	  in	  almost	  all	  organisms.	  While	  dedicated	  Fe-­‐S	  cluster	  forming	  pathways	  can	  exist	  for	   individual	  Fe-­‐S	  proteins,	   such	  as	   the	  nitrogen	   fixation	   (Nif)	  pathway	   that	  provides	  an	  Fe-­‐S	  cluster	  for	  the	  nitrogenase	  enzyme	  in	  nitrogen-­‐fixing	  bacteria,5	  this	  introduction	  will	  focus	  only	  on	  the	  general	  Fe-­‐S	  cluster	  production	  pathways.	  
1.3.1	  Iron	  Sulfur	  Cluster	  (ISC)	  Pathway	  The	  most	  robust	  and	  best-­‐characterized	  pathway	  for	  Fe-­‐S	  cluster	  biosynthesis	  is	  the	  iron	   sulfur	   cluster	   (ISC)	  pathway.	  A	   simplified	  description	  of	   this	  pathway	   is	  provided	   in	  Figure	   1.2.	   The	   ISC	   pathway,	   present	   in	   bacteria	   and	   in	   the	  mitochondria	   of	   eukaryotes,	  provides	   general	   housekeeping	   Fe-­‐S	   clusters	   to	   a	   large	   number	   of	   Fe-­‐S	   proteins.	   In	  eukaryotes,	   this	   pathway	   provides	   Fe-­‐S	   clusters	   for	   several	   key	   mitochondrial	   Fe-­‐S	  proteins.	   ISC	   was	   initially	   identified	   in	   the	   Azotobacter	   vinelandii	   and	   Escherichia	   coli	  bacterial	  species,	  where	  ISC	  genes	  are	  arranged	  in	  the	  isc	  operon.	  Additional	  early	  work	  in	  eukaryotes	   (in	   Saccharomyces	   cerevisiae	   and	   human	   proteins)	   revealed	   a	   highly	  homologous	   system	   localized	   to	   the	   mitochondria.	   In	   addition	   to	   providing	   for	  mitochondrial	   Fe-­‐S	   proteins,	   the	   ISC	   system	   provides	   a	   component	   to	   the	   cytosolic	   and	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nuclear	   Fe-­‐S	   cluster	   formation	   pathways,	   thus	   ISC	   is	   essential	   for	   the	   maturation	   of	   all	  cellular	  Fe-­‐S	  proteins	  in	  eukaryotes.6-­‐7	  	  ISC	   serves	   as	   a	   template	   for	   understanding	   general	   Fe-­‐S	   cluster	   production.	   In	  human	  ISC,	  de	  novo	  2Fe-­‐2S	  synthesis	  occurs	  on	  the	  dedicated	  scaffold	  protein	  ISCU.8	  Sulfur	  for	   this	   reaction	   is	   provided	   by	   ISC’s	   dedicated	   cysteine	   desulfurase	   enzyme	  NFS1	   via	   a	  persulfide	   intermediate	   that	   gets	   transferred	   to	   ISCU9	   upon	   formation	   of	   an	   ISCU-­‐NFS1	  complex.	  In	  eukaryotes,	  NFS1	  has	  a	  dedicated	  protein	  co-­‐factor	  ISD11	  that	  is	  essential	  for	  NFS1	  function.10	  Electrons	  for	  NFS1	  persulfide	  release	  are	  provided	  by	  the	  2Fe-­‐2S	  cluster	  containing	   ferredoxin	  FDX,	  which	   in	   turn	  gets	  reduced	  by	   the	   ferredoxin	  reductase	  FDXR	  that	  uses	  NADPH	  as	  its	  final	  electron	  source.11-­‐12	  FDX	  also	  interacts	  with	  ISCU,	  providing	  2	  reducing	   equivalents	   for	   assimilation	  of	   two	  2Fe-­‐2S	   clusters	  on	  an	   ISCU	  dimer	   to	   form	  a	  single	  4Fe-­‐4S	  cluster8.	  An	  additional	  Fe-­‐binding	  protein	  Frataxin	  interacts	  with	  the	  NFS1-­‐ISCU	  complex	  and	  regulates	  NFS1	  activity.13	  Additionally,	  there	  are	  other	  scaffold	  proteins	  (ISCA14	  and	  NFU115)	  that	  interact	  with	  ISC	  proteins	  and	  these	  are	  believed	  to	  be	  required	  for	  the	  maturation	  of	  a	  specific	  subset	  of	  Fe-­‐S	  proteins.	  	  Despite	   intense	   study,	   the	   physiologic	   source	   of	   iron	   for	   ISC	   remains	   a	   subject	   of	  debate.	  Several	  potential	  iron	  donors	  have	  been	  investigated	  and	  iron	  delivery	  to	  ISCU	  has	  been	  demonstrated	  from	  several	  potential	  sources	  in	  vitro	  within	  a	  variety	  of	  systems.	  The	  protein	  frataxin16,17	  interacts	  with	  the	  ISCU-­‐NFS1	  complex	  and	  could	  be	  the	  source	  of	  iron	  for	   the	   pathway.17	   In	   bacteria,	   two	   additional	   members	   of	   the	   isc	   operon	   have	   been	  investigated	  as	  potential	  iron	  donors,	  IscX	  and	  IscA.	  The	  small	  acidic	  protein	  IscX	  binds	  iron	  and	   regulates	   cysteine	   desulfurase	   activity	   in	   a	   manner	   very	   similar	   to	   frataxin.18	   The	  alternative	   scaffold	   IscA	   is	   also	   an	   interesting	   candidate	   because	   of	   its	   tight	   (KD~1019)	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binding	  affinity	  for	  mononuclear	  iron19	  and	  its	  capability	  of	  delivering	  iron	  to	  IscU.20-­‐21	  An	  additional	   interesting	   hypothesis	   is	   that	   iron	  may	   come	   from	   a	   glutathione-­‐glutaredoxin	  complex22.	  The	  lack	  of	  conclusive	  evidence	  for	  a	  specific	   iron	  source	  suggests	  that	  in	  vivo,	  there	  could	  be	  multiple	  iron	  sources	  or	  that	  the	  mode	  of	  iron	  delivery	  may	  be	  atypical.	  	  A	  detailed	  mechanism	  for	  Fe-­‐S	  cluster	  delivery	  from	  ISCU	  to	  downstream	  targets	  is	  currently	   under	   investigation.	   The	   Fe-­‐S	   cluster	   bound	   to	   ISCU	   is	   transferred	   to	   the	  glutaredoxin	  GLRX5.23-­‐24	  Efficient	  transfer	  from	  ISCU	  to	  GLRX5	  requires	  involvement	  of	  the	  ATPase	  SSQ1,	  which	  binds	  to	  both	  ISCU	  and	  GLRX5.25	  Binding	  of	  SSQ1	  to	  ISCU,	  along	  with	  the	   interaction	   of	   a	   DnaJ-­‐like	   co-­‐chaperone	   JAC1,26	   destabilizes	   the	   Fe-­‐S	   cluster	   on	   ISCU	  facilitating	   its	   transfer	   from	   ISCU	   to	   GLRX5.27	   GLRX5	   is	   considered	   the	   end	   of	   the	   ISC	  pathway	   because	   it	   is	   the	   last	   common	   Fe-­‐S	   cluster	   carrier	   for	   all	   mitochondrial	   Fe-­‐S	  proteins.	  GLRX5	  continues	  the	  cluster	  transfer	  process,	  however,	  and	  it	   is	  able	  to	  interact	  with	   a	   variety	   of	   downstream	   Fe-­‐S	   proteins.28-­‐30	   The	   specific	   recipient	   depends	   on	   the	  ultimate	   destination	   of	   the	   Fe-­‐S	   cluster.	   For	   example,	   4Fe-­‐4S	   cluster	   conversion	   and	  delivery	   is	   facilitated	   by	   GLRX5’s	   interaction	   with	   two	   other	   Fe-­‐S	   proteins,	   ISCA	   and	  IBA57.31	  Despite	  being	  mostly	  localized	  to	  mitochondria,32	  ISC	  is	  required	  for	  maturation	  of	  all	   cellular	   Fe-­‐S	   proteins.7	   The	   mechanism	   by	   which	   cytosolic	   Fe-­‐S	   proteins	   depend	   on	  mitochondrial	  ISC	  is	  actively	  being	  investigated.	  Because	  Fe-­‐S	  clusters	  are	  not	  able	  to	  cross	  the	   inner	  mitochondrial	  membrane,33	   this	  mechanism	   likely	   involves	   the	   transport	   of	   an	  Fe-­‐S	   cluster	   precursor	   out	   of	   the	   mitochondria	   and	   into	   the	   cytosol.	   Recent	   work	   has	  identified	  an	  unknown	  compound	  produced	  by	  mitochondrial	  NFS1	  (named	  ‘X-­‐S’)	  that	  may	  provide	  reduced	  sulfur	  for	  cytosolic	  Fe-­‐S	  cluster	  formation.34	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1.3.2	  Cytosolic	  Iron-­‐Sulfur	  Assembly	  (CIA)	  Pathway	  	  Recent	   studies	   have	   revealed	   the	   involvement	   of	   another	   essential	   and	   highly	  conserved	   Fe-­‐S	   biosynthetic	   pathway	   that	   is	   present	   within	   the	   cytosol	   and	   nucleus	   of	  eukaryotes.	   	   This	   pathway	   is	   called	   cytosolic	   iron-­‐sulfur	   assembly	   (CIA).35	   This	   pathway	  has	  been	  identified	  in	  many	  eukaryotic	  systems	  and	  is	  essential	  in	  almost	  all	  cases.36	  CIA	  is	  unique	   among	   Fe-­‐S	  maturation	   pathways	   in	   that	   it	   does	   not	   obtain	   reduced	   sulfur	   via	   a	  dedicated	  cysteine	  desulfurase.	  A	  simplified	  description	  of	  the	  CIA	  pathway	  is	  provided	  in	  Figure	   1.2.	   Instead	   of	   an	   NFS1	   analog,	   CIA	   relies	   on	   mitochondrial	   export	   of	   a	   sulfur-­‐containing	   compound,	   ‘X-­‐S’,	   via	   the	   mitochondrial	   export	   protein	   ABCB737	   and	   the	  intermembrane	  space	  protein	  ALR.38	  The	  identity	  of	  X-­‐S	  is	  currently	  unknown,	  but	  may	  be	  glutathione-­‐complexed	  to	  an	  Fe-­‐S	  cluster.36	  In	  human	  CIA,	  the	  primary	  scaffold	  for	  de	  novo	  Fe-­‐S	   assembly	   is	   a	   tetrameric	   complex	   formed	  between	  CFD1	  and	  NBP35,	  which	  binds	   a	  bridging	  4Fe-­‐4S	  cluster	  between	  the	  CFD1	  and	  NBP35	  subunits.39	  Reducing	  equivalents	  for	  this	  reaction	  are	  provided	  by	  an	  Fe-­‐S	  containing	  protein	  CIAPIN1	  (similar	   to	  FDX	   in	   ISC),	  which	   in	   turn	   gets	   reduced	   by	   the	   diflavin	   reductase	   NDOR1	   (similar	   to	   FDXR	   in	   ISC),	  utilizing	  reducing	  equivalents	  from	  NADPH.40-­‐41	  	  The	  4Fe-­‐4S	  clusters	  from	  the	  NBP35-­‐CFD1	  complex	  get	  transferred	  to	  another	  Fe-­‐S	  protein	  IOP1,	  which	  binds	  two	  4Fe-­‐4S	  clusters	  per	  monomer.42-­‐43	  IOP1,	  in	  turn,	  delivers	  its	  Fe-­‐S	   clusters	   to	   a	   multi-­‐component	   complex	   called	   the	   CIA	   targeting	   complex,	   which	  consists	  of	  at	  least	  three	  proteins	  CIA1,	  CIA2B,	  and	  MMS19.44	  The	  CIA	  targeting	  complex	  is	  able	  to	  interact	  with	  a	  variety	  of	  recipient	  Fe-­‐S	  proteins,	  likely	  an	  indication	  of	  its	  function	  in	  downstream	  Fe-­‐S	  cluster	  delivery.	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1.3.3	  Sulfur	  Assimilation	  (SUF)	  Pathway	  	  Of	  the	  three	  Fe-­‐S	  general	  cluster	  formation	  pathways,	  the	  sulfur	  assimilation	  (SUF)	  pathway	  is	  probably	  the	  most	  ancient.	  SUF	  predominantly	  exists	  in	  prokaryotes,	  however	  it	  is	  found	  in	  specific	  locations	  in	  eukarya,	  including	  the	  chloroplasts	  in	  some	  plants45	  and	  the	  apicoplasts	   in	  some	  plasmodium	  species,46	  and	  recently	  proteins	  homologous	  to	  bacterial	  SUF	  were	  discovered	  in	  the	  cytosol	  of	  a	  blastocystis	  species.47	  At	  present,	  SUF	  has	  been	  best	  characterized	   in	   the	   Gram-­‐negative	   bacteria	   Escherichia	   coli	   and	   Erwynia	   chrysanthemi	  where	  its	  genes	  are	  organized	  into	  the	  suf	  operon	  (Figure	  1.3).	  The	  SUF	  pathway	  is	  similar	  to	  ISC	  in	  many	  ways.	  Like	  in	  ISC,	  SUF	  provides	  general	  Fe-­‐S	  cluster	  formation	  to	  accommodate	  a	  variety	  of	  Fe-­‐S	  proteins.	  In	  fact,	  SUF	  and	  ISC	  seem	  to	  be	  redundant	   in	  Gram-­‐negative	  bacteria,	  as	   the	  removal	  of	   the	  entire	   isc	  or	  suf	  operon	  results	  in	  no	  deleterious	  effects.	  Simultaneous	  suf/isc	  operon	  deletion,	  however,	  is	  lethal.48	  While	  ISC	  and	  SUF	  follow	  the	  same	  general	  mechanism	  for	  Fe-­‐S	  cluster	  formation	  (Figure	  1.2),	  SUF	  seems	  to	  be	  favored	  under	  conditions	  of	  oxidative	  stress	  and	  iron	  limitation49	  and	  the	  SUF	  proteins	  are	  correspondingly	  more	  stable	  under	  adverse	  conditions	  in	  vitro.50	  In	  E.	  
coli,	  the	  SUF	  pathway	  centers	  around	  two	  heteromeric	  complexes	  called	  SufBC	  and	  SufSE.	  The	  primary	  scaffold	  SufB	  requires	  a	  binding	  partner	  SufC	  for	  activity,	  forming	  the	  SufBC	  complex	  in	  a	  SufB2C2	  arrangement.	  The	  SufBC	  complex	  can	  form	  a	  4Fe-­‐4S	  cluster	  on	  SufB	  that	  can	  be	  transferred	  to	  recipient	  proteins.51	  The	  exact	  role	  of	  SufC	  in	  this	  process	  is	  unknown,	  but	   it	  has	  ATPase	  activity	  that	   is	  essential	   for	  Fe-­‐S	  cluster	  formation	  on	  SufB.52	  SufB,	  on	  its	  own	  is	  relatively	  unstable	  and	  prone	  to	  spontaneous	  oligomerization.	  There	  is	  also	  a	  paralogue	  of	  SufB,	  named	  SufD	  that	   is	  able	  to	  replace	  a	  SufB	  in	  the	  SufBC	  complex,	  resulting	  in	  the	  SufBCD	  complex.53	  However,	  SufBC	  is	  likely	  the	  most	  active	  form.54	  The	  SUF	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cysteine	   desulfurase	   SufS	   functions	   in	   a	   similar	   manner	   to	   NFS1,	   accepting	   sulfur	   from	  cysteine	  via	  a	  persulfide	  intermediate.	  SufS	  has	  an	  essential	  binding	  partner	  SufE,	  which	  is	  required	   for	   activity,	   forming	   the	   SufSE	   complex.55	  While	   it	  may	   seem	   SufE	   is	   similar	   to	  ISD11	   from	   eukaryotic	   ISC,	   SufE	   functions	   differently	   from	   ISD11	   in	   that	   it	   accepts	   the	  persulfide	  from	  SufS	  and	  allows	  the	  SufS	  enzyme	  to	  complete	  its	  turnover.56	  Details	  of	  SUF’s	  downstream	  cluster	  delivery	  are	  not	  as	  well	  established	  as	  in	  the	  ISC	  pathway.	   The	   4Fe-­‐4S	   cluster	   formed	   by	   SufBC	   can	   be	   transferred	   to	   the	   A-­‐type	   carrier	  protein	  SufA	   in	  vitro,51,	  54	  but	  SufBC	  also	  may	  be	  able	  to	  transfer	  directly	  to	  recipient	  apo-­‐proteins.	   In	  vivo,	   SufA	   is	   functionally	   redundant	  with	   the	   ISCA	  bacterial	  homologue57	  and	  possibly	  acts	   as	  an	   intermediate	   carrier	  of	   the	  4Fe-­‐4S	   cluster	   from	  SufB,	  passing	   it	  off	   to	  downstream	   apoproteins.58-­‐59	   Another	   protein	   involved	   in	   this	   process	   (ErpA)	   has	  redundant	   function	   with	   SufA	   but	   is	   necessary	   for	   the	   development	   of	   active	   Fe-­‐S	  proteins.60	  Several	  important	  details	  of	  the	  SUF	  pathway	  remain	  to	  be	  identified.	  As	  in	  ISC,	  the	  
in	  vivo	   source	   of	   iron	   is	   unknown.	  Also	   of	   interest	   is	   SufD’s	   incorporation	   in	   the	   SufBCD	  complex,	   which	   allows	   SufB	   to	   accept	   iron	   in	   vivo52	   and	   facilitates	   binding	   of	   a	   FADH2	  cofactor.53	  This	  cofactor	  may	  be	  able	  to	  reduce	  ferric	  iron,	  facilitating	  potential	  Fe3+	  sources	  such	   as	   ferritins	   or	   ferric	   citrate.61	  While	   SufA	   can	  deliver	  mononuclear	   iron	   to	   SufBC	   in	  
vitro,20	   it	   is	  currently	  believed	   to	   function	  downstream	  of	  de	  novo	  Fe-­‐S	   formation	  (Figure	  1.2).	   The	   source	   of	   electrons	   for	   SufS	   turnover	   and	   for	   Fe-­‐S	   formation	   remains	   in	  question.62	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Figure	  1.2:	  Diagram	  depicting	  the	  main	  Fe-­‐S	  cluster	  transfer	  steps	  in	  the	  ISC,	  SUF,	  and	  CIA	  systems.	   Protein	   names	   used	   are	   from	   the	   human	   system	   for	   ISC	   and	   CIA,	   and	   from	   the	  bacterial	  system	  for	  SUF.	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1.4	  Fe-­‐S	  Cluster	  Biogenesis	  Regulation	  The	  best-­‐developed	  model	  for	  Fe-­‐S	  biogenesis	  pathway	  regulation	  comes	  from	  work	  done	   in	   Gram-­‐negative	   bacterial	   systems,	   where	   both	   the	   ISC	   and	   SUF	   pathways	   are	  present.	   This	   work	   reveals	   a	   fascinating	   interplay	   between	   ISC	   and	   SUF,	   where	   the	  necessary	  ISC	  and	  SUF	  genes	  are	  organized	  into	  their	  respective	  isc	  and	  suf	  operons	  (Figure	  1.3).	  While	  this	  introduction	  has	  focused	  on	  eukaryotic	  systems,	  regulatory	  mechanisms	  in	  bacteria	  may	  provide	  insight	  into	  how	  this	  regulation	  occurs	  in	  eukaryotes.	  At	  the	  center	  of	  
E.	  coli	  Fe-­‐S	  cluster	  biogenesis	  regulation	  is	  a	  DNA-­‐binding	  protein	  IscR,	  the	  first	  member	  of	  the	  isc	  operon,	  which	  directly	  regulates	  both	  the	  ISC	  and	  SUF	  systems.	  	  Under	  non-­‐stressed	  conditions,	  ISC	  is	  favored	  over	  SUF	  for	  general	  housekeeping	  of	  Fe-­‐S	   cluster	   biosynthesis.63	   The	   transcriptional	   regulator	   IscR	   can	   bind	   a	   2Fe-­‐2S	   cluster	  (forming	   holo-­‐IscR),	   obtaining	   its	   Fe-­‐S	   cluster	   from	   the	   same	   ISC	   machinery	   utilized	   by	  other	  Fe-­‐S	  proteins.64	  In	  the	  holo	  configuration,	  IscR	  binds	  to	  the	  isc	  promoter	  and	  prevents	  binding	   of	   RNA	   polymerase.65	   Thus,	   holo-­‐IscR	   acts	   as	   a	   feedback	   regulator,	   inhibiting	  transcription	  of	   the	   entire	   isc	   operon	  when	   ISC	  activity	   is	   sufficient.66	   IscR	   is	   a	   relatively	  poor	   substrate	   for	   ISC-­‐mediated	  Fe-­‐S	   cluster	   loading67	   and	  holo-­‐IscR	   can	  only	   form	  after	  the	  ISC	  proteins	  have	  exhausted	  their	  interactions	  with	  other	  apo-­‐Fe-­‐S	  proteins.	  In	  addition	  to	  being	  a	  weak	  ISC	  substrate,	  IscR	  does	  not	  bind	  its	  Fe-­‐S	  cluster	  tightly	  and	  effectively	  acts	  as	   a	   sensor	   of	   cellular	   iron	   and	   oxygen	   conditions.68	   Under	   high-­‐oxygen	   or	   low-­‐iron	  conditions,	   holo-­‐IscR	   quickly	   reverts	   to	   apo-­‐IscR.	   Therefore	   under	   typical	   aerobic	  conditions,	   high	  oxygen	   levels	   cause	  holo-­‐IscR	   to	   revert	   to	  apo-­‐IscR.	  Apo-­‐IscR	  dissociates	  from	  the	  isc	  promoter	  and	  isc	  is	  uninhibited.	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In	  the	  apo	  configuration,	  IscR	  does	  not	  bind	  to	  the	   isc	  promoter	  but	   instead	  favors	  binding	   to	   the	   suf	   promoter,	   activating	   transcription	   of	   SUF	   genes69.	   Appropriate	  interaction	  of	  apo-­‐IscR	  with	  the	  suf	  promoter	  involves	  two	  additional	  transcription	  factors:	  the	   ferric	   uptake	   regulator	   (Fur)	   and	   the	   peroxide	   responsive	   regulator	   (OxyR).	   Suf	  expression	   is	   constitutively	   repressed	   by	   Fur,	   which	   binds	   Fe2+	   under	   non-­‐stressed	  conditions	  when	  iron	  levels	  are	  sufficient	  and	  oxidative	  stress	  is	  low.	  With	  its	  Fe2+	  cofactor,	  Fur	   binds	   to	   the	   suf	   promoter	   at	   the	   same	   site	   as	   apo-­‐IscR,	   inhibiting	   suf	   expression70.	  When	   the	   cell	   faces	   iron	   deficiency,	   Fur	   loses	   its	   iron	   cofactor,	   dissociates	   from	   the	   suf	  promoter,	  thus	  triggering	  transcription	  of	  suf.	  The	  cell’s	  preference	  for	  SUF	  over	  ISC	  in	  the	  presence	   of	   oxidative	   stress	   also	   reveals	   the	   involvement	   of	   another	   transcription	   factor	  (OxyR),	  as	  oxidized	  OxyR	  recruits	  RNA	  polymerase	  to	  the	  suf	  promoter.	  There	   are	   additional	   regulatory	   mechanisms	   for	   cluster	   bioassembly	   beyond	   the	  level	   of	   gene	   expression.	   The	   small	   non-­‐coding	   RNA	   RyhB,	   for	   example,	   is	   encoded	   just	  upstream	   of	   the	   SUF	   promoter	   and	   can	   bind	   to	   the	   iscRSUA	   mRNA	   to	   prevents	   its	  translation71.	  RyhB	  expression,	  however,	   is	   constitutively	   repressed	  by	  Fur-­‐Fe2+,	   so	  RyhB	  effectively	  inhibits	  ISC	  when	  conditions	  favor	  SUF72.	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Figure	   1.3:	   Illustration	   of	   suf	   and	   isc	   operons,	   which	   describe	   an	   important	   regulatory	  mechanism	  for	  SUF	  and	  ISC	  in	  bacteria.	  Operons	  depicted	  are	  from	  the	  E.	  coli	  model	  system.	  Steps	  are	  colored	  based	  on	  on	  the	  encoded	  protein’s	  function	  as	  follows:	  red	  (regulatory),	  yellow	  (sulfur	  delivery),	  green	  (primary	  scaffold),	  blue	  (downstream	  Fe-­‐S	  cluster	  delivery),	  gray	  (unknown).	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1.5	  Fe-­‐S	  Cluster	  Function	  Fe-­‐S	   clusters	   are	   versatile	   biological	   cofactors	   found	   in	   the	   most	   fundamental	  biochemical	  pathways,	   including	  aconitase	  and	  succinate	  dehydrogenase	  of	   the	  citric	  acid	  cycle	   and	   respiratory	   complexes	   I-­‐III	   of	   the	   electron	   transport	   chain.32	   Nuclear	   Fe-­‐S	  proteins	  also	  have	  a	  unique	  role	   in	  DNA	  damage	  recognition	  and	  repair.	  Several	   forms	  of	  DNA	  polymerase,	  helicase,	  glycosylase,	  and	  primase	  all	  contain	  Fe-­‐S	  clusters.36	  Considering	  their	  remarkable	  range	  of	  functions,	  a	  thorough	  summary	  of	  various	  Fe-­‐S	  proteins	  is	  well	  beyond	  the	  limited	  scope	  of	  this	  introduction.	  New	  Fe-­‐S	  proteins	  continue	  to	  be	  discovered	  but	   in	  many	  cases,	   the	  role	  of	   the	  Fe-­‐S	  cluster	  within	   the	  Fe-­‐S	  protein	  remains	  unknown,	  even	  if	  the	  cluster’s	  presence	  is	  essential	  for	  proper	  protein	  function.	  Fe-­‐S	  clusters	  can	  be	  found	  in	  the	  active	  site	  of	  many	  essential	  enzymes	  and	  usually	  are	  involved	  directly	  in	  catalysis.	  Being	  stable	  in	  a	  variety	  of	  redox	  states,	  Fe-­‐S	  clusters	  are	  best	   known	   for	   their	   role	   as	   electron	   carriers.	   Fe-­‐S	   clusters	   can	   carry	   usually	   one,	   but	  sometimes	   two	   electrons	   and	   are,	   subsequently,	   stable	   in	   various	   reduced	   states.	   2Fe-­‐2S	  clusters,	  for	  example,	  can	  exist	  in	  oxidized	  (Fe3+/Fe3+)	  or	  reduced	  (Fe3+/Fe2+)	  forms	  while	  4Fe-­‐4S	   clusters	   are	   stable	   in	   oxidized	   (Fe3+/Fe3+/Fe3+/Fe2+),	   intermediate	  (Fe3+/Fe3+/Fe2+/Fe2+),	  and	  reduced	  (Fe3+/Fe2+/Fe2+/Fe2+)	  forms.73	  The	  reduction	  potential	  of	   an	   Fe-­‐S	   cluster	   is	   often	   modulated	   by	   interactions	   with	   nearest	   neighbor	   protein	  residues	   and	   by	   access	   to	   solvent,	   allowing	   for	   a	   large	   range	   of	   biological	   functions.	  Ferredoxins	   are	   considered	   the	   archetypical	   Fe-­‐S	   cluster	   electron	   carriers	   and	  were	   the	  earliest	  Fe-­‐S	  proteins	  to	  be	  functionally	  characterized.74	  Ferredoxins	  are	  involved	  in	  many	  essential	   biochemical	   pathways,	   transferring	   electrons	   for	   cellular	   respiration,	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photosynthesis,	  and	  nitrogen	  fixation.75	  A	  ferredoxin	  is	  even	  involved	  in	  the	  ISC	  iron	  sulfur	  cluster	  biogenesis	  pathway,	  as	  discussed	  previously	  (see	  section	  3.3.1).76	  	  But	  Fe-­‐S	  cluster-­‐mediated	  electron	  transfer	  is	  not	  limited	  to	  ferredoxins.	  In	  fact,	  one	  of	  the	  most	  the	  fundamental	  electron	  transfer	  processes,	  the	  electron	  transport	  chain	  (ETC),	  utilizes	  numerous	  Fe-­‐S	  clusters.	  Respiratory	  complexes	  I,	   II,	  and	  III	  of	   the	  ETC	  all	  contain	  Fe-­‐S	   clusters.	   Respiratory	   complex	   I	   uses	   a	   network	   of	   8	   Fe-­‐S	   clusters	   for	   step-­‐wise	  electron	  transfer.77	  Similarly,	  complex	  II	  contains	  an	  Fe-­‐S	  protein	  component	  called	  SDHB	  with	  a	  2Fe-­‐2S,	  3Fe-­‐4S,	  and	  4Fe-­‐4S	  cluster78.	  Lastly,	  complex	  III	  utilizes	  a	  unique	  Fe-­‐S	  cluster	  called	  a	  “Rieske	  center”.79	  The	  Rieske	  center	  is	  a	  2Fe-­‐2S	  cluster	  where	  one	  of	  the	  iron	  atoms	  is	  coordinated	  by	  histidines	  instead	  of	  cysteines,	  resulting	  in	  a	  Cys2His2	  coordination.80	  	  Fe-­‐S	   clusters	   can	   also	   be	   involved	   in	   non-­‐redox	   reactions.	   The	   4Fe-­‐4S	   cluster	   in	  aconitase,	  for	  example,	  catalyzes	  a	  hydration-­‐dehydration	  reaction,	  ligating	  directly	  to	  the	  citrate	  substrate.81	   In	  some	  cases,	  Fe-­‐S	  clusters	  appear	  to	  only	  serve	  a	  structural	   function	  and	  not	  participate	  in	  chemistry	  directly,	  as	  is	  the	  case	  in	  endonuclease	  III.82	  	  
1.6	  Fe-­‐S	  Clusters	  in	  Human	  Disease	  Unlike	  in	  Gram-­‐negative	  bacteria,	  where	  ISC/SUF	  redundancy	  allows	  for	  removal	  of	  an	   entire	   pathway,	   in	   humans	   the	   absence	   or	   mutation	   of	   a	   single	   component	   is	   often	  incompatible	  with	   life.	   In	   select	   cases	   there	  are	  human	  diseases	   that	  have	  been	   linked	   to	  defective	   Fe-­‐S	   cluster	   biogenesis	   pathways.	   Below	  we	   describe	   several	   diseases	   directly	  linked	  to	  dysfunctional	  Fe-­‐S	  cluster	  formation.	  
1.6.1	  Friedreich’s	  Ataxia	  With	  an	  incidence	  of	  1	  in	  50,000,83-­‐84	  and	  a	  carrier	  prevalence	  of	  1	  in	  100	  in	  certain	  populations,85	   Friedreich’s	   ataxia	   (FRDA)	   is	   by	   far	   the	   most	   prevalent	   disease	   linked	   to	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defective	  Fe-­‐S	  cluster	  formation.	  FRDA	  is	  an	  autosomal	  recessive	  genetic	  disease	  caused	  by	  a	  GAA-­‐trinucleotide	  repeat	  expansion	  in	  an	  intron	  of	  the	  frataxin	  gene,	  a	  protein	  involved	  in	  the	   ISC	   pathway.86	   This	   trinucleotide	   repeat	   expansion	   leads	   to	   under-­‐expression	   of	   the	  frataxin	   gene	  and	   subsequently,	   low	   levels	  of	   frataxin.87	  These	   insufficient	   frataxin	   levels	  are	   responsible	   for	   the	   pathophysiology	   of	   FRDA,	   but	   the	   precise	   role	   of	   frataxin	   is	   still	  unknown.88	  Frataxin	  may	  deliver	  iron	  to	  the	  ISC	  pathway,89	  be	  an	  allosteric	  activator	  of	  the	  ISCU-­‐NFS1	   complex,13	   or	   may	   have	   a	   combination	   of	   roles.	   FRDA	   tissues	   demonstrate	  increased	  mitochondrial	  iron	  deposits90	  which	  leads	  to	  increased	  oxidative	  stress	  and	  cell	  death	  in	  metabolically	  active	  tissues	  such	  as	  cardiomyocytes	  and	  neurons	  of	  the	  dorsal	  root	  ganglia.	   FRDA	   presents	   early	   in	   adolescence	   with	   progressive	   ataxia,	   or	   difficulty	  coordinating	  movement,	  sensory	  loss,	  weakness,	  and	  dysarthria.	  FRDA	  patients	  are	  usually	  wheelchair	   bound	   in	   their	   teens	   with	   a	   significantly	   reduced	   quality	   of	   life	   and	   life	  expectancy.91	  Median	  age	  of	  survival	  is	  35	  years	  with	  cardiac	  dysfunction	  usually	  being	  the	  cause	  of	  death.92	  	  
1.6.2	  ISCU	  Myopathy	  
ISCU	  myopathy	   (IM)	   is	   an	   additional	   condition	   related	   to	   a	   defect	   in	   Fe-­‐S	   cluster	  biogenesis.	   It	   is	   the	  2nd	  most	   common	  disorder	   linked	   to	  defective	  Fe-­‐S	   cluster	   synthesis	  but	   is	   much	   less	   common	   than	   FRDA	   with	   only	   25	   known	   cases.	   To	   date,	   all	   patients	  identified	  with	  IM	  have	  come	  from	  families	  of	  Swedish	  ancestry.32	  Similar	  to	  FRDA,	  the	  IM	  phenotype	  is	  inherited	  in	  an	  autosomal	  recessive	  pattern.	  IM	  is	  caused	  by	  a	  splicing	  defect	  during	  ISCU	  post-­‐transcriptional	  processing	  that	   leads	  to	  defective	   ISCU	  protein.93-­‐94	  Loss	  of	   ISCU	   leads	   to	   lower	   ISC	   activity	   and	   a	   resulting	   deficiency	   of	   essential	   Fe-­‐S	   proteins,	  including	  succinate	  dehydrogenase	  and	  aconitase	  of	   the	  citric	  acid	  cycle.95	  Symptoms	  are	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exacerbated	  in	  cells	  that	  are	  metabolically	  active,	  such	  as	  the	  myocytes	  of	  skeletal	  muscle	  during	  exercise,	  and	  patients	  with	  IM	  experience	  exercise	  intolerance.96	  Prolonged	  activity	  can	  lead	  to	  tachycardia,	  tachypnea,	  and	  muscle	  pain.97	  Unlike	  FRDA,	  IM	  is	  not	  progressive	  and	  most	  cases	  have	  a	  normal	  life	  expectancy.	  
1.6.3	  GLRX5	  Sideroblastic	  Anemia	  
GLRX5	   Sideroblastic	   Anemia	   (GSA),	   a	   disease	   caused	   by	   mutated	   GLRX5,	   has	   only	  been	   identified	   in	   a	   single	   patient	   to	   date.	  While	   GSA	   is	   exceedingly	   rare,	   this	   particular	  case	  study	  has	  revealed	  a	  unique	  mechanism	  linking	  Fe-­‐S	  cluster	  production	  to	  general	  iron	  homeostasis.98-­‐99	  GLRX5,	   involved	   in	   the	   last	  step	  of	   the	   ISC	  pathway,	  directs	  Fe-­‐S	  cluster	  delivery	  from	  ISCU	  to	  downstream	  targets.	  One	  target	  is	  the	  iron-­‐responsive	  protein	  IRP1,	  an	   Fe-­‐S	   protein	   activated	   when	   its	   Fe-­‐S	   cluster	   is	   absent.98	   Defective	   GLRX5,	   therefore,	  leads	   to	   constitutively	   active	   IRP1.	   IRP1	   regulates	   several	   proteins	   involved	   in	   iron	  homeostasis,100	   including	   those	   involved	   in	   heme	   production.	   In	   particular,	   apo-­‐IRP1	  inhibits	   expression	   of	   the	   initial	   enzyme	   in	   heme	   synthesis,	   aminolevulinate	   synthase	  (ALAS2).	   Defective	   GLRX5,	   therefore,	   leads	   to	   insufficient	   heme	   and	   impaired	  erythropoiesis,	  resulting	  in	  anemia.	  Iron	  that	  would	  be	  directed	  towards	  heme	  production	  accumulates	   in	   the	   mitochondria	   of	   erythroblasts,	   creating	   the	   characteristic	   ringed-­‐sideroblasts.62	  	  
1.6.4	  Additional	  Diseases	  Related	  to	  Dysfunctional	  Fe-­‐S	  cluster	  Biogenesis	  Succinate	  Dehydrogenase	  (SDH)	  subunit	  B,	  the	  Fe-­‐S	  cluster	  containing	  protein	  of	  the	  succinate	  dehydrogenase	  complex,	   is	  a	  known	  tumor	  suppressor.	  Succinate,	   the	  substrate	  for	   SDH,	   stabilizes	   hypoxia-­‐inducible	   factor	   (HIF),	   which	   regulates	   key	   processes	   in	   cell	  division	  and	  blood	  vessel	  growth	  under	  hypoxic	  conditions.	  Mutations	   in	  SDHB	  or	   in	   fact	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any	   of	   the	   other	  main	   subunits	   of	   SDH	   (SDHA,	   SDHC,	   and	   SDHD)	   cause	   susceptibility	   to	  tumor	  formations	  known	  as	  paragangliomas	  or	  phaeochromocytomas	  in	  a	  disorder	  called	  
Hereditary	   Paraganglioma-­‐Pheochromocytoma,101	   stemming	   from	   the	   accumulation	   of	  succinate	  and	  stabilization	  of	  HIF.	  	  SDHAF2,	  an	  assembly	  protein	  that	  flavinates	  SDH,	  is	  also	  implicated	   in	  paragangliomas.	   	   Recently,	   two	   additional	   Fe-­‐S	   assembly	  proteins,	   SDHAF1	  and	   SDHAF3,	   were	   found	   to	   stabilize	   Fe-­‐S	   cluster	   assembly	   in	   SDH.102	   The	   later	   two	  proteins	   have	   LYR-­‐motifs	   (Leu-­‐Tyr-­‐Arg)	   common	   to	   proteins	   involved	   in	   Fe-­‐S	   cluster	  assembly.	  SDHAF1	  deficiency	  is	  known	  to	  cause	  leukoencephalopathy.103	  	   Lastly,	   mutations	   in	   either	   NFU1	   or	   BOLA3,	   two	   different	   genes	   involved	   in	   Fe-­‐S	  cluster	   biogenesis,	   leads	   to	   multiple	   mitochondrial	   dysfunction	   syndrome,	   a	   condition	  characterized	   by	   defects	   in	   Complexes	   I,	   II,	   and	   III	   and	   pyruvate/α-­‐ketoglutarate	  dehydrogenases.	   NFU1	   is	   thought	   to	   be	   an	   alternative	   to	   ISCU	   as	   a	   scaffold	   for	   Fe-­‐S	  assembly.	   Both	   BOLA3	   and	   NFU1	   appear	   to	   be	   involved	   in	   lipoate	   synthesis,	   possibly	  related	  to	  a	  role	  in	  assembling	  Fe-­‐S	  clusters	  in	  lipoic	  acid	  synthase	  (LIAS),	  thus	  providing	  an	  explanation	  for	  the	  reduced	  PDH	  and	  α−KGDH	  activities	  characteristic	  of	  this	  syndrome.	  The	   impaired	   energy	   production	   results	   in	   lactic	   acidosis,	   encephalopathy104	   and	   early	  death.	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CHAPTER	  2:	  DEVELOPMENT	  AND	  VALIDATION	  OF	  OPTIMAL	  METHOD	  
FOR	  APO-­‐ISU1	  TO	  FES-­‐ISU1	  TRANSFORMATION	  IN	  VITRO	  
	  
2.0	  Prelude	  One	   of	   the	   earliest	   goals	   of	  my	   project	  was	   to	  measure	   the	   ‘activity’	   of	   Isu1.	   This	  required	  a	  detailed	  understanding	  of	   the	  method	   that	  had	  been	  developed	   to	  assess	   Isu1	  activity.105	  This	  method,	  which	  I	  will	  call	  the	  “FeS-­‐Isu1	  formation	  method”,	  would	  become	  the	   focus	   of	   my	   dissertation	   and	   will	   be	   used	   extensively	   throughout	   this	   work.	   This	  chapter	   is	  probably	   the	  most	   important	   chapter	   in	  my	  dissertation,	   as	   it	  describes	  how	   I	  needed	   to	   change	   the	   aims	   of	   my	   research	   from	   what	   was	   originally	   outlined	   in	   my	  dissertation	  proposal.	  In	  this	  section,	  I	  describe	  my	  original	  project	  on	  the	  characterization	  of	  the	  Isu1	  Fe-­‐S	  cluster	  coordination	  site	  and	  explain	  why	  the	  primary	  method	  I	  was	  relying	  on	  for	  these	  studies,	  the	  FeS-­‐Isu1	  formation	  method,	  was	  not	  suitable	  for	  this	  application.	  Next,	  I	  describe	  how	  the	  method	  was	  modified	  to	  maximize	  Fe-­‐S	  cluster	  yield	  and	  describe	  steps	   taken	   to	   validate	   these	   new	   conditions.	   I	   need	   to	   give	   credit	   and	   thanks	   to	   former	  graduate	   student	   Dr.	   Andria	   Rodrigues,	   who	   provided	   many	   valuable	   insights	   and	  experiences	  during	  my	  first	  two	  years	  on	  these	  topics.	  I	  did	  all	  the	  writing	  and	  experiments	  in	  this	  section.	  
2.1	  Introduction	  	   Fe-­‐S	   clusters	   are	   essential	   cofactors	   found	   throughout	   biology.	   Proteins	   that	   bind	  Fe-­‐S	  clusters	  are	  termed	  “FeS-­‐proteins”	  and	  these	  proteins	  are	  found	  in	  many	  of	  the	  most	  fundamental	  biochemical	  pathways.	  In	  eukaryotes,	  there	  is	  a	  single	  mitochondrial	  pathway	  that	  is	  essential	  for	  the	  formation	  of	  most	  cellular	  Fe-­‐S	  clusters.106	  This	  pathway,	  called	  the	  “Fe-­‐S	   cluster	  Pathway”	   or	   “ISC”,	   is	   a	   focus	   of	  my	   lab’s	   research.	   The	  model	   organism	  my	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project	  uses	  for	  this	  work	  is	  the	  yeast	  Saccharomyces	  cerevesiae	  species.	   In	  yeast,	  de	  novo	  mitochondrial	  Fe-­‐S	  cluster	  formation	  occurs	  on	  the	  scaffold	  protein	  “Isu1”.105,	  107	  Reduced	  sulfur	   is	   provided	   via	   a	   persulfide	   intermediate	   from	   the	   cysteine	   desulfurase	   enzyme	  “Nfs1”,108	   with	   the	   protein	   cofactor	   “Isd11”	   essential	   for	   Nfs1	   activity.109	   Reducing	  equivalents	   for	   Nfs1	   activity	   are	   provided	   by	   the	   ferredoxin	   “Yah1”.110	   Another	   protein,	  frataxin,	   is	  believed	   to	  be	   involved	   in	   this	  process	  as	  an	  allosteric	   regulator	  of	  Nfs1111-­‐113	  and/or	  in	  Fe(II)	  delivery	  to	  Isu1.114-­‐116	  	  Among	   the	   earliest	   goals	   for	   researchers	   studying	   ISC	  was	   to	   reproduce	   the	   Fe-­‐S	  cluster	   forming	  ability	  of	   the	  pathway	   in	  vitro	  using	   isolated	  proteins.	  Agar	  et	  al.105	   	  were	  the	  first	  to	  succesfully	  produce	  an	  Fe-­‐S	  cluster	  on	  apo-­‐Isu1,	  creating	  “FeS-­‐Isu1”,	  in	  vitro	   in	  the	   bacterial	   system,	   and	   this	   work	   was	   adapted	   into	   eukaryotic	   ISC	   by	   the	   Lill117	   and	  Barondeau118	  research	  groups.	  Originally,	  the	  major	  goal	  of	  this	  project	  was	  to	  characterize	  the	   Fe-­‐S	   cluster	   coordination	   site	   of	   the	   scaffold	   protein	   Isu1	   utilizing	   this	   method.	  Specifically,	   we	   set	   out	   to	   identify	   the	   cysteine	   residue	   that	   accepts	   the	   persulfide	  intermediate	  from	  Nfs1.	  Previous	  students	  Andria	  Rodrigues,	  John	  Rotondo,	  and	  myself	  had	  synthesized	   Isu1	   mutant	   plasmid	   constructs	   where	   the	   active-­‐site	   cysteine	   residues	   (at	  positions	  69,	  96,	   and	  139	   in	  yeast)	  were	   substituted	   for	   inert	   alanines.	  We	  hypothesized	  that	   the	   Isu1	   species	   with	   this	   cysteine	   residue	   absent	   would	   be	   uniquely	   unable	   to	  perform	  de	  novo	  Fe-­‐S	  cluster	  formation.	  The	  results	  obtained	  using	  this	  strategy,	  however,	  were	   the	   opposite	   of	   similar	   studies	   reported	   using	   human	   ISC	   proteins.15	   This	   led	   to	  questions	  regarding	  the	  methodology	  and	  further	  investigation	  suggested	  that	  this	  method	  was	  not	  strictly	  measuring	  Fe-­‐S	  cluster	  formation	  on	  Isu1.	  	  
	   22	  
This	  chapter	  describes	  the	  original	  conditions	  that	  were	  used	  for	  FeS-­‐Isu1	  formation	  and	  unexpected	  behavior	  that	  was	  observed	  under	  these	  conditions.	  Data	  provided	  in	  the	  results	   section	   will	   demonstrate	   why	   these	   original	   conditions	   did	   not	   provide	   suitable	  results	  for	  the	  desired	  application.	  Modifications	  that	  were	  made	  to	  the	  FeS-­‐Isu1	  reaction	  conditions	  to	  generate	  the	  “optimal	  conditions”	  for	  FeS-­‐Isu1	  formation	  are	  also	  described	  and	  validated.	  
2.2	  Methods	  
2.2.1	  Protein	  Expression	  and	  Isolation	  	   Expression	  and	  purification	  of	  wild-­‐type	  Isu1	  and	  Nfs1-­‐Isd11	  was	  done	  as	  described	  in	  chapter	  3.	  The	  C69A,	  C96A,	  and	  C139A	  Isu1	  mutants	  were	  synthesized	  via	  site-­‐directed	  mutagenesis	   using	   the	   Quikchange	   Lightning	   kit	   (Agilent).	   21	   basepair	   primers	   were	  ordered	  from	  GENEWIZ	  with	  a	  single	  nucleotide	  mismatch	  at	  the	  location	  corresponding	  to	  the	  appropriate	  CysàAla	  mutation.	  Mutant	  CysàAla	  plasmids	  synthesized	  and	  amplified	  via	   PCR	   were	   sent	   to	   GENEWIZ	   for	   Sanger	   sequencing	   to	   confirm	   successful	   mutation	  propagation.	   Transformation,	   expression,	   and	   isolation	   for	   CysàAla	   Isu1	   mutants	   were	  identical	  to	  that	  done	  for	  wild-­‐type	  Isu1,	  as	  described	  in	  chapter	  3.	  
2.2.2	  Original	  Conditions	  for	  FeS-­‐Isu1	  Formation	  This	  section	  describes	  the	  original	  conditions	  that	  were	  used	  for	  FeS-­‐Isu1	  formation.	  Results	  sections	  2.2.1	  and	  2.2.2	  include	  more	  information	  regarding	  why	  these	  conditions	  were	   flawed	   for	   assessing	   FeS-­‐Isu1	   formation.	   The	   original	   protocol	   for	   converting	   apo-­‐Isu1	   to	   FeS-­‐Isu1	  was	   taken	   from	  Tsai.	   et	   al.118	   This	  method	  was	   intended	   for	   enzymatic	  analysis,	   treating	  the	   Isu1	  scaffold	  as	  an	  enzyme	  for	  Fe-­‐S	  cluster	  production.	  As	  such,	   the	  original	  protocol	  utilized	  excess	   substrate	  under	   the	   following	   solution	  conditions:	  10μM	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Nfs1-­‐Isd11,	   50μM	   Isu1,	   200μM	   Fe,	   and	   5mM	   DTT.	   The	   buffer	   used	   was	   20mM	   HEPES,	  150mM	  NaCl,	  5mM	  BME	  at	  pH=7.5	  at	  room	  temperature.	  Reactions	  were	  made	  to	  a	  1-­‐mL	  volume	   to	   accommodate	   a	   1-­‐cm	   cuvette.	   FeS-­‐Isu1	   transformation	   was	   monitored	   by	  measuring	  visible	  absorption	  at	  427nm	  using	  a	  Cary	  50	  Bio	  UV-­‐visible	  spectrometer	  every	  20	  seconds	   for	  1	  hour	  at	  room	  temperature.	  After	   initiating	   the	  reaction	  with	  addition	  of	  cysteine	   to	  a	   concentration	  of	  250μM,	   reactions	  were	   immediately	   sealed	   in	   the	  cuevette	  within	  the	  glovebox	  and	  transferred	  to	  the	  spectrometer	  for	  analysis.	  	  
2.2.3	  Optimal	  Conditions	  for	  FeS-­‐Isu1	  Formation	  	   This	  section	  describes	  the	  optimal	  conditions	  that	  I	  identified	  for	  FeS-­‐Isu1	  formation.	  The	   results	   section	   2.3.3	   explains	  why	   these	   conditions	   have	   been	   identified	   as	   optimal.	  These	  conditions	  are	  as	  follows:	  10μM	  Nfs1-­‐Isd11,	  50μM	  Isu1,	  75μM	  Fe,	  and	  5mM	  DTT	  in	  20mM	   HEPES,	   500mM	   NaCl,	   5mM	   BME	   buffer	   at	   pH=7.5	   at	   room	   temperature.	   The	  procedure	   is,	   otherwise,	   identical	   to	   that	   of	   the	   original	   method	   with	   reactions	   being	  initiated	   by	   addition	   of	   cysteine	   to	   a	   concentration	   of	   500μM.	   These	   optimal	   conditions	  ultimately	  were	   similar	   to	   the	  methods	   described	   by	  Tsai	  et	  al.,118	   but	  with	   1/4th	   the	   Fe	  concentration	  and	  twice	  the	  apo-­‐Isu1	  concentration.	  The	  optimal	  method	  also	  uses	  circular	  dichroism	   (CD)	   spectroscopy	   in	   place	   of	   visible	   absorption	   spectroscopy.	   CD	   data	   was	  collected	  using	  a	   Jasco	   J-­‐1500	  spectropolarimeter	  with	  1cm	  cuvette	   collecting	  data	  every	  20	  seconds	  at	  560nm	  for	  50	  minutes	  at	  room	  temperature.	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2.3	  Results	  
2.3.1	   Original	   FeS-­‐Isu1	   Formation	   Method	   Unable	   to	   Identify	   Persulfide-­‐Accepting	  
Cysteine	  of	  Isu1	  FeS-­‐Isu1	   formation	   using	   the	   C69A,	   C96A,	   and	   C139A	   Isu1	   mutants	   under	   the	  original	   FeS-­‐Isu1	   conditions	   revealed	   all	   Isu1	   species	   had	   reduced	   ability	   to	   form	   Fe-­‐S	  clusters	   (Figure	   2.1).	   While	   the	   reduction	   in	   FeS-­‐Isu1	   formation	   was	   appreciable,	   there	  remained	   a	   significant	   increase	   in	   absorbance	   at	   427nm,	   corresponding	   to	   Fe-­‐S	   cluster	  formation,	  in	  all	  Isu1	  species.	  Our	  hypothesis	  was	  that	  the	  Isu1	  mutant	  species	  lacking	  the	  persulfide-­‐accepting	  cysteine	  residue	  would	  be	  uniquely	  unable	  to	  transform	  into	  FeS-­‐Isu1.	  Thus,	   the	   original	   FeS-­‐Isu1	   method	   had	   failed	   to	   identify	   a	   unique	   persulfide	   accepting	  cysteine	   in	   Isu1.	  Alternative	  methods	   for	   these	  studies	  were	  considered,	   such	  as	  utilizing	  the	  “hot”	  S35	  cysteine	  technique,113	  but	  never	  pursued.	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Figure	   2.1:	   FeS-­‐Isu1	   formation	   for	   various	   Isu1	   mutants.	   Wild	   type	   (red),	   C69A	   (blue),	  C96A	  (green),	  and	  C139A	  (black).	  Note	  all	  Cys2His1Ala1-­‐Isu1	  mutants	  maintain	  some	  Fe-­‐S	  cluster	  forming	  ability.	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2.3.2	  Secondary	  Species	  Forms	  During	  FeS-­‐Isu1	  Formation	  Using	  Original	  Conditions	  	   Observations	  made	  using	  the	  original	  FeS-­‐Isu1	   formation	  method	  suggested	  that	  a	  secondary	  reaction	  was	  occurring.	  One	  observation	  made	  under	  the	  original	  conditions	  was	  that	  the	  increased	  absorbance	  observed	  during	  FeS-­‐Isu1	  formation	  was	  not	  specific	  to	  the	  chromaphore	   associated	  with	   an	   Fe-­‐S	   cluster	   at	   427nm.	   This	   observation	  was	   not	  made	  with	   chemical	   delivery	   of	   sulfur	   to	   Isu1	   (via	   Na2S)	   indicating	   distinct	   differences	   in	   the	  cluster	  formation	  reaction	  mechanisms	  under	  protein	  driven	  events.120	  Instead,	  there	  was	  a	  uniform	  increase	  in	  absorption	  present	  at	  all	  wavelengths	  (Figure	  2.2).	  The	  upward	  shift	  in	  the	  absorption	  spectra	  was	  consistent	  with	  an	  increase	  in	  light-­‐scattering,	  possibly	  due	  to	  a	  precipitation	   of	   some	   reaction	  materials.	   After	   consultation	   and	   literature	   review,	   it	  was	  deduced	   that	   this	   species	   is	   most	   likely	   an	   insoluble	   or	   semi-­‐soluble	   FeS-­‐mineral	   not	  associated	   to	   protein.111	   A	   similar	   species	   was	   mentioned	   briefly	   in	   the	   literature	   as	   a	  byproduct	  of	  FeS-­‐Isu1	  formation,105	  but	  had	  not	  been	  adequately	  explained.	  It	  was	  possible	  that	   FeS-­‐Isu1	   formation	   and	   FeS	   mineralization	   were	   occurring	   simultaneously,	   but	  attempts	  to	  separate	  FeS-­‐mineral	  from	  the	  reaction	  mixture	  were	  unsuccessful.	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Figure	   2.2:	   Non-­‐specific	   increase	   light-­‐scattering	   observed	   using	   original	   FeS-­‐Isu1	  formation	  method	  suggests	  precipitation	  of	  reaction	  materials.	  Entire	  absorption	  spectrum	  shifts	  up	  from	  time	  =	  0	  (gray)	  to	  time	  =40	  minutes	  (black	  solid).	  Intermediate	  spectra	  are	  provided	  (black	  dashed)	  in	  5	  minute	  intervals.	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2.3.3	  Optimization	  of	  FeS-­‐Isu1	  Formation	  Method	  After	   identifying	   problems	   with	   the	   FeS-­‐Isu1	   formation	   method,	   we	   investigated	  modifications	  to	  the	  protocol	  in	  order	  to	  maximize	  yield	  of	  FeS-­‐Isu1,	  minimize	  FeS-­‐mineral	  production,	   and	   afterwards	   rigorously	   validate	   the	   new	  method.	   Visible	   absorption	   was	  replaced	  with	  circular	  dichroism	  (CD)	  spectroscopy	  because	  CD	  is	  insensitive	  to	  formation	  of	  the	  FeS-­‐mineral	  species	  and	  2Fe2S-­‐clusters	  have	  a	  characeristic	  CD	  signal	  between	  300-­‐700nm121	   (see	   Chapter	   3).	   Addition	   of	   excess	   exogenous	  apo-­‐Isu1	   to	   limiting	  Nfs1-­‐Isd11	  results	  in	  successful	  FeS-­‐Isu1	  formation.	  Analysis	  of	  the	  FeS-­‐Isu1	  product	  via	  CD	  produces	  a	  spectra	  similar	  to	  that	  found	  for	  the	  2Fe2S-­‐protein	  Yah1110	  (Chapter	  3)	  and	  the	  human	  wild	  type	  FeS-­‐ISCU111	   found	   in	   the	   literature.	  To	  assess	   if	   the	  product	   is	   truly	   an	  Fe-­‐S	   cluster,	  necessary	   components	   were	   systematically	   excluded	   one	   by	   one	   from	   the	   FeS-­‐Isu1	  formation	   reaction	   (Figure	   2.3).	   apo-­‐Isu1,	   Nfs1-­‐Isd11,	   DTT,	   cysteine,	   and	   Fe2+	   are	   all	  necessary	  to	  observe	  this	  signal,	  consistent	  with	  the	  presumed	  necessary	  components	  for	  Fe-­‐S	   cluster	   formation.3	   One	   important	   note	   is	   that	   FeS-­‐Isu1	   formation	   can	   occur	   at	   a	  reduced	  rate	  in	  the	  absence	  of	  DTT	  if	  the	  amount	  of	  cysteine	  is	  increased	  10-­‐fold	  (to	  5mM),	  matching	   the	   original	   DTT	   concentration	   (data	   not	   shown).	   	   The	   CD	   signal	   observed	  depends	  directly	  on	   the	  starting	  concentration	  of	  apo-­‐Isu1,	  which	  was	  not	   the	  case	  using	  the	  original	  conditions	  (Figure	  2.4).	  After	  performing	  successful	  FeS-­‐Isu1	  formation,	  this	  reaction	  was	  further	  studied	  to	  identify	  additional	  changes	  that	  would	   increase	  the	  yield	  of	  Fe-­‐S	  clusters	  and	  reduce	  side	  reactions.	   In	  addition	  to	  the	  use	  of	  circular	  dichroism,	  two	  other	   important	  changes	  were	  made.	  First,	  the	  Fe	  concentration	  was	  reduced	  to	  75μM.	  By	  varying	  the	  amount	  of	  Fe(II)	  in	  the	   reaction,	   it	  was	  observed	   that	  excess	  Fe(II)	  unexpectedly	   inhibits	  FeS-­‐Isu1	   formation	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using	   the	   Isu1	  ortholog	   from	  Drosophila	  melanogaster	   (Chapter	  3).	  This	  effect	   is	  possibly	  due	  to	  the	  FeS-­‐mineral	  side-­‐reaction	  competing	  for	  reduced	  sulfur	  with	  Fe-­‐Isu1.	  Under	  sub-­‐stoichiometric	  Fe	  levels,	  the	  effect	  from	  this	  side-­‐reaction	  is	  kept	  minimal.	  	  Second,	  the	  salt	  concentration	  of	  the	  experimental	  buffer	  was	  increased	  to	  500mM	  NaCl.	  Unexpectedly,	  salt	  has	  a	  dramatic	   effect	  on	   the	   role	  of	   frataxin	   in	   this	   reaction	   (see	  Chapter	  5)	   and	   frataxin	  stimulation	  requires	  500mM	  NaCl	  conditions.	  Using	  the	  described	  optimal	  conditions,	   the	  non-­‐specific	   increase	   in	   absorbance	   during	   FeS-­‐Isu1	   formation	   is	   minimal,	   suggesting	  reduced	  FeS	  mineralization	  is	  occurring	  compared	  to	  the	  original	  method	  (Chapter	  3).	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Figure	   2.3:	   Isu1,	   Nfs-­‐Isd11,	   DTT,	   Cysteine,	   and	   Fe	   are	   required	   for	   FeS-­‐Isu1	   formation	  under	   optimal	   conditions.	   50μM	   Isu1,	   10μM	   Nfs1-­‐Isd11,	   5mM	   DTT,	   75μM	   Fe,	   500μM	  cysteine	  (black),	  Fe	  excluded	  (pink),	  cysteine	  excluded	  (red),	  Nfs1-­‐Isd11	  excluded	  (green),	  Isu1	  excluded	  (blue),	  and	  DTT	  excluded	  	  (cyan).	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Figure	  2.4:	  FeS-­‐Isu1	  formation	  for	  varying	  apo-­‐Isu1	  concentrations	  using	  the	  original	  FeS-­‐Isu1	   formation	  method	   (A)	   compared	   to	   the	   optimal	  method	   (B).	   No	   Isu1	   (red),	   1xIsu1	  (blue),	  2xIsu1	  (green).	  Under	  optimal	  conditions,	   the	  Fe-­‐S	  cluster	  signal	  depends	  directly	  on	  the	  concentration	  of	  apo-­‐Isu1.	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2.4	  Discussion	  
2.4.1	  Active-­‐site	  Cysteines	  Essential	  for	  Fe-­‐S	  cluster	  Coordination	  on	  Isu1	  After	   further	   literature	   review,	   it	   was	   recognized	   that	   in	   addition	   to	   accepting	  persulfide,	   cysteine	   residues	   of	   Isu1	   have	   a	   critical	   role	   in	   Fe-­‐S	   cluster	   coordination.122	  Therefore,	  the	  finding	  that	  all	  CysàAla	  Isu1	  had	  retained	  Fe-­‐S	  cluster	  forming	  ability	  using	  the	  original	  FeS-­‐Isu1	   formation	  method	  were	  difficult	   to	   reconcile	  with	  established	  basic	  understandings	  for	  how	  ISC	  functions.	  These	  results	  called	  into	  question	  the	  original	  FeS-­‐Isu1	   formation	   method	   and	   this	   led	   to	   further	   investigation	   for	   a	   protocol	   to	   more	  accurately	   monitor	   Fe-­‐S	   cluster	   assembly.	   Furthermore,	   Bridwell-­‐Rabb	   et	   al.	   performed	  similar	  experiments	  with	   the	  human	   Isu1	  ortholog	  and	   found	   the	  opposite	   result	   that	  all	  CysàAla	   Isu1	   mutants	   were	   completely	   unable	   to	   form	   FeS-­‐Isu1.119	   This	   work	   did,	  however,	   identify	   a	   unique	   persulfide-­‐accepting	   cysteine	   using	   a	   method	   involving	  radioactive	  S35-­‐labeled	  cysteine	  and	  not	  FeS-­‐Isu1	  formation.119	  	  The	  original	  hypothesis	  for	  a	  uniquely	  inactive	  CysàAla	  Isu1	  mutant	  may	  have	  been	  misguided.	   It	   is	   unlikely	   that	   any	   of	   the	   CysàAla	   Isu1	  mutants	   can	   produce	   stable	   Fe-­‐S	  clusters,	   because	   in	   addition	   to	   accepting	   persulfide,	   cysteine	   is	   a	   critical	   component	   for	  coordination	   of	   the	   Fe	   in	   the	   Fe-­‐S	   cluster.122	  While	   most	   FeS-­‐proteins	   utilize	   4	   cysteine	  residues	   for	   cofactor	   coordination,123	   Isu1	   utilizes	   3	   cysteines	   and	   1	   histidine.124	   This	  Cys3His1	  coordination	  results	  in	  a	  less-­‐stable	  cluster	  that	  facilitates	  Fe-­‐S	  cluster	  delivery.124	  In	   the	   CysàAla	   Isu1	   mutants,	   however,	   there	   are	   only	   be	   2	   cysteine	   residues	   and	   1	  histidine	  and	  this	  likely	  is	  not	  sufficient	  for	  Fe-­‐S	  cluster	  coordination.	  Therefore,	  all	  of	  the	  CysàAla	  Isu1	  mutants	  probably	  should	  have	  been	  inactive,	  but	  it	  was	  conversely	  observed	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they	  all	  had	  retained	  activity.	  This	  contradictory	  finding	  led	  to	  questions	  about	  the	  validity	  of	  the	  original	  FeS-­‐Isu1	  formation	  method	  that	  was	  used.	  	  
2.4.2	  Identifying	  FeS-­‐Mineral	  Secondary	  Species	  During	  FeS-­‐Isu1	  Formation	  	  The	  most	  likely	  explanation	  for	  the	  unexpected	  behavior	  of	  the	  FeS-­‐Isu1	  formation	  method	  was	  the	  presence	  of	  a	  FeS-­‐mineralization	  side-­‐reaction.	  This	  FeS-­‐mineral	   is	   likely	  an	   insoluble	   or	   semi-­‐soluble	   Fe-­‐S	   species	   that	   is	   not	   associated	   to	   protein.125	   This	   was	  deduced	  after	  making	  several	  observations	  on	  the	  original	  method	  for	  FeS-­‐Isu1	  formation.	  First,	   the	   increase	   in	   absorbance	   was	   not	   specific	   to	   the	   Fe-­‐S	   cluster	   chromaphore	   at	  427nm	   (Figure	  2.2),	   but	  was	   almost	   identical	   at	   any	  wavelength,	   consistent	  with	   a	   light-­‐scattering	  phenomenon.126	  Second,	   the	  FeS-­‐Isu1	  absorption	  signal	  observed	  did	  not	  seem	  to	   depend	   directly	   on	   the	   starting	   concentration	   of	   apo-­‐Isu1	   (Figure	   2.3).	   It	   was	   very	  irregular	  to	  find	  that	  the	  yield	  of	  FeS-­‐protein	  produced	  was	  not	  directly	  proportional	  to	  the	  amount	  of	  apo-­‐protein	  added.	  In	  fact,	  Isu1	  could	  be	  completely	  excluded	  and	  a	  significant	  amount	   of	   apparent	   FeS-­‐Isu1	   formation	   was	   still	   observed	   by	   the	   original	   method.	  Formation	   of	   the	   FeS-­‐mineral	   also	   could	   explain	   why	   all	   CysàAla	   Isu1	   mutants	   had	  retained	   Fe-­‐S	   cluster	   forming	   ability.	   A	   similar	   FeS-­‐mineral	   byproduct,	   termed	   “High	  Molecular	  Weight	  Species”,	  was	  identified	  in	  Fox	  et	  al.	  while	  studying	  human	  ISC.125	  
2.4.3	  Behavior	  of	   FeS-­‐Isu1	  Formation	  Under	  Optimal	  Conditions	   is	  Consistent	  With	  
Fe-­‐S	  cluster	  Formation	  Under	   the	   described	   optimal	   conditions,	   the	   behavior	   of	   the	   FeS-­‐Isu1	   formation	  reaction	   is	   consistent	   with	   de	   novo	   Fe-­‐S	   cluster	   formation	   on	   the	   scaffold	   Isu1.	   The	  requirement	   for	   DTT,	   cysteine,	   apo-­‐Isu1,	   Nfs1-­‐Isd11,	   and	   Fe2+	   reagents	   in	   FeS-­‐Isu1	  formation	  is	  consistent	  with	  reports	  from	  human,118	  yeast,127	  and	  bacterial105	  ISC.	  This	  was	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not	  the	  case	  using	  the	  original	  method,	  where	  apo-­‐Isu1	  could	  be	  excluded	  and	  a	  significant	  Fe-­‐S	  cluster	  signal	  would	  still	  develop	  (Figure	  2.3).	  One	  notable	  exception	  to	  these	  required	  reagents	   is	   frataxin,	   which	   has	   been	   previously	   reported	   is	   necessary	   for	   FeS-­‐Isu1	  formation	  when	  using	  sodium	  sulfide	   in	  place	  of	  Nfs1-­‐Isd11	  and	  cysteine.115	  The	  product	  from	  the	  FeS-­‐Isu1	  reaction,	  obtained	  using	  the	  Isu1	  ortholog	  from	  Drosophila	  melanogaster,	  will	  be	  further	  characterized	  in	  Chapter	  3.	  
2.4.4	  Significance	  of	  Competing	  FeS-­‐Mineralization	  During	  FeS-­‐Isu1	  Formation	  There	  are	  significant	  implications	  for	  the	  identification	  of	  FeS-­‐mineralization	  during	  
in	   vitro	   FeS-­‐Isu1	   formation	   reactions.	   In	   various	   literature	   articles	   that	   utilize	   visible	  absorption	  spectroscopy,	  it	  has	  been	  reported	  that	  FeS-­‐Isu1	  formation	  demonstrates	  a	  ‘bi-­‐phasic’	   pattern.	   This	   bi-­‐phasic	   pattern	   has	   been	   interpreted	   differently	   among	   different	  researchers.	   Some	   researchers	   believe	   the	   second	   phase	   is	   associated	   with	   FeS-­‐Isu1	  formation,117	  while	  others	  believe	  FeS-­‐Isu1	  formation	  occurred	  during	  the	  first	  phase.128	  To	  our	  knowledge,	  no-­‐one	  has	  been	  able	  to	  explain	  what	  creates	  this	  bi-­‐phasic	  pattern.	  These	  results	  suggest	  that	  this	  bi-­‐phasic	  pattern	  is	  the	  result	  of	  simultaneous	  FeS-­‐Isu1	  formation	  and	  FeS-­‐mineralization	  pathways,	  where	  the	  first	  phase	  is	  FeS-­‐Isu1	  formation	  followed	  by	  the	  second	  phase	  of	  FeS-­‐mineralization.	  To	  support	  this,	  circular	  dichroism	  studies	  of	  FeS-­‐Isu1	   formation	   identify	  mono-­‐phasic	   behavior	   that	   begins	   immediately	   upon	   addition	   of	  cysteine	  (Figure	  2.3).	  Also	  note	  that	  FeS-­‐mineralization	  in	  the	  absence	  of	  Isu1	  (see	  Chapters	  3	   and	  4)	  produces	   a	  dramatic	   increase	   in	   absorption	   following	   a	  ~10	  minute	   lag	  period.	  Second,	  there	  have	  been	  reports	  that	  excess	  Fe2+	  inhibits	  FeS-­‐Isu1	  formation	  for	  unknown	  reasons.23	   This	   work	   suggests	   a	   model	   that	   can	   explain	   this	   behavior	   where	   free	   Fe2+	  competes	  for	  reduced	  sulfur	  with	  Fe-­‐Isu1	  (see	  Chapter	  4).	  
	   35	  
CHAPTER	  3:	  IN	  VITRO	  CHARACTERIZATION	  OF	  A	  NOVEL	  ISU	  
HOMOLOGUE	  FROM	  DROSOPHILA	  MELANOGASTER	  FOR	  DE	  NOVO	  FE-­‐S	  
CLUSTER	  FORMATION.	  
	  
3.0	  Prelude	  	   While	  investigating	  the	  FeS-­‐Isu1	  formation	  method	  described	  in	  Chapter	  2,	  I	  began	  to	  utilize	   the	   fly	   Isu1	  ortholog,	   “fIscU”,	  as	   it	  had	  demonstrated	   favorable	  stability	  over	   its	  yeast	  counterpart.	   	  Former	  graduate	  students	  Dr.	  Kalyan	  Kondapalli	  and	  Dr.	  Swati	  Rawat	  had	   previously	   characterized	   this	   protein,	   but	   none	   of	   their	   results	   had	   ever	   been	  published.	   In	   particular,	   Chapter	   3	   of	   Dr.	   Rawat’s	   dissertation	   contained	   several	   fIscU	  experiments	  that	  could	  serve	  as	  a	  springboard	  for	  my	  own	  studies.	  As	  I	  was	  struggling	  with	  my	   own	   project,	   characterization	   of	   fIscU	   seemed	   like	   a	   logical	   alternative.	   During	   the	  course	   of	   this	   work,	   I	   visited	   Dr.	   Andrew	   Dancis’s	   laboratory	   at	   the	   University	   of	  Pennsylvania	  to	  conduct	  fIscU	  complementation	  studies	  with	  yeast	  in	  vivo	  with	  the	  help	  of	  Dr.	  Agostinho	  Rocha.	  This	  chapter	  contains	  a	  manuscript	  in	  preparation	  for	  submission	  to	  the	  journal	  Biochemistry.	  Except	  for	  the	  in	  vivo	  component	  of	  the	  paper,	  the	  entire	  rest	  of	  the	   paper	   was	   written	   by	   me.	   This	   article	   has	   been	   a	   collaborative	   effort	   between	   the	  following	  co-­‐authors:	  
Stephen	  P.	  Dzul	  ‡,	  Agostinho	  G	  Rocha#,	  Swati	  Rawat	  ‡,	  Ashoka	  Kandegadara‡,	  April	  Kusowski‡,	  
Andrew	  Dancis#,	  Timothy	  L.	  Stemmler	  ‡*	  
Wayne	   State	   University,	   Biochemistry	   and	   Molecular	   Biology‡,	   University	   of	   Pennsylvania,	  
Department	  of	  Hematology#	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3.1	  Abstract	  Fe-­‐S	   clusters	   are	   iron-­‐containing	   cofactors	   utilized	   by	   numerous	   proteins	   within	  several	  biological	  pathways	  essential	   to	   life.	   In	  eukaryotes,	   the	  primary	  pathway	   for	  Fe-­‐S	  cluster	   production	   is	   the	   iron-­‐sulfur	   cluster	   (ISC)	   pathway.	   The	   ISC	   pathway,	   localized	  primarily	   within	   the	   mitochondria,	   has	   been	   extensively	   characterized	   within	  
Saccharomyces	  cerevisiae.	  In	  yeast,	  de	  novo	  Fe-­‐S	  cluster	  formation	  is	  accomplished	  through	  coordinated	  assembly	  of	   the	  substrates	   iron	  and	  sulfur	  on	   the	  primary	  scaffold	  assembly	  protein	  “Isu1”.	  The	  sulfur	  used	  for	  cluster	  assembly	  is	  provided	  by	  the	  cysteine	  desulfurase	  “Nfs1”,	   a	   protein	   that	  works	   in	   union	  with	   its	   accessory	   protein	   “Isd11”.	   Frataxin	   “Yfh1”	  helps	  direct	  cluster	  assembly	  by	  serving	  as	  a	  modulator	  of	  Nfs1	  activity,	  by	  assisting	  in	  the	  delivery	  of	  Fe(II)	  to	  Isu1,	  or	  more	  likely	  through	  a	  combination	  of	  roles.	  In	  vitro	  studies	  on	  the	   yeast	   ISC	   system	   have	   been	   limited,	   however,	   due	   to	   the	   inherent	   instability	   of	  recombinant	  Isu1,	  a	  molecule	  prone	  to	  degradation	  and	  aggregation	  in	  vitro.	  To	  circumvent	  Isu	   stability	   issues,	   a	   recent	   report	   replaced	   yeast	   Isu1	   with	   a	   homolog	   from	   the	  thermophilic	   fungus	  Chaetomium	  thermophilum,	   facilitating	   novel	   experimentation	   of	   the	  pathway.	  There	  are	  concerns,	  however,	  regarding	  the	  validity	  of	  replacing	  yeast	  Isu1	  with	  different	   Isu1	  orthologs.	  Given	  the	  unique	  utility	  of	  proteins	  within	   the	   fly	  model	  system,	  we	   were	   interested	   in	   pursuing	   a	   similar	   strategy	   by	   replacing	   yeast	   Isu1	   with	   the	   fly	  ortholog	  in	  order	  to	  stabilize	  our	  in	  vitro	  ISC	  assembly	  system	  and	  assist	  us	  in	  elucidating	  molecular	  details	  of	  the	  yeast	  ISC	  pathway.	  Our	   lab	   previously	   observed	   that	   recombinant	   frataxin	   from	   Drosophila	  
melanogaster	  has	  remarkable	  stability	  compared	  to	  Yfh1.	  Here	  we	  have	  provided	  the	  first	  characterization	   of	  D.	  melanogaster	   Isu1	   (fIscU)	   and	   demonstrated	   its	   ability	   to	   function	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within	  the	  yeast	  ISC	  machinery	  both	   in	  vivo	  and	   in	  vitro.	   Interestingly,	  fIscU	  demonstrates	  increased	   stability	   compared	   to	   yeast	   Isu1,	   and	   increased	   yield	   when	   expressed	  recombinantly	   in	   bacteria.	   As	   expected	   based	   on	   their	   high	   sequence	   conservation,	  recombinant	   fIscU	   has	   similar	   physical	   properties	   to	   yeast	   Isu1,	   functioning	   as	   a	   stable	  dimer	  with	  similar	  Fe(II)	  affinity	  and	  ability	  to	  form	  two	  2Fe-­‐2S	  clusters	  per	  dimer.	  Upon	  inspection,	   fIscU	  and	  yeast	   ISC	  proteins	  are	  compatible	   in	  vitro;	  addition	  of	  Yfh1	   to	  Nfs1-­‐Isd11	  increases	  the	  rate	  of	  Fe-­‐S	  cluster	  formation	  on	  fIscU	  to	  a	  similar	  extent	  as	  observed	  with	  yeast	  Isu1.	  Finally,	  fIscU	  expressed	  in	  mitochondria	  of	  a	  yeast	  strain	  lacking	  Isu1	  (and	  its	   paralog	   Isu2)	   is	   able	   to	   completely	   reverse	   the	   deletion	   phenotypes.	   These	   results	  demonstrate	  fIscU	  can	  functionally	  replace	  yeast	  Isu1	  and	  it	  can	  serve	  as	  a	  powerful	  tool	  for	  exploring	  molecular	  details	  within	  the	  yeast	  ISC	  pathway,	  both	  in	  vivo	  and	  in	  vitro.	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3.2	  Introduction	  Fe-­‐S	   cluster	   cofactors	   are	   ubiquitous	   in	   biology	   and	   play	   integral	   roles	   in	   nearly	  every	  biochemical	  pathway.	   In	   recent	  years,	   several	  human	  diseases	  have	  been	   linked	   to	  dysfunctional	   Fe-­‐S	   cluster	   metabolism,	   including	   Friedreich’s	   ataxia129-­‐130	   and	   IscU	  myopathy.131-­‐132	  Research	  at	  the	  molecular	  level	  into	  the	  Fe-­‐S	  cluster	  production	  pathway	  is	  paramount	  to	  understanding	  disease	  pathology	  within	  these	  and	  related	  disorders.	  Since	  both	   free	   iron	   and	   sulfur	   are	   toxic	   in	   abundance,	   production	  of	   Fe-­‐S	   clusters	  must	   occur	  within	  cells	  in	  a	  tightly	  regulated	  manner.	  In	  eukaryotes,	  the	  core	  pathway	  for	  Fe-­‐S	  cluster	  production	   is	   the	   iron-­‐sulfur	   cluster	   (ISC)	   pathway.	   This	   pathway	   is	   localized	   primarily	  within	  the	  mitochondria133	  and	  is	  essential	  for	  the	  formation	  of	  all	  cellular	  Fe-­‐S	  clusters.134	  
In	   vivo	   yeast	   ISC	   studies	   have	   provided	   molecular	   and	   genetic	   insight	   into	   how	   this	  pathway	   functions.	   In	   Saccharomyces	   cerevisiae,	   de	   novo	   mitochondrial	   Fe-­‐S	   cluster	  formation	   occurs	   on	   the	   scaffold	   protein	   “Isu1”,	   which	   provides	   the	   architecture	   for	  cofactor	   assembly.135-­‐136	   The	   cysteine	   desulfurase	   “Nfs1”,	   when	   in	   combination	   with	   its	  accessory	   protein	   partner	   “Isd11”,	   provides	   sulfur	   for	   cluster	   assembly.137-­‐138	   The	  ferredoxin	  “Yah1”	  provides	  reducing	  equivalents	  to	  direct	  and	  stabilize	  cofactor	  assembly	  and	  to	  reduce	  sulfur	  and	  perhaps	  iron	  cofactors.139	  	  Frataxin	  “Yfh1”,	  an	  allosteric	  regulator	  of	   ISC,140-­‐141	   helps	   facilitate	   Fe	   delivery	   to	   Isu1	   by	   possibly	  mediating	   iron	   binding	   onto	  Isu1142-­‐143	   or	   by	   serving	   in	   a	   yet	   uncharacterized	   manner.	   These	   proteins	   work	   in	   a	  coordinated	   manner	   to	   assemble	   Fe-­‐S	   cluster	   intermediates	   onto	   Isu1,	   however	   the	  molecular	  details	  of	  this	  process	  are	  still	  poorly	  understood.	  	  Investigative	   studies	   of	   the	   S.	   cerevisiae	   ISC	   pathway	   in	  vitro	   have	   provided	   some	  insights	   into	  mitochondrial	   Fe-­‐S	   cluster	   assembly.134	   	  These	   studies,	   however,	   have	   been	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hampered	   due	   to	   the	   instability	   of	   recombinant	   Isu1,	  which	   has	   relatively	   low	   solubility	  and	   is	   prone	   to	   spontaneous	   aggregation.139	   Recently,	   Webert	   et	   al	   circumvented	   this	  limitation	  within	  their	  yeast	  characterizational	  studies	  by	  replacing	  S.	  cerevisiae	  Isu1	  with	  the	   thermophilic	   ortholog	   from	   Chaetomium	   thermophilum.139	   While	   Isu1	   ortholog	  replacement	   facilitated	  novel	  experimentation	   in	  this	  system,	  there	   is	  a	  potential	  concern	  regarding	  incomplete	  complementation	  between	  the	  S.	  cerevisiae	  and	  C.	  thermophilum	   ISC	  molecular	  partners.	  A	  recent	  study	  demonstrating	  that	  frataxin,	  a	  central	  component	  of	  ISC,	  functions	   differently	   in	   the	   yeast	   and	   bacterial	   systems144	   highlights	   these	   concerns.	  Previous	  characterizational	  studies	  on	  the	  frataxin	  ortholog	  from	  Drosophila	  melanogaster,	  “Dfh”,	   found	   that	   this	  protein	  behaves	  highly	   similarly	   to	  Yfh1,	  however	   it	   had	  enhanced	  stability.143	   In	   this	  current	  article,	  we	  characterize	  an	   Isu1	  ortholog	   from	  D.	  melanogaster	  “fIscU”	   and	   compare	   it	   to	   the	   S.	   cerevisiae	   Isu1	   ortholog,	   “yIsu1”	   with	   regards	   to	   its	  biophysical	  properties	  and	  functionality	  related	  to	  cluster	  assembly.	  We	  demonstrate	  that	  fIscU	  is	  functionally	  active	  in	  mediating	  Fe-­‐S	  cluster	  assembly	  and	  is	  able	  to	   interact	  with	  yeast	   ISC	  proteins	  both	   in	  vitro	  and	   in	  vivo.	  Our	  data	  support	   the	  Webert	  results	  of	   the	  C.	  
thermophilum	   ISC	   characterizational	   studies	   and	  provide	   an	   additional,	   and	  highly	   stable	  Isu	  ortholog,	  which	  can	  be	  used	  to	  further	  investigate	  the	  yeast	  ISC	  system.	  
3.3	  Methods	  
3.3.1	  Protein	  Expression	  and	  Purification.	  
S.	   cerevisiae	   Isu1	   (yIsu1),	   Nfs1-­‐Isd11,	   Yfh1,	   Yah1,	   Nfs1-­‐Isd11-­‐yIsu1-­‐Yfh1	   complex,	  and	   D.	  melanogaster	   Isu	   (fIscU)	   were	   expressed	   in	   E.	   coli	   and	   purified	   in	   the	   following	  manner.	  Plasmid	  constructs	  were	  synthesized	  for	  each	  respective	  protein	  as	  follows:	  fIscU	  and	   yIsu1	   vectors	   were	   prepared	   in	   pET151/D-­‐TOPO	   (ThermoFisher),	   Nfs1-­‐Isd11	   in	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pST39145	  (Addgene),	  Yfh1	  in	  pCOLAduet	  (Novagen),	  and	  Yah1	  in	  pET21b	  (Novagen).	  Cells	  with	   the	   pET151/D-­‐TOPO,	   pST39,	   and	   pET21b	   plasmids	   were	   grown	   in	   100	   µg/mL	  ampicillin;	   cells	   with	   pCOLAduet	   were	   grown	   in	   50	   µg/mL	   kanamycin.	   All	   constructs	  contained	   a	   6xHis-­‐tag	   on	   either	   the	   C-­‐	   (Yfh1,	   yIsu1,	   Nfs1,	   Yah1)	   or	   N-­‐	   (fIscU)	   terminus.	  Plasmids	   were	   transformed	   into	   competent	   cells	   via	   heat-­‐shock	   at	   42oC	   for	   30	   seconds.	  Optimal	  growth	  conditions	  were	  identified	  for	  each	  respective	  protein.	  Individual	  proteins	  (yIsu1,	   Yfh1,	   and	   the	   Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	   complex)	   were	   expressed	   in	   BL21-­‐RIL	  competent	   cells146	   (Agilent),	   Nfs1-­‐Isd11	   and	   fIscU	   was	   expressed	   in	   BL21-­‐DE3	   cells	  (Agilent),	  and	  Yah1	  was	  expressed	  in	  C41	  cells	  (Lucigen).	  Cells	  with	  yIsu1,	  Yfh1,	  Yah1,	  and	  Nfs1-­‐Isd11-­‐yIsu1-­‐Yfh1	  plasmids	  were	  grown	  to	  an	  optical	  density	  (OD)	  ~0.6,	  induced	  with	  0.8	  mM	  IPTG,	  and	  incubated	  for	  3	  hours	  at	  37°C.	  Nfs1-­‐Isd11	  expressing	  cells	  were	  induced	  at	  OD	  ~0.4	  and	  incubated	  for	  18	  hours	  at	  18°C.	  PLP	  was	  added,	  to	  a	  final	  concentration	  of	  10µM,	  to	  Nfs1-­‐Isd11	  and	  Nfs1-­‐Isd11-­‐yIsu1-­‐Yfh1	  cells	  at	  the	  time	  of	  induction.	  The	  protein	  fIscU	   was	   expressed	   using	   an	   auto-­‐induction	   protocol147	   utilizing	   inoculation	   into	   ZYP-­‐5052	   rich	   media	   at	   27oC	   for	   24	   hours.	   After	   harvesting,	   cells	   were	   lysed	   using	   an	  Emulsiflex-­‐C3	  homogenizer	  (AVESTIN).	  Lysis	  buffer	  for	  yIsu1,	  fIscU,	  Yfh1,	  Nfs1-­‐Isd11,	  and	  Yah1	   included	  50mM	  Sodium	  Phosphate	   (NaPi),	   300mM	  NaCl,	   and	  20mM	   imidazole.	  The	  lysis	   buffer	   for	   Nfs1-­‐Isd11-­‐yIsu1-­‐Yfh1	   complex	   purification	   was	   20mM	   HEPES,	   150mM	  NaCl,	  and	  20mM	  imidazole.	  Lysate	  was	  centrifuged	  at	  21	  krpm	  for	  45	  minutes.	  The	  soluble	  fraction	  was	  decanted	  and	   filtered	  before	  being	   run	   through	  a	  Ni-­‐column.	  The	  Ni-­‐column	  was	   then	  washed	  with	  5	   column	  volumes	  of	   50mM	   imidazole	  buffer	   to	   remove	  bacterial	  proteins.	   The	   His-­‐tagged	   target	   protein	   was	   eluted	   with	   5x	   column	   volumes	   of	   200mM	  imidazole	  buffer.	  After	  elution	  from	  the	  Ni-­‐column,	  the	  protein	  was	  concentrated	  to	  ~2	  mL	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via	  a	  10	  kDa	  cutoff	  membrane	  Amicon	  centricon	  and	  run	  on	  a	  gel	  filtration	  column	  where	  buffer	  was	  switched	  to	  the	   final	  experimental	  buffer.	  The	  experimental	  buffer	  was	  20mM	  HEPES	   at	   pH=7.5	  with	  differing	   amounts	   of	   salt	   depending	  on	  protein	   species.	   For	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	  this	  was	  50mM	  NaCl,	  for	  Nfs1-­‐Isd11,	  Yfh1,	  Yah1	  this	  was	  150mM	  NaCl,	  and	  for	  yIsu1	  and	  fIscU	  this	  was	  300mM	  NaCl.	  The	  proteins	  fIscU,	  yIsu1,	  Yah1,	  and	  Yfh1	  were	  run	  on	  a	  S75	  size	  exclusion	  column,	  while	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	  and	  Nfs1-­‐Isd11	  were	  run	  on	   a	   S200	   size	   exclusion	   column.	   Purified	   fractions	   were	   pooled	   and	   concentrated	   via	  Amicon	   centrifugation.	   Protein	   concentration	   was	   determined	   using	   a	   Direct-­‐detect	   IR	  spectrometer148	  (Millipore)	  and	  protein	  purity	  was	  assessed	  via	  SDS-­‐PAGE.	  Typical	  protein	  purities	  were	  ~95%.	   Concentrated	   pure	   protein	   solutions	  were	   flash-­‐frozen	   in	   liquid	  N2	  and	  stored	  at	  -­‐80oC	  until	  immediately	  prior	  to	  experimentation.	  
3.3.2	  Secondary	  Structure	  Characterization	  of	  yIsu1	  and	  fIscU	  Circular	   dichroism	   (CD)	   spectroscopy	   was	   used	   to	   determine	   and	   compare	   the	  general	   folding	   parameters	   of	   both	   yIsu1	   and	   fIscU.	   Protein	   secondary	   structures	   were	  determined	   using	   CD	   spectroscopy	   by	   focusing	   within	   the	   far	   UV-­‐region	   (185-­‐260	   nm).	  Homogeneous	  protein	  samples	  were	  diluted	  to	  10µM	  and	  switched	  into	  a	  1mM	  NaPi	  buffer	  via	  Amicon	  centrifugation	  in	  order	  to	  allow	  far-­‐UV	  transparency.	  Data	  were	  collected	  using	  a	   1-­‐mm	   pathlength	   CD	   cuvette	   on	   a	   Jasco	   J-­‐1500	   spectrometer.	   Spectra	   were	   analyzed	  using	   the	   Spectra	  Manager	   CDPro	   software	   system149	   (Jasco).	   Simulations	   of	   the	   spectra	  were	  calculated	  using	  the	  SP37	  reference	  set150	  and	  CONTIN	  method.151	  Spectra	  provided	  in	   Figure	   3.2B	   are	   the	   average	   of	   6	   scans.	   This	   process	  was	   done	   in	   triplicate	   to	   ensure	  reproducibility.	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3.3.3	  Fe-­‐Binding	  Analysis	  to	  fIscU	  While	   the	   Fe-­‐binding	   characteristics	   of	   yIsu1	   have	   previously	   been	   reported,142	  metal	  binding	  competition	  analysis	  was	  used	  to	  characterize	  the	  Fe-­‐binding	  properties	  of	  fIscU.	   Fe-­‐binding	   to	   fIscU	   was	   assessed	   using	   two	   secondary	   methods	   involving	   the	  competition	   of	   limiting	   amounts	   of	   iron	   between	   fIscU	   and	   each	   of	   the	   two	   Fe-­‐binding	  ligands,	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF	  (Molecular	  Probes).	  Experiments	  were	  done	  in	  triplicate	  to	  confirm	  reproducibility	  and	  to	  identify	  uncertainty	  intervals	  from	  this	  method.	  Fe-­‐binding	   competition	   between	   fIscU	   and	   the	  Mag-­‐Fura-­‐2	   ligand	  was	   performed	  using	   a	   protocol	   recently	   outlined	   for	   yIsu1.152	   Under	   anaerobic	   conditions	   at	   room	  temperature,	  a	  10mM	  Fe(II)	  solution	  was	  added	  in	  0.5µL	  increments	  to	  a	  1mL	  solution	  with	  8µM	  fIscU	  and	  8µM	  Mag-­‐Fura-­‐2.	  All	  samples	  were	  in	  20mM	  HEPES	  and	  150mM	  NaCl	  buffer	  at	   pH=7.5.	   A	   UV-­‐visible	   absorption	   spectrum	   was	   collected	   for	   each	   Fe(II)	   consecutive	  concentration,	   again	   under	   anaerobic	   conditions,	   and	   spectral	   intensities	   at	   366nm	   are	  indicative	  of	  uncomplexed	  (apo)	  Mag-­‐Fura-­‐2	  ligand	  were	  used	  for	  binding	  characterization	  determination.152	   Controls	  was	   performed	   by	   anaerobically	   adding	   the	   Fe(II)	   solution	   to	  8µM	  Mag-­‐Fura-­‐2	  	  or	  to	  8µM	  fIscU,	  independently.	  Using	  an	  analogous	  method	  to	  what	  was	  described	  with	  Mag-­‐Fura-­‐2,	  competition	  for	  Fe-­‐binding	  to	  fIscU	  was	  also	  tested	  using	  the	  Fe-­‐binding	  fluorophore	  Fura-­‐FF.	  In	  principle,	  Fe-­‐competition	  between	  fIscU	  and	  Fura-­‐FF	   is	   the	  same	  as	  competition	  between	  fIscU	  and	  Mag-­‐Fura-­‐2.	  A	  key	  difference	  with	  Fura-­‐FF,	  however,	   is	  that	  Fura-­‐FF	  is	  a	  fluorophore	  that	  complexes	  calcium	  (Ca-­‐Fura-­‐FF).	  Addition	  of	  Fe	  causes	  the	  calcium	  to	  dissociate	  from	  Fura-­‐FF	   and	  bind	  Fe(II).	  The	   fluorescence	  of	   Fe-­‐Fura-­‐FF	   complex	   is	   about	   twenty	   times	   lower	  than	  that	  seen	  in	  the	  Ca-­‐Fura-­‐FF	  complex	  and,	  as	  a	  result,	  the	  total	  fluorescence	  decreases	  
	   43	  
as	   more	   Fe(II)	   is	   added	   to	   the	   solution.	   Therefore,	   instead	   of	   measuring	   the	   UV-­‐visible	  absorption,	  the	  fluorescence	  excitation	  spectrum	  between	  250nm-­‐450nm	  is	  collected	  after	  each	  incremental	  titration	  of	  Fe(II)	  while	  keeping	  the	  emission	  wavelength	  at	  510nm.	  	  For	  binding	  parameter	  determination,	  excitation	  at	  only	  350nm	  considered.	  The	  experimental	  conditions	  and	  data	  analysis	  procedure	  are,	  otherwise,	  identical	  to	  that	  described	  for	  Mag-­‐Fura-­‐2.	  Fe-­‐binding	  parameters	  for	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF	  were	  determined	  using	  best-­‐fit	  simulations	  with	   the	  Dyna-­‐Fit	  software	  module153	   for	  a	  1-­‐	  or	  2-­‐binding	  site	  model.	  These	  simulations	   serve	   as	   controls	   for	   the	  binding	   affinity	   and	   stoichiometry	   of	   each	   chelator.	  Best-­‐fit	   dissociation	   constants	   are	   identified	   using	   a	   fixed	   concentration	   and	   extinction	  coefficients	  for	  Mag-­‐Fura-­‐2/Fura-­‐FF	  when	  added	  with	  the	  solution	  of	  the	  fIscU	  protein.	  	  
3.3.4	  X-­‐ray	  Absorption	  Spectroscopy	  (XAS)	  Studies	  of	  Fe	  Bound	  to	  fIscU	  	  	   	   XAS	  was	  used	  to	  study	  the	  local	  coordination	  environment	  around	  the	  Fe-­‐center	  in	  fIscU.	  A	  solution	  of	  ferrous	  ammonium	  sulfate	  was	  added	  directly	  to	  fIscU	  under	  sulfur	  free	  (Fe-­‐fIscU)	   and	   sulfur	   available	   (FeS-­‐fIscU)	   conditions.	   Both	   XAS	   samples	   were	   prepared	  anaerobically	  within	   a	   Coy	   glove	   box	   using	   protein,	   along	  with	   iron	   and	   sulfur	   solutions	  initially	   degassed	   on	   a	   Schlenk	   line	   before	   use.	   XAS	   samples	   were	   prepared	   in	   20mM	  HEPES	   buffer	   (pH	   7.5),	   150mM	   NaCl,	   5mM	   β-­‐mercaptanol	   (BME)	   and	   30%	   glycerol.	  Multiple	  independent	  duplicate	  samples	  were	  prepared	  under	  the	  following	  conditions:	  A)	  Fe-­‐fIscU	  was	  prepared	  by	  incubating	  fIscU	  with	  0.9	  equivalents	  of	  ferrous	  iron	  and	  B)	  FeS-­‐fIscU	  was	  prepared	  by	  following	  Fe-­‐S	  cluster	  assembly	  conditions	  outlined	  below.	  Samples	  were	   given	   3	   hours	   to	   equilibrate	   at	   10oC	   before	   being	   loaded	   into	   Lucite	   sample	   cells	  wrapped	   with	   Kapton	   tape.	   Loaded	   samples	   were	   immediately	   flash	   frozen	   in	   liquid	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nitrogen,	   removed	   from	   the	   glove	   box	   and	   stored	   in	   liquid	   nitrogen	   until	   XAS	   data	  collection	  was	  performed.	  	  	   	   XAS	  data	  were	   collected	  at	   the	  Stanford	  Synchrotron	  Radiation	  Laboratory	   (SSRL)	  on	   beamline	   7-­‐3.	   Beamline	   7-­‐3	   is	   equipped	  with	   a	   rhodium-­‐coated	   silicon	  mirror	   and	   a	  Si[220]	   double	   crystal	   set	   monochromator;	   rejection	   of	   harmonics	   was	   achieved	   by	  detuning	   the	  monochromator	   to	   30%.	   Samples	  were	  maintained	   at	   10K	  using	   an	  Oxford	  Instrument	  continuous-­‐flow	  liquid	  helium	  cryostat.	  Protein	  fluorescence	  excitation	  spectra	  were	  collected	  using	  a	  30-­‐element	  Ge	  solid-­‐state	  Canberra	  array	  detector.	  XAS	  spectra	  were	  measured	  using	  5eV	  steps	   in	   the	  pre-­‐edge	  region	  (6,900	  –	  7,094	  eV),	  0.25eV	  steps	   in	   the	  edge	  region	  (7,095-­‐7,135	  eV)	  and	  0.05	  Å-­‐1	  increments	  in	  the	  extended	  X-­‐ray	  absorption	  fine	  structure	  (EXAFS)	  region	  (to	  k	  =	  13	  Å-­‐1),	  integrating	  from	  1	  to	  20	  seconds	  in	  a	  k3	  weighted	  manner	  for	  a	  total	  scan	  length	  of	  approximately	  40	  minutes.	  X-­‐ray	  energies	  were	  calibrated	  by	  collecting	  an	  iron	  foil	  absorption	  spectrum	  simultaneously	  with	  collection	  of	  the	  protein	  data.	  Each	  fluorescence	  channel	  of	  each	  scan	  was	  examined	  for	  spectral	  anomalies	  prior	  to	  averaging	  and	  spectra	  were	  closely	  monitored	  for	  photoreduction.	  Protein	  data	  represent	  the	  average	  of	  7-­‐8	  scans.	  	  	   	   XAS	   data	   were	   processed	   using	   the	   Macintosh	   OS	   X	   version	   of	   the	   EXAFSPAK	  program	   suite,154	   integrated	  with	   Feff	   version	   7.2	   for	   theoretical	  model	   generation.	   Data	  reduction	   and	   processing	   followed	   previously	   established	   protocols.142	   X-­‐ray	   absorption	  near-­‐edge	  spectroscopy	  (XANES)	  analyses	  were	  performed	  using	  XAS	  data	  near	  the	  Fe	  K-­‐edge	   (7,100-­‐7,160	  eV)	   for	  both	  Fe-­‐fIscU	  and	  FeS-­‐fIscU.	  The	   first	  derivative	  of	   the	  protein	  XANES	  spectra	  was	   compared	   to	  values	  obtained	   for	  aqueous	  Fe(II)	   and	  Fe(III)	   standard	  solutions	  to	  approximate	  the	  Fe	  oxidation	  state	  of	  metal	  in	  the	  all	  protein	  samples.	  EDG_FIT	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software	  was	  used	  to	  analyze	  the	  pre-­‐edge	  region	  in	  all	  protein	  samples.	  A	  spline	  function	  was	   fit	   over	   the	   pre-­‐edge	   region	   (7,109-­‐7,117	   eV)	   and	  Gaussian	  models	  were	   applied	   to	  accommodate	   features	   observed	   that	   deviated	   from	   the	   spline.	   Best-­‐fit	   models	   were	  integrated	  to	  approximate	  the	  normalized	  pre-­‐edge	  feature	  area.	  	  	   	   EXAFS	  fitting	  analysis	  was	  performed	  on	  raw/unfiltered	  data	  following	  a	  previously	  established	   strategy.155	   EXAFS	   data	   were	   fit	   using	   both	   single-­‐	   and	   multiple-­‐scattering	  theoretical	   model	   amplitude	   and	   phase	   functions	   for	   Fe-­‐O/N,	   Fe-­‐S,	   Fe-­‐Fe	   and	   Fe-­‐C	  interactions.	  During	  spectral	  simulations,	  metal-­‐ligand	  coordination	  numbers	  were	  fixed	  at	  half-­‐integer	   values	   and	   only	   the	   absorber-­‐scatterer	   bond	   length	   (R)	   and	   Debye-­‐Waller	  factor	  (σ2)	  were	  allowed	  to	  freely	  vary.	  Criteria	  for	  judging	  the	  best-­‐	  fit	   simulation	   utilized	   both	   the	   lowest	  mean	   square	   deviation	   between	   data	   and	   fit	   (F’),	  corrected	  for	  the	  number	  of	  degrees	  of	  freedom,	  and	  a	  reasonable	  Debye-­‐Waller	  factor.156-­‐
157	  
3.3.5	  Fe-­‐S	  Cluster	  Formation	  Reaction	  Fe-­‐S	   cluster	   loaded	   yIsu1	   (FeS-­‐yIsu1)	   and	   cluster	   loaded	   fIscU	   (FeS-­‐fIscU)	   were	  prepared	   from	   purified	   apo-­‐yIsu1	   and	   apo-­‐fIscU.	   The	   procedure	   for	   measuring	   this	  transformation	   has	   been	  modified	   from	  what	   has	   been	   previously	   reported	   both	   by	   our	  lab142	  and	   from	  the	  original	  method.135	  All	   solutions	  were	  prepared	  and	  mixed	  within	  an	  anaerobic	  glovebox	   (Coy).	   In	  order	   to	  achieve	  optimal	  yield	  of	  FeS-­‐Isu,	  Nfs1-­‐Isd11	  or	   the	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	  complex	  were	  added	   in	  a	   lesser	  amount	   (10µM)	   than	   Isu1	   (50µM).	  This	   is	   essential	   as,	   under	   stoichiometric	   conditions	   of	   Nfs1-­‐Isd11	   and	   Isu1,	   FeS-­‐Isu	  formation	  is	  reduced	  or	  absent.158	  Yfh1,	  when	  present,	  was	  added	  to	  a	  10µM	  concentration	  where	   stimulation	  was	   observed	   to	   be	  maximal.	   A	   limiting	   amount	   of	   Fe(II)	   ammonium	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sulfate	  (75µM)	  was	  added	  to	  prevent	  adverse	  FeS-­‐mineralization.158	  L-­‐cysteine	  was	  added	  in	  5-­‐fold	  excess	  to	  a	  concentration	  of	  500µM.	  The	  reaction	  buffer	  contained	  20mM	  HEPES	  (pH	  =	  7.5),	  500mM	  NaCl,	  5mM	  BME,	  and	  5mM	  dithiothreitol	  (DTT).	  Reaction	  formation	  was	  monitored	   both	   by	   visible	   absorption	   and	   circular	   dichroism	   (CD).	   Visible	   spectra	   were	  collected	  with	  a	  Shimadzu	  UV-­‐1800	  spectrophotometer	  and	  CD	  spectra	  were	  collected	  with	  a	  Jasco	  J-­‐1500	  spectropolarimeter	  using	  a	  1-­‐cm	  cuvette.	  	  Cuvettes	  were	   sealed	  prior	   to	   being	   transferred	   from	   the	   glovebox	   to	  prevent	   Fe-­‐oxidation.	  The	  reaction	  volume	  used	  was	  1.1mL	  to	  accommodate	  the	  size	  of	  the	  cuvette.	  For	  quantifying	  FeS-­‐fIscU	  formation,	  the	  size	  of	  the	  2Fe-­‐2S	  characteristic	  negative	  CD	  feature	  at	  560nm	   was	   measured	   every	   20	   seconds	   until	   reactions	   reached	   completion.	   Circular	  dichroism	   has	   several	   advantages	   over	   visible	   absorption159	   signals,	   so	   this	   technique	   is	  currently	   selected	   as	   the	   preferred	   method	   for	   measuring	   Fe-­‐S	   cluster	   assembly.	   At	  completion	  of	  assembly,	  visible	  absorption	  and	  CD	  spectra	  were	  collected	  between	  350nm-­‐700nm.	   Adverse	   FeS-­‐mineralization	  was	   estimated	   as	   the	   change	   in	   light	   scattering	   that	  occurred	  during	  the	  course	  of	  the	  reaction.	  Light	  scattering	  was	  estimated	  as	  the	  change	  in	  absorption	   at	   700nm,	   a	   wavelength	   distinct	   from	   the	   expected	   2Fe-­‐2S	   chromophore	  measured	  at	  ~456nm.	  
3.3.6	  Complementation	  of	  Yeast	  ISC	  by	  fIscU	  For	   in	   vivo	   studies,	   the	   transit	   peptide	   sequence	   of	   yeast	   CoxIV	   (cytochrome	   c	  oxidase	  subunit	  IV)	  was	  fused	  to	  the	  mature	  sequence	  of	  fIscU.	  The	  fIscU	  gene	  lacking	  the	  first	  25	  amino	  acids	  was	  amplified,	   including	   the	   in	   frame	  restriction	  sites	  XbaI	  and	  XhoI	  from	  the	  pET151/D-­‐TOPO	  vector	  used	   for	  bacterial	   fIscU	  expression.	  Primers	  used	  were:	  XbaI-­‐dIscU-­‐fw	  5’	   ataataTCTAGAtatcatgaaaatgtcgttgag	   3’;	  XhoI-­‐dIscU-­‐rv	   5’	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tattatCTCGAGgttggccaccttcttctgctg	   3’.	   This	   fragment	   was	   inserted,	   using	   the	   respective	  restriction	  sites,	  into	  the	  engineered	  YCplac22	  plasmid-­‐Isu1prom-­‐CoxIVL-­‐XbaI-­‐XhoI-­‐STOP-­‐ISU1	   3’	   UTR160	   thereby	   targeting	   the	   fIscU	   to	   yeast	  mitochondria	   with	   the	   CoxIV	   leader	  sequence.	  Strain	  GAL1-­‐ISU1/Δisu2	  with	  the	  ISU2	  paralog	  deleted	  and	  the	  ISU1	  gene	  under	  control	  of	  the	  regulated	  GAL1	  promoter	  was	  used	  for	  complementation	  studies.	  The	  strain	  was	  transformed	  with	  the	  YCplac22	  plasmid	  containing	  the	  fIscU	  (see	  above),	  an	  identical	  plasmid	   containing	   the	   yeast	   Isu1	   or	   the	   empty	   YCplac22	   plasmid,	   selecting	   for	   Trp1	  prototrophy.	   The	   chromosomal	   GAL1	   promoter	   was	   switched	   off	   by	   shifting	   cells	   from	  galactose	   to	   glucose	   as	   the	   carbon	   source.	   For	   spotting	   on	   agar	   plates,	   serial	   10-­‐fold	  dilutions	  of	   the	   transformants	  were	   spotted	  onto	  defined	  medium	  agar	  plates	   containing	  CSM-­‐Trp/glucose,	   thereby	  maintaining	  selection	  for	  the	  plasmid	  and	  repressing	  the	  GAL1	  promoter	  at	  the	  same	  time.	  The	  plates	  were	  photographed	  4	  days	  later.	  	  
3.3.7	  Cellular	  Iron-­‐Uptake	  Cellular	   iron	   uptake	   was	   measured	   as	   previously	   described161	   with	   minor	  modifications.	   Briefly,	   cells	   were	   grown	   for	   16	   hours	   in	   CSM	   (complete	   supplemented	  defined	  glucose	  medium)	  at	  30°C	   and	  diluted	  back	   to	   a	  density	  of	   4	   x	  106	   cells/ml.	   Cells	  were	  washed	   in	   50mM	   citrate	   (pH	   6.6)	   and	   5%	   glucose.	   An	   aliquot	   of	   1	   x	   105	   cells	  was	  further	  incubated	  at	  30°C	  for	  90min	  with	  1µM	  55Fe2+	  ascorbate	  dissolved	  in	  50mM	  citrate	  (pH	  6.6),	  5%	  glucose.	  After	  washing	  away	  unincorporated	  iron	  and	  harvesting	  cells	  with	  a	  PHD	  cell	  harvester,	  cells	  were	  incubated	  with	  scintillation	  fluid,	  and	  55Fe	  radioactivity	  was	  measured	  in	  a	  Beckman	  scintillation	  counter.	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3.4	  Results	  
3.4.1	  Molecular	  Characteristics	  of	  Recombinant	  fIscU	  The	  molecular	  characteristics	  of	  both	  fIscU	  and	  yIsu1	  were	  compared	  to	  gain	  insight	  into	   the	   possible	   compatibility	   of	   these	   two	   orthologs.	   Alignment	   of	   the	   amino	   acid	  sequences	   indicates	   fIscU	   and	   yIsu1	   are	   highly	   homologous	   (Figure	   3.1),	   with	   71%	  sequence	   identity	   and	   82%	   sequence	   similarity.	   As	   with	   the	   yeast	   ortholog,142,	   152	   fIscU	  expresses	  in	  E.	  coli	  in	  sufficient	  abundance	  (~10mg/L	  culture),	  and	  can	  be	  isolated	  at	  high	  enough	  purity	   (>95%),	   to	   allow	   for	   in	  vitro	   characterizational	   studies	   (Figure	  3.2A).	   Size	  exclusion	  chromatography	  indicates	  fIscU	  elutes	  with	  a	  retention	  volume	  (61.0mL)	  similar	  to	  that	  observed	  with	  yIsu1	  under	  the	  same	  solution	  conditions	  (60.6mL),	  with	  both	  eluting	  between	  the	  44	  kDa	  (58.2mL)	  and	  17	  kDa	  (73.8mL)	  molecular	  control	  standards	  (data	  not	  shown).	   The	   approximated	   molecular	   weight	   of	   fIscU	   is	   ~33	   kDa	   and	   that	   of	   yIsu1	   is	  ~35kDa	  as	  assessed	  by	  gel	  filtration	  (versus	  the	  size	  of	  the	  monomer	  resolved	  on	  SDS	  PAGE	  in	   Figure	   3.2A)	   consistent	   with	   both	   fIscU	   and	   yIsu1	   existing	   as	   molecular	   dimers,	   in	  agreement	  with	  the	  reported	  characteristics	  of	  bacterial	  IscU.135,	  162	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Figure	   3.1:	   Sequence	  alignment	  of	   full-­‐length	  open	   reading	   frames	   (ORFs)	  between	   Isu1	  from	   Saccharomyces	   cerevisiae	   (yIsu1,	   lower	   case)	   and	   Drosophila	   melanogaster	   (fIscU,	  upper	   case).	   fIscU	   has	   71%	   sequence	   identity	   and	   82%	   sequence	   similarity	   to	   yIsu1.	  Residues	   colored	   by	   the	   ClustalW	   coloring	   convention	   are	   as	   follows:	   acidic	   (blue),	  hydrophobic	  (red),	  basic	  (magenta),	  and	  hydroxyl/sulfhydryl/amine	  (green).	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Figure	   3.2:	   A)	   Representative	   SDS-­‐PAGE	   gel	   comparing	   recombinant	   mature	   D.	  
melanogaster	  IscU	  (fIscU)	  to	  S.	  cerevisiae	  Isu1	  (yIsu1).	  B)	  Far	  UV	  circular	  dichroism	  of	  yIsu1	  (blue)	  and	  fIscU	  (red)	  reveals	  that	  both	  proteins	  share	  a	  similar	  composition	  of	  secondary	  structural	  features.	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3.4.2	  Biophysical	  Characterization	  of	  fIscU	  
Secondary	  Structure	  and	  Fe	  Binding	  Affinity	  -­‐ Quantitation	  of	  the	  secondary	  structure	  content	   of	   fIscU	   and	   yIsu1	   was	   determined	   by	   circular	   dichroism	   (CD)	   spectroscopy	   to	  provide	  further	  insight	  into	  the	  molecular	  similarities	  between	  these	  orthologs.	  CD	  spectra,	  collected	  for	  fIscU	  and	  yIsu1	  under	   identical	  solution	  conditions,	  show	  a	  strong	  degree	  of	  complementary	  fold	  (Figure	  3.2B).	  The	  relative	  comparison	  of	  secondary	  structural	  content	  measured	  for	  fIscU	  and	  yIsu1	  provides	  a	  picture	  of	  the	  two	  proteins	  that	  is	  highly	  similar,	  and	  consistent	  with	  structurally	  characterized	  orthologs.	  Both	  fIscU	  and	  yIsu1	  have	  an	  α-­‐helical	  content	  of	  23%	  and	  24%,	  a	  β-­‐strand	  content	  of	  21%	  and	  20%,	  turn	  and	  loop	  content	  of	   24%	   and	   24%,	   and	   an	   unstructured	   content	   of	   32%	   and	   32%	   for	   fIscU	   and	   yIsu1,	  respectively.	   In	   comparison,	   the	   structural	   content	   from	   the	   E.	   coli	   ortholog’s	   crystal	  structure	   shows	   a	   28%	  α-­‐helical	   content,	   12%	  β-­‐strand	   content,	   25%	   turn/loop	   content	  and	  a	  35%	  unstructured	  content.163	  The	  Fe	  binding	  capacity	  of	  fIscU	  was	  tested	  to	  support	  the	  role	  of	  the	  protein	  as	  the	  
de	  novo	  Fe-­‐S	  cluster	  assembly	  scaffold.	  The	  Fe(II)-­‐binding	  capacity	  of	  fIscU	  was	  measured	  using	   an	   iron	   chelation	   competition	   assay,	   developed	   to	   match	   conditions	   similar	   to	  circumstances	  observed	  in	  vivo	  where	  a	  variety	  of	  biomolecules	  compete	  to	  coordinate	  the	  metal.	  Two	  Fe-­‐binding	   ligands,	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF,	  have	  been	  shown	  to	  be	  effective	  Fe-­‐binding	   chromophores/fluorophores,	   hence	   these	   were	   used	   to	   measure	   the	   metal	  binding	  affinity	  of	  fIscU	  and	  yIsu1	  under	  our	  competition	  conditions.	  Spectral	  correlations	  at	   progressive	   [Fe],	   as	  well	   as	   the	   subsequent	  Fe-­‐binding	   curve	  with	   simulation	   for	  both	  ligands	  in	  the	  presence	  of	  fIscU,	  are	  given	  in	  Figure	  3.3.	  As	  controls,	  dissociation	  constants	  for	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF	  Fe(II)	  binding	  in	  the	  absence	  of	  protein	  were	  measured	  as	  2.0	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±	   0.2	  µM	   and	   0.4	   ±	   0.1	  µM,	   respectively.	   Best-­‐fit	   simulation	   parameters	   from	   ligand	   Fe-­‐binding	  profiles	  with	   fIscU	  are	  provided	   in	  Table	  3.1.	  For	  both	   ligands,	  data	   indicate	   two	  Fe(II)	  dissociation	  constants:	  a	  tighter	  binding	  constant	  of	  695	  ±	  242	  nM	  and	  720	  ±	  150	  nM	  for	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF,	  and	  a	  weaker	  binding	  constant	  of	  5.55	  ±	  2.54	  µM	  and	  2.21	  ±	  0.13	  µM	  for	  Mag-­‐Fura-­‐2	  and	  Fura-­‐FF,	  respectively.	  Differences	   in	  binding	  constant	  values	  between	  both	  Fe-­‐binding	  sites	  are	  below	   the	   lower	   limits	  of	  detection	   for	   these	  methods	  and	  should	  be	  considered	  approximately	  equivalent.	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Figure	  3.3:	  Fe-­‐Binding	  Competition	  Assay	  with	  MagFura	  (A)	  and	  Fura-­‐FF	  (B)	  ligands	  upon	  titration	  of	  Fe(II)	  in	  the	  presence	  of	  8µM	  fIscU.	  Solid	  line	  represents	  best-­‐fit	  simulation	  of	  data.	  Inset	  demonstrates	  disappearance	  of	  chromaphore	  observed	  during	  Fe(II)	  titration.	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Method KD1 KD2 
Competition with Mag-Fura-2 695 ± 242 nM 5.55 ± 2.54 µM 
Competition with Fura-FF 720 ± 150 nM 2.21 ± 0.13 µM 
Table	  3.1:	  Average	  simulation	  results	  including	  averaged	  values	  for	  dissociation	  constants	  (KD1	  and	  KD2).	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X-­‐ray	  Absorption	  Spectroscopy	  (XAS)	   -­‐	   XAS	  was	  used	   to	   characterize	   the	  metal-­‐site	  structure	   for	   Fe	   bound	   to	   fIscU	   unaccompanied	   or	   in	   the	   presence	   of	   sulfur.	   X-­‐ray	  absorption	  near	   edge	   spectroscopy	   (XANES)	   analyses	   for	   Fe-­‐fIscU	   and	  FeS-­‐fIscU	   indicate	  iron	   is	   coordinated	   in	   a	   reduced	   (Fe(II)	   only)	   or	   semi-­‐reduced	   state	   (Fe(II)/Fe(III)	  mixture),	   respectively	   (Figure	  3.4),	  when	   compared	   to	   authentic	   Fe-­‐O/N	   and	  Fe-­‐S	  model	  compounds.	   The	   1st	   inflection	   point	   energy	   values	   for	   Fe-­‐fIscU	   and	   FeS-­‐fIscU	   are	   7123.4	  and	  7123.3	  eV,	  similar	  to	  the	  values	  obtained	  for	  the	  Fe(II)	  sulfate	  (7123.2	  eV)	  and	  Fe(II)	  chloride	  (7119.5	  eV)	  standards.	  A	  distinct	  pre-­‐edge	  feature,	  attributed	  to	  a	  1s-­‐3d	  electronic	  transition,	  is	  observed	  in	  all	  samples	  at	  ~7,112	  eV.	  This	  feature	  is	  small	  (<0.05	  NFU*eV)	  in	  Fe-­‐fIscU	   (Figure	   3.4,	   inset),	   consistent	   with	   6-­‐coordinate	   Fe-­‐O/N	   symmetric	   model	  compounds.164	   In	  the	  FeS-­‐fIscU	  sample,	   this	   feature	   is	  over	  4-­‐times	   larger	  (0.22	  NFU*eV),	  similar	  to	  1s-­‐3d	  features	  observed	  for	  4-­‐coordinate	  Fe	  constrained	  within	  Fe-­‐S	  clusters.142	  The	  large	  1s-­‐3d	  transition	  in	  the	  FeS-­‐fIscU	  spectrum	  suggests	  the	  4-­‐coordinate	  geometry	  in	  this	   sample	   is	   more	   tetrahedral	   than	   planar,	   consistent	   with	   other	   Fe-­‐S	   clusters.165-­‐166	  There	   are	   no	   apparent	   1s-­‐4p	   features	   in	   either	   sample,	   making	   pyramidal	   geometries	  highly	  unlikely.167	   	  Comparison	  of	   the	  FeS-­‐fIscU	  edge	  with	   that	   from	  as	   isolated	  Yah1,	   an	  authentic	  Fe-­‐S	  cluster	  containing	  protein,	  shows	  distinct	  similarities	  in	  edge	  features	  and	  in	  1s-­‐3d	   electronic	   transition	   height.	   	   Subtle	   pre-­‐edge	   max	   and	   edge	   1st	   inflection	   point	  energies	  between	  these	  two	  samples	  may	  suggest	  Fe	   in	  Yah1	  is	  slightly	  more	  reduced,	  or	  more	  likely	  indicate	  the	  Fe-­‐S4	  first	  ligand	  coordination	  sphere	  in	  Yah1	  does	  not	  completely	  match	  the	  Fe	  environment	  found	  in	  FeS-­‐fIscU.	  Analysis	  of	  the	  extended	  x-­‐ray	  absorption	  fine	  structure	  (EXAFS)	  region	  of	  the	  XAS	  data	  was	  used	  to	  provide	  extremely	  high-­‐resolution	  bond	  lengths,	  as	  well	  as	  ligand	  identity	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and	  coordination	  numbers,	  for	  iron	  bound	  in	  both	  Fe-­‐fIscU	  and	  FeS-­‐fIscU.	  EXAFS	  from	  Fe-­‐fIscU	  and	  FeS-­‐fIscU	  reveal	  a	  pattern	  consistent	  with	  the	  structural	  pictures	  suggested	  from	  the	   XANES	   above.	   Figure	   3.5	   compares	   the	   raw	   EXAFS	   data	   and	   best-­‐fit	   simulations	   for	  each	  fIscU	  sample,	  as	  well	  as	  thier	  subsequent	  Fourier	  transforms	  of	  the	  EXAFS	  data;	  best-­‐fit	   simulation	   parameters	   for	   both	   samples	   are	   provided	   in	   Table	   3.2.	   For	   Fe-­‐fIscU,	  scattering	   in	   the	   nearest-­‐neighbor	   ligand	   environment	   is	   strictly	   constructed	   from	   two	  independent	  environments	  of	  oxygen/nitrogen	  ligands	  at	  1.99	  Å	  and	  2.15	  Å.	  For	  FeS-­‐fIscU,	  however,	   in	  addition	  to	  Fe-­‐O/N	  scattering	  at	  2.03	  Å,	   there	   is	  significant	  Fe-­‐S	  scattering	   in	  the	  nearest	  neighbor	  environment	  at	  2.28	  Å,	  and	  Fe-­‐Fe	  scattering	  features	  at	  2.72	  Å.	  Finally,	  there	   is	   long	   range	   Fe•••C	   scattering	   observed	   at	   R	   >	   3.0	   Å	   in	   both	   fIscU	   samples.	   	   The	  EXAFS	  and	  FT	  data	  for	  Yah1	  is	  compared	  to	  that	  of	  FeS-­‐fIscU	  as	  an	  authentic	  Fe-­‐S	  cluster	  containing	  molecule.	  	  The	  Fe-­‐S	  and	  Fe•••Fe	  bond	  lengths	  for	  Yah1	  are	  consistent	  with	  the	  values	   seen	   for	   FeS-­‐fIscU.	   There	   are	   however	   subtle	   differences	   in	   the	   iron	   nearest	  neighbor	   environment’s	   between	   these	   two	   samples,	   specifically	   FeS-­‐fIscU	   has	   an	  additional	  Fe-­‐O/N	  nearest	  neighbor	  ligand	  environment	  and	  smaller	  coordination	  numbers	  for	   both	   the	   Fe-­‐S	   and	   Fe•••Fe	   environments,	   suggesting	   subtle	   differences	   in	   cluster	  coordination	  between	  the	  two	  samples.	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Figure	   3.4:	   X-­‐ray	   Absorption	   Near-­‐Edge	   Spectra	   (XANES)	   for	   Fe-­‐fIscU	   (blue),	   FeS-­‐fIscU	  (red),	  and	  FeS-­‐Yah1	  (black).	  Pre-­‐edge	  region	  (inset)	  demonstrates	  increased	  1s-­‐3d	  feature	  in	  FeS-­‐fIscU,	  similar	  to	  that	  observed	  with	  FeS-­‐Yah1.	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Figure	   3.5:	   Extended	   X-­‐ray	   Absorption	   Fine	   Structure	   (EXAFS)	   and	   Fourier	   transforms	  (FT)	   of	   fIscU	   and	   Yah1.	   EXAFS	   spectra	   are	   provided	   in	   panels	   A,	   C,	   and	   E	   and	   FTs	   are	  provided	  in	  panels	  B,	  D,	  and	  F.	  Data	  (black)	  is	  compared	  to	  best	  fit	  simulations	  (green)	  of	  Fe-­‐fIscU	  (A,B),	  FeS-­‐fIscU	  (C,D),	  and	  FeS-­‐Yah1	  (E,	  F).	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   Fe-Nearest Neighbor Ligandsa Fe•••Long Range Ligandsa 	  
Sample	   Atomb	   R(Å)c	   C.N.d	   σ2	  e	   Atomb	   R(Å)c	   C.N.d	   σ2	  e	   F’	  f	  Fe	  –	  fIscU	   O/N	   1.99	   3.0	   3.78	   C	   3.13	   1.5	   3.01	   0.32	  	   O/N	   2.15	   2.0	   2.94	   	   	   	   	   	  	   	   	   	   	   	   	   	   	   	  FeS-­‐fIscU	   O/N	   2.03	   1.5	   4.37	   C	   4.07	   2.0	   2.37	   0.46	  	   S	   2.28	   2.0	   5.03	   C	   4.83	   4.0	   0.76	   	  	   Fe	   2.72	   0.5	   3.84	   	   	   	   	   	  	   	   	   	   	   	   	   	   	   	  FeS-­‐Yah1	   S	   2.29	   4.0	   5.58	   	   	   	   	   0.40	  	   Fe	   2.71	   0.75	   2.36	   	   	   	   	   	  
a Independent metal-ligand scattering environment  
b Scattering atoms: O (Oxygen), N (Nitrogen), C (Carbon), S (Sulfur) and Fe (Iron)  
c Metal-ligand bond length  
d Metal-ligand coordination number  
e Debye-Waller factor given in Å2 x 103  
f Number of degrees of freedom weighted mean square deviation between data and fit 
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3.4.3	  Transformation	  of	  apo-­‐fIscU	  to	  FeS-­‐fIscU	  in	  vitro	  
Validation	  of	  Fe-­‐S	  Cluster	  Formation	  Assay	  -­‐	  As	  purified,	  wild-­‐type	  fIscU	  is	  in	  the	  apo-­‐state,	   as	   evident	   by	   spectrophotometric	   analysis	   of	   the	   sample	   and	   the	   absence	   of	   a	   CD	  signal	  at	  560nm,	  a	  region	  phenotypic	  of	  Fe-­‐S	  clusters.	  Upon	  addition	  of	  reduced	  Fe	  and	  S	  to	  
apo-­‐Isu,	  de	  novo	  Fe-­‐S	  cluster	   formation	  can	  be	  observed.135	  Recently,	  concerns	  have	  been	  raised	   regarding	   the	   traditional	   spectroscopic	   methodology	   used	   for	   monitoring	   Fe-­‐S	  cluster	  formation	  on	  Isu.135,	  168	  Notably,	  the	  use	  of	  DTT	  as	  a	  reducing	  agent	  was	  associated	  with	   the	   formation	   of	   a	   secondary	   iron	   containing	   high-­‐molecular	   weight	   species	  (HMWS).34	  HMWS	  is	  likely	  an	  insoluble	  FeS-­‐mineral	  not	  bound	  to	  protein	  and	  distinct	  from	  a	  Fe-­‐S	  cluster	  in	  its	  character.	  In	  order	  to	  address	  these	  concerns,	  we	  optimized	  our	  method	  for	  monitoring	  conversion	  of	  apo-­‐	  to	  the	  Fe-­‐S	  cluster	  loaded	  fIscU	  species	  in	  optimal	  yield	  and	  with	  minimal	  formation	  of	  this	  secondary	  FeS-­‐mineral	  species.	  	  The	  preliminary	  hypothesis	  was	   that	  FeS-­‐mineral	   formation	  would	  not	   affect	  FeS-­‐fIscU	  formation,	  as	  measured	  by	  CD,	  because	  unlike	  with	  visible	  absorption	  spectroscopy,	  CD	  spectroscopy	  is	  not	  sensitive	  to	  the	  HMWS.	  Therefore,	  to	  assess	  potential	  formation	  of	  FeS-­‐mineral,	   we	   monitored	   various	   FeS-­‐Isu	   reaction	   conditions	   via	   visible	   absorption	  spectroscopy	   for	   a	   non-­‐specific	   increase	   in	   light	   scattering	   (Figure	   3.6).	   To	   quantify	   the	  amount	   of	   light	   scattering,	   we	   measured	   visible	   absorbance	   at	   700nm,	   a	   wavelength	  sufficiently	  distinct	  from	  the	  456nm	  chromophore	  of	  a	  Fe-­‐S	  cluster.	  FeS-­‐mineral	  formation	  is	   increased	  when	   Isu	   is	   excluded	   (Figure	  3.6,	   solid	  black)	  and	  decreased	  when	   the	   iron-­‐chelator	  EDTA	  is	  added	  (Figure	  3.6,	  dashed	  black),	  suggesting	  that	  FeS-­‐mineral	  formation	  is	  related	  to	  the	  presence	  of	  free	  Fe2+	  in	  the	  reaction.	  In	  support	  of	  this	  hypothesis,	  addition	  of	  excess	  Fe2+	  unexpectedly	  inhibits	  FeS-­‐fIscU	  formation	  (Figure	  3.8A).	  Keeping	  in	  mind	  that	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under	   these	   conditions	   (described	   in	   section	   3.3.5),	   production	   of	   reduced	   sulfur	   is	   the	  rate-­‐limiting	   step	   of	   FeS-­‐Isu	   formation,	   we	   hypothesize	   that	   free	   Fe2+	   can	   bind	   reduced	  sulfur	   from	  Nfs1-­‐Isd11	   to	  produce	  FeS-­‐mineral.	  This	   inhibitory	  effect	   from	  excess	  Fe	  has	  been	  previously	  observed	  but	  not	   clarified	   in	   extensive	  detail.168	  Under	   these	   conditions,	  there	   is	   little	   (<0.05	   AU)	   increase	   in	   light	   scattering	   at	   this	  wavelength,	   suggesting	   FeS-­‐mineralization	   is	   minimal.	   Interestingly,	   when	   Fe	   is	   present	   in	   excess	   under	   these	  conditions,	  the	  same	  yield	  of	  FeS-­‐fIscU	  is	  achieved,	  suggesting	  free	  Fe	  inhibits	  but	  does	  not	  abolish	  Fe-­‐S	  cluster	  formation	  on	  fIscU.	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Figure	   3.6:	   Increase	   in	   light	   scattering	   observed	   during	   FeS-­‐Isu	   formation	   reaction,	   as	  estimated	  by	  the	  increase	  in	  absorbance	  at	  700nm	  under	  various	  reaction	  conditions:	  yIsu1	  (red),	  fIscU	  (blue),	  fIscU	  with	  Yfh1	  (green),	  No	  Isu	  (black	  solid),	  No	  Isu	  with	  Yfh1	  (pink),	  No	  Isu	   with	   EDTA	   (black	   dashed).	   Note	   that	   minimal	   FeS-­‐mineralization	   is	   observed	   under	  optimal	  reaction	  conditions	  (red,	  blue,	  green).	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Characterization	   of	   Fe-­‐S	   cluster	   formation	   on	   fIscU	   -­‐	   After	   validation	   of	   optimal	  solution	   conditions	   for	   assembly,	   the	   FeS-­‐fIscU	   production	   pathway	   was	   characterized	  using	   UV/Vis	   and	   CD	   methodologies	   in	   a	   combined	   manner	   (Figure	   3.7).	   The	   molar	  extinction	   coefficient	   determined	   for	   FeS-­‐fIscU	   is	   7.5	   AU/mM*cm	   (visible)	   and	   0.6	  degrees/mM*cm	  (CD)	  at	  456nm.	  The	  CD	  spectrum	  for	  Yah1	  (Figure	  3.7,	  red)	  was	  used	  as	  a	  positive	  control	  of	  an	  Fe-­‐S	  cluster	  containing	  protein	  (Figure	  3.7,	  green).	  Similarities	  in	  the	  visible	  absorption	  and	  CD	  spectra	  (Figure	  3.7)	  suggest	  fIscU	  and	  yIsu1	  both	  form	  a	  similar	  type	  of	  Fe-­‐S	  cluster	  than	  found	  in	  Yah1.	  Both	  fIscU	  and	  yIsu1	  spectra	  have	  features	  similar	  to	   those	  seen	   in	   the	  Yah1	  control	   (negative	  peaks	  at	  390nm	  and	  560nm,	  positive	  peak	  at	  450nm).	  The	  larger	  signal	  observed	  for	  fIscU,	  as	  compared	  to	  yIsu1,	  is	  likely	  representative	  of	   a	  higher	   specific	   activity	   for	  2Fe-­‐2S	   cluster	  production	   in	   the	  more	   stable	   fly	  ortholog	  since	  loading	  conditions	  between	  the	  proteins	  is	  equal.	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Figure	  3.7:	  Circular	  dichroism	  (A)	  and	  visible	  absorption	  (B)	  spectra	  comparing	  FeS-­‐fIscU	  (green)	   and	   FeS-­‐yIsu1	   (blue).	   Both	   fIscU	   and	   yIsu1	   have	   similar	   CD	   features	   to	   an	  archetypical	   2Fe-­‐2S	   cluster	   from	   the	   yeast	   ferredoxin,	   Yah1	   (red).	   All	   spectra	   represent	  50µM	  protein	  in	  a	  1-­‐cm	  path-­‐length	  cuvette.	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3.4.4	  Cross-­‐Reactivity	  of	  fIscU	  with	  yeast	  Nfs1-­‐Isd11	  and	  Yfh1	  Our	  in	  vitro	  functional	  assay	  outlined	  above	  and	  tuned	  for	  optimal	  substrate/protein	  stoichiometry	  was	  used	  to	  assess	  the	  interaction	  of	  fIscU	  with	  other	  yeast	  ISC	  proteins.	  As	  expected,	   the	   amount	  of	   FeS-­‐fIscU	   formed	  depends	  directly	  on	   the	   amount	  of	   Fe	  present	  (Figure	  3.8A).	  Finally,	  maximal	  FeS-­‐fIscU	  formation	  is	  demonstrated	  at	  1.5	  x	  Fe	  equivalents,	  which	  is	  less	  than	  the	  expected	  saturation	  at	  2	  x	  Fe	  equivalents	  for	  one	  2Fe-­‐2S	  cluster	  per	  fIscU	  monomer.	   Upon	   addition	   of	   Yfh1,	   significant	   stimulation	   (~3-­‐fold)	   is	   observed	   for	  FeS-­‐fIscU	   formation	   (Figure	   3.8B,	   green).	   This	   stimulation	   is	   very	   similar	   to	   what	   was	  observed	  with	  yIsu1	  (Figure	  3.8B,	  blue),	  suggesting	  Yfh1	  also	  stimulates	  cluster	  assembly	  in	   the	  presence	  of	   fIscU.	  Under	  physiologic	  salt	  concentrations	  (150mM),	  Yfh1’s	  effect	  on	  Fe-­‐S	   cluster	   assembly	   is	   concentration	   dependent	   (Figure	   S1).	   Maximum	   Yfh1-­‐mediated	  stimulation	   occurs	   at	   a	   Yfh1	   concentration	   ~1/15th	   the	   Fe(II)	   concentration,	   but	  approximately	   equal	   to	   the	   Nfs1-­‐Isd11	   concentration.	   At	   higher	   Yfh1	   concentrations,	  equimolar	  with	  fIscU	  under	  our	  reaction	  conditions,	   frataxin	  inhibits	  FeS-­‐fIscU	  formation.	  This	   effect	   has	   also	  been	  observed	  with	   the	  D.	  melanogaster	   frataxin	   (unpublished	  data),	  however	   the	   extent	   is	   minimized	   under	   high-­‐salt	   buffer	   conditions	   (500mM	   NaCl).	  Therefore,	  in	  the	  FeS-­‐fIscU	  formation	  assay,	  we	  used	  a	  sub-­‐stoichiometric	  amount	  of	  Yfh1	  (10	  µM,	  matching	  Nfs1-­‐Isd11	  concentrations)	  to	  reach	  reaction	  conditions	  where	  frataxin	  stimulation	   is	  maximal.	   Finally,	   Fe-­‐S	   cluster	   formation	   can	   also	   be	   observed	   using	   yIsu1	  (Figure	  3.8B,	   black	  dashed),	   however,	   the	   yield	   is	   significantly	   lower	  possibly	  due	   to	   the	  instability	  of	  recombinant	  yIsu1.	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Figure	  3.8:	  A)	  Change	  in	  Circular	  Dichroism	  signal	  at	  560nm	  for	  50µM	  fIscU	  monomer	  and	  10µM	  Nfs1-­‐Isd11	  monomer	  under	  varying	  Fe(II)	  concentrations:	  25µM	  (red),	  50µM	  (blue)	  75µM	   (green),	   100µM	   (black).	   Maximal	   yield	   at	   1.5xFe	   suggests	   fIscU	   forms	   two	   Fe-­‐S	  clusters	   form	   per	   dimer.	   Free	   Fe2+	   inhibits	   FeS-­‐fIscU	   formation	   by	   facilitating	   FeS-­‐mineralization.	  B)	  FeS-­‐fIscU	  formation	  via	  50µM	  apo-­‐fIscU	   in	  the	  presence	  of	  10µM	  Nfs1-­‐Isd11	   (red),	  10µM	  Nfs1-­‐Isd11	  and	  10µM	  Yfh1	   (blue),	   and	  10µM	  Nfs1-­‐Isd11,	  10µM	  yIsu1,	  and	   10µM	   Yfh1	   (green);	   all	   proteins	   overexpressed	   in	   E.	   coli.	   The	   rate	   of	   FeS-­‐fIscU	  formation	  increases	  in	  the	  presence	  of	  Yfh1	  (blue)	  to	  a	  similar	  extent	  as	  observed	  with	  Yfh1	  and	  yIsu1	  (green).	  Fe-­‐S	  cluster	  formation	  using	  50µM	  apo-­‐yIsu1	  in	  place	  of	  50µM	  apo-­‐fIscU	  is	  included	  as	  a	  comparison	  (black-­‐dashed).	  	  	   	  
	   67	  
3.4.5	  In	  vivo	  Replacement	  of	  yIsu1	  with	  fIscU	  To	   test	   the	   physiological	   consequences	   of	   replacing	   yIsu1	   with	   fIscU	   in	   vivo,	   we	  engineered	  a	  yeast	  strain	  where	  native	  yIsu1	  and	  yIsu2	  was	  replaced	  by	  fIscU.	  To	  perform	  this	   experiment,	   the	   paralogous	   yeast	   Isu2	  was	   deleted	   and	   the	   chromosomal	   yIsu1	  was	  placed	  under	  control	  of	  the	  GAL1	  promoter.	  The	  resulting	  Gal-­‐Isu1	  ∆yIsu2	  strain	  can	  grow	  in	  raffinose/galactose,	   inducing	  for	  Gal-­‐yIsu1	  but	  not	   in	  glucose,	  repressing	   for	  Gal-­‐yIsu1.	  The	   strain	   was	   transformed	   with	   empty	   plasmid	   YCplac22,	   with	   fIscU	   targeted	   to	  mitochondria	  or	  with	  yIsu1,	  and	  expression	  of	  Gal-­‐yIsu1	  was	  shut	  down	  upon	  shifting	   to	  glucose	   as	   the	   carbon	   source.	   As	   shown	   in	   Figure	   3.9A,	   fIscU	   conferred	   normal	   growth	  similar	   to	   yIsu1,	   whereas	   empty	   plasmid	   conferred	  minimal	   growth	   consistent	   with	   the	  essentiality	  of	  Isu.	  Iron	  uptake	  at	  the	  cellular	   level	  correlates	  strongly	  with	  mitochondrial	  Fe-­‐S	  cluster	  assembly	  activity,169	  and	  therefore	  we	  analyzed	  the	  high	  affinity	  cellular	   iron	  uptake	   of	   both	   strains	   using	   55Fe	   (Figure	  3.9B).	  A	  nfs1-­‐14	  mutant	  with	   a	  missense	  NFS1	  allele	  (I191S)170	  showed	  increased	  iron	  uptake	  activity,	  and	  the	  ∆aft1	  deletion	  strain	  was	  a	  control	   for	   low	   iron	   uptake	   activity.	   These	   data	   show	   that	   the	   fIscU	   and	   yIsu1	  complemented	  strains	  had	  equivalent	  cellular	   iron	  uptake	  activities,	  suggesting	  that	   fIscU	  can	  completely	  replace	  the	  yeast	  homologs	  and	  support	  in	  vivo	  Fe-­‐S	  cluster	  assembly.	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Figure	  3.9:	  In	  vivo	  rescue	  of	  strain	  lacking	  yIsu1	  by	  expression	  of	  fIscU.	  A)	  Growth	  of	  GAL-­‐Isu1/Δisu2	   strain	   transformed	   with	   either	   the	   empty	   YCplac22	   plasmid	   or	   YCplac22	  carrying	  the	  mitochondrial	  targeted	  fIscU	  gene	  or	  the	  yeast	  Isu1	  gene.	  Transformants	  were	  compared	  by	  spotting	  serial	  10-­‐fold	  dilutions	  of	  106	  cells	  on	  CSM-­‐TRP/Glucose	  plates	  and	  photographing	  four	  days	  later.	  yIsu1	  and	  fIscU	  show	  equivalent	  complementing	  activity.	  B)	  Cellular	   iron	  uptake	   for	   fIscU	  and	  yIsu1	  complemented	  GAL-­‐Isu1/Δisu2	  strain.	  The	  strain	  with	  the	  empty	  plasmid	  did	  not	  grow	  and	  so	  iron	  uptake	  could	  not	  be	  assessed.	  Iron	  uptake	  was	  measured	   for	   1	   hour	   in	   sodium	   citrate	   buffer.	   Other	  mutants	   served	   as	   controls	   for	  high	  uptake	  activity	  (nfs1-­‐14)	  and	  low	  uptake	  activity	  (∆aft1).	  	  	  	   	  
	   69	  
3.5	  Discussion	  	   It	   is	   not	   surprising	   that	   the	   yeast	   and	   fly	   scaffold	   proteins	   are	   so	   similar	   in	   their	  molecular	  details.	  The	  transition	  from	  an	  anaerobic	  to	  aerobic	  environment	  3	  billion	  years	  ago	   necessitated	   evolution	   of	  molecules	  within	   pathways	   that	  would	   continue	   to	   remain	  functional,	   while	   at	   the	   same	   time	   protect	   the	   solubility	   and	   redox	   activity	   of	   iron	   to	  continue	  to	  promote	  assembly	  of	  Fe-­‐S	  clusters;	  at	  this	  point	  in	  the	  evolutionary	  scale	  Fe-­‐S	  clusters	  were	  already	  ancient	  and	  highly	  utilized	  in	  life.	  Given	  the	  close	  similarity	  between	  fly	   and	   yeast	   Isu	   orthologs,	   based	   on	   their	   sequence	   homology,	   similar	   structure,	   and	  activity	   towards	   Fe-­‐S	   cluster	   assembly,	   what	   is	   surprising	   is	   the	   difference	   in	   stability	  between	  the	  actual	  fIscU	  and	  yIsu1	  proteins.	  The	  high	  stability	  of	  fIscU	  makes	  this	  protein	  an	  excellent	  candidate	  for	  utilization	  when	  studying	  molecular	  details	  of	  the	  ISC	  pathway.	  	  	  	   Metal	   binding	   properties	   of	   fIscU,	   as	   compared	   to	   yIsu1,	   are	   consistent	   with	   the	  presumed	   role	   of	   both	   proteins	   as	   the	   scaffold	   for	   de	   novo	   2Fe-­‐2S	   cluster	   synthesis.	  Consistent	  results	  from	  two	  independent	  Fe-­‐binding	  methods	  provide	  confidence	  that	  the	  binding	  interaction	  between	  Fe(II)	  and	  fIscU	  is	  within	  the	  micromolar	  to	  nanomolar	  range.	  Fe-­‐binding	  parameters	  for	  fIscU,	  obtained	  from	  our	  chelation	  assay,	  match	  very	  closely	  to	  the	   value	  we	   reported	  with	   our	   chelation	   assay	   for	   yIsu1.152	   Binding	   constants	   from	   the	  competition	   assay	   are	   close	   but	   slightly	   tighter	   to	   values	   obtained	   from	   our	   initial	  isothermal	   titration	   calorimetric	   values	   published	   previously,142	   indicating	   that	  competition	  provides	  a	  better	  evaluation	  for	  how	  these	  proteins	  likely	  bind	  metal	  in	  vivo.	  Interestingly,	  the	  structural	  characterization	  of	  iron	  bound	  to	  fIscU	  by	  XAS	  confirmed	  that	  the	  fly	  protein	  binds	  Fe(II)	   initially	  at	  a	  site	  devoid	  of	  sulfur	   ligation;	  a	  similar	  initial	   iron	  binding	   site	  was	   observed	   for	   the	   yIsu1152	   as	  well	   as	   the	   human	   and	  bacterial	   orthologs	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(manuscript	  in	  preparation).	  These	  data	  indicate	  IscU	  orthologs	  bind	  iron	  initially	  at	  a	  site	  independent	   of	   the	   protein’s	   cysteine	   rich	   active	   site.	   Identification	   of	   which	   specific	  residues	   are	   at	   that	   site	   is	   currently	   under	   investigation.	   However,	   once	   both	   iron	   and	  sulfur	   are	  provided	   to	   the	   scaffold,	   as	   is	   the	   case	   for	  FeS-­‐fIscU,	   these	  data	   are	   consistent	  with	   iron	   coordinated	   in	   a	   Fe-­‐S	   cluster.24,25	  This	   suggests	   a	  model	  where	  Fe	   translocates	  from	  the	  Fe-­‐binding	  site	  to	  the	  Fe-­‐S	  cluster	  coordination	  site	  after	  accepting	  the	  persulfide	  from	  Nfs1.	  The	  pattern	  of	  Fe-­‐N,	  Fe-­‐S,	  and	  Fe-­‐Fe	  scattering	   in	  the	  FeS-­‐fIscU	  sample	  agrees	  with	  the	  expected	  Fe-­‐S	  cluster	  coordination	  at	  the	  active	  site	  of	  fIscU,	  which	  contains	  three	  cysteines	  and	  one	  histidine,	  as	  compared	  to	  the	  4	  cysteine	  site	  observed	  in	  the	  ferredoxin	  Yah1.171	  However,	   iron-­‐ligand	  bond	   lengths	  we	  observe	  are	   similar	   to	   those	   reported	   for	  Fe(II)-­‐binding	   proteins	   from	   other	   biological	   systems172-­‐173	   and	   to	   bond	   lengths	   we	  previously	  reported	  for	  yIsu1.142	  With	   regards	   to	   Fe-­‐S	   cluster	   biosynthesis,	   our	   data	   show	   maximal	   FeS-­‐fIscU	  formation	   is	   observed	   at	   1.5	   x	   Fe	   equivalents	   per	   Isu	   molecule,	   a	   value	   less	   than	   the	  expected	   saturation	   value	   of	   2	   x	   Fe	   equivalents	   for	   a	   single	   2Fe-­‐2S	   cluster	   per	   fIscU	  monomer.	  Incomplete	  homogeneity	  of	  our	  isolated	  recombinant	  fIscU	  is	  likely	  the	  cause	  of	  nonstoichiometric	   assembly.	   Considering	  our	   SDS-­‐PAGE	  gel	   characteristics	   (Figure	  3.2A),	  fIscU	   is	   likely	  ~95%	  pure,	   and	   from	  our	   activity	  measurements	  ~80%	  active	   as	   isolated	  which,	  taken	  together,	  would	  likely	  account	  for	  FeS-­‐fIscU	  saturation	  at	  1.5	  x	  Fe	  equivalents.	  Strategies	  to	  increase	  the	  fraction	  of	  active	  protein	  in	  fIscU	  >80%	  have	  been	  unsuccessful.	  Considering	  the	  incomplete	  activity	  of	  recombinant	  fIscU,	  Figure	  3.8A	  suggests	  that	  a	  single	  2Fe-­‐2S	  cluster	  forms	  per	  fIscU	  monomer,	  in	  agreement	  with	  findings	  for	  the	  bacterial	  and	  human	  Isu1	  orthologs.135,	  158	  Under	  Fe-­‐limiting	  conditions,	  there	  is	  only	  a	  slight	  (<0.05	  AU)	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increase	   in	   non-­‐specific	   light	   scattering,	   suggesting	   that	   adverse	   FeS	   chemistry	   was	  minimal	  in	  our	  activity	  assay	  (Figure	  3.6).	  	   As	   noted	   by	   several	   labs,	   clarification	   of	   Fe-­‐S	   cluster	   assembly	   kinetics	   and	   the	  molecular	   involvement	   of	   proteins	   within	   the	   ISC	   pathway	   have	   been	   hindered	   by	  heterogeneity	   in	   the	   FeS-­‐Isu	   product	   formation,	   which	   has	   been	   shown	   to	   vary	   under	  different	   reaction	   conditions.	   Specifically	   with	   regards	   to	   substrate	   concentrations,	  production	  of	  a	  high	  molecular	  weight	  species	  consisting	  of	  both	  iron	  and	  sulfur	  can	  divert	  substrate	  from	  intended	  product.34,35	  Our	  results	  confirm	  that	   limiting	  the	  amount	  of	   free	  Fe(II)	   available	   in	   solution	   dramatically	   reduces	   the	   extent	   of	   FeS-­‐mineralization.	  Regarding	  the	  stoichiometry	  of	  the	  ISC	  protein	  partners,	  our	  results	   indicate	  that	   limiting	  Yfh1	   levels	   to	   be	   stoichiometric	   with	   Nfs1-­‐Isd11	   causes	   the	   maximal	   frataxin	   induced	  stimulation	   in	   Fe-­‐S	   cluster	   assembly	   activity.	   Under	   elevated	   stoichiometric	   abundance,	  excess	  frataxin	  has	  a	  negative	  impact	  on	  cluster	  assembly.	  These	  data	  are	  consistent	  with	  observations	   that	   show	  overexpression	  of	  Yfh1	   in	  vivo	   causes	   a	   reduction	   in	  Fe-­‐S	   cluster	  synthesis.174	  Finally,	  using	  excess	  Isu	  and	  limiting	  Nfs1-­‐Isd11	  are	  important	  for	  driving	  FeS-­‐Isu	  formation,	  indicating	  Isu	  in	  complex	  with	  Nfs1/Isd11	  likely	  can	  transfer	  cluster	  to	  the	  excess	  unbound	  Isu	  under	  in	  vitro	  assembly	  conditions,	  as	  previously	  suggested.158	  Combined,	   our	   results	   suggest	   a	   model	   where	   optimal	   in	   vitro	   FeS-­‐Isu	   formation	  conditions	   (i.e.,	   low	   Nfs1-­‐Isd11	   concentrations,	   high	   concentration	   of	   Isu,	   limiting	  concentrations	   of	   Fe)	   enable	   a	   high	   yield	   of	   FeS-­‐fIscU	   formation	   with	   minimal	   side	  reactions	   (Figure	   3.10).	   In	   this	  model,	   free	   Fe	   is	   able	   to	   bind	   reduced	   sulfur,	   preventing	  sulfur	  transfer	  to	  Fe-­‐Isu,	  and	  thus	  inhibiting	  FeS-­‐Isu	  formation.	  This	  model	  agrees	  with	  the	  presumed	  in	  vivo	  environment,	  where	  substrate	  concentration	  must	  be	  tightly	  regulated	  to	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help	  control	  cluster	  assembly,	  as	  both	  Fe	  and	  S	  substrates	  are	  toxic	  in	  excess.	  In	  addition,	  the	   stability	   of	   the	   formed	   cluster	   is	   likely	   enhanced	   by	   the	   distribution	   of	   cluster	  chaperone	   proteins	   that	   accept	   and	   deliver	   the	   synthesized	   Fe-­‐S	   clusters	   to	   recipient	  proteins	  downstream	  to	  assembly.	  Further	  regulation	  within	  the	  ISC	  pathway	  is	  provided	  by	   control	   at	   the	   genetic	   level	   where	   expression	   of	   the	   ISC	   genes	   occurs	   at	   levels	   that	  optimize	   activity.	   Establishing	   these	   optimal	   relative	   stoichiometries	   in	   vitro	   therefore	  provides	  direct	  insight	  into	  conditions	  of	  maximal	  efficiency	  that	  likely	  exist	  in	  vivo.	  	   Finally,	   the	   physiological	   consequence	   of	   using	   fIscU	   in	   combination	   with/in	  replacement	  of	  the	  yeast	  proteins	   in	  vitro	  has	  been	  tested	   in	  vivo	   for	  validation	  that	  there	  are	  no	  species-­‐specific	  effects	   that	  would	  dissuade	  using	   fly	   IscU	  in	  combination	  with	  the	  yeast	   proteins	   within	   our	   yeast	   activity	   assay.	   In	   vivo	   studies	   show	   fIscU	   completely	  complements	  yeast	  lacking	  Isu1	  and	  Isu2.	  In	  vitro,	  the	  behavior	  of	  fIscU	  is	  superior	  to	  yIsu1,	  likely	   as	   a	   result	   of	   the	   high	   stability	   of	   the	   fly	   protein.	   Our	   biophysical	   characterization	  studies	   showed	   the	   similarity	   in	   many	   physical	   properties	   between	   the	   yeast	   and	   fIscU	  proteins,	   however	   the	   stability	   and	   functional	   activity	   of	   the	   fly	   ortholog	   are	   superior	   to	  those	  for	  the	  yeast	  protein.	  Given	  our	  finding	  that	  excess	  Isu	  is	  necessary	  to	  drive	  multiple	  Nfs1	   turnovers	   within	   the	   yeast	   reaction	   system	   and	   since	   fIscU	   can	   easily	   function	   as	  recipients	   for	   clusters,	   fIscU	   appears	   to	   be	   a	   better	   recipient	   of	   the	   cluster	   to	   help	  characterize	   the	  molecular	   interactions	  with	   the	  pathway.	  The	   in	  vitro	   data	   coupled	  with	  our	   in	  vivo	   findings	   therefore	  validates	   the	  use	  of	   the	   fly	  protein	   to	  help	  us	  elucidate	   the	  molecular	  details	  of	  the	  ISC	  pathway	  in	  yeast.	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Figure	   3.10:	   Model	   for	   competing	   FeS-­‐Isu	   (black	   arrows)	   and	   FeS	  mineralization	   (gray	  arrows)	  pathways.	  The	  persulfide	   from	  Nfs1-­‐Isd11	  does	  not	  have	  a	  strong	  preference	   for	  Fe2+-­‐Isu	   over	   free	   Free	   Fe2+,	   resulting	   in	   competition	   between	   these	   two	   reactions	  when	  free	  Fe2+	  is	  present.	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CHAPTER	  4:	  ISU1’S	  INTERACTION	  WITH	  NFS1	  INHIBITS	  FES-­‐ISU1	  
FORMATION	  IN	  VITRO	  
4.0	  Prelude	  The	  following	  chapter	  investigates	  the	  interaction	  between	  the	  Nfs1,	  Isd11,	  Isu1,	  and	   Yfh1	   proteins	   during	   FeS-­‐cluster	   bioassembly.	   This	   was	   done	   by	   isolating	   and	  characterizing	   the	   complexes	   that	   form	  between	   these	  proteins	  under	  overexpression	  conditions	   in	  bacteria.	  This	  work	  correlates	  with	  aim	  2	  from	  my	  original	  prospectus.	   I	  need	  to	  thank	  Dulmini	  Barupala	  and	  Andria	  Rodrigues	  for	  allowing	  me	  to	  analyze	  their	  data	   on	   the	   melting	   behavior	   of	   the	   Nfs1-­‐Isd11	   and	   Isu1.	   I	   also	   need	   to	   thank	   Dr.	  Andrew	  Dancis	   and	   his	   laboratory	  members	   for	   providing	   the	   plasmid	   constructs	   for	  the	   protein	   expression.	   I	   did	   the	   writing	   and	   experiments	   in	   this	   section	   and	   this	  chapter	  is	  being	  converted	  for	  publication.	  
4.1	  Abstract	  FeS-­‐clusters	  are	  essential	  cofactors	  found	  in	  all	  organisms.	  In	  eukaryotes,	  a	  single	  highly	  conserved	  pathway,	  called	   the	  FeS-­‐cluster	  pathway	  or	  “ISC”,	   is	  essential	   for	   the	  formation	  of	  most	   cellular	  FeS-­‐clusters.	  Eukaryotic	   ISC	  has	  been	  best	   characterized	   in	  
Saccharomyces	  cerevisiae	  where	  it	  localizes	  to	  the	  mitochondria.	  In	  yeast,	  reduced	  sulfur	  is	   provided	   as	   a	   persulfide	   from	   cysteine	   by	   the	   cysteine	   desulfurase	   enzyme	   “Nfs1”,	  with	   its	  essential	  protein	  cofactor	   “Isd11”.	  The	  primary	  scaffold,	   “Isu1”,	  assembles	   the	  Fe2+	  and	  S2-­‐	  atoms	  into	  a	  stable	  FeS-­‐cluster.	  Frataxin,	  “Yfh1”,	  is	  an	  allosteric	  regulator	  of	  Nfs1	  and	  plays	  a	  role	  in	  iron	  delivery	  to	  Isu1.	  In	  vivo	  FeS-­‐cluster	  assembly	  occurs	  via	  a	  coordinated	   interaction	   of	   these	   ISC	   proteins,	   however	   the	   mechanism	   of	   how	   these	  proteins	  interact	  to	  accomplish	  cluster	  biosynthesis	  remains	  unclear.	  	  This	   study	   isolates	   complexes	   formed	   between	   recombinant	   Nfs1-­‐Isd11,	   Nfs1-­‐Isd11-­‐Isu1,	   and	   Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1,	   and	   characterizes	   their	   activity	   related	   to	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substrate	  binding	  and	  cluster	  assembly.	  The	  individual	  complexes	  are	  abbreviated	  “SD”,	  “SDU”,	   and	   “SDUF”,	   for	   their	   respective	   Nfs1	   (S),	   Isd11	   (D),	   Isu1	   (U),	   and	   Yfh1	   (F)	  components.	   Isu1	   and	   Yfh1	   have	   a	   weak	   association	   to	   SD	   that	   requires	   low	   salt	  (~50mM)	  conditions	   for	  stable	  binding,	   in	  comparison	  to	  SD	  association	  that	   is	  highly	  stable	  under	  multiple	  solution	  conditions.	  Our	   isolation	  studies	  show	  these	  complexes	  exist	  as	  dimeric	  Nfs1	  species	  in	  the	  S2D4,	  S2D4U2,	  and	  S2D4U2F2	  arrangements.	  SDUF,	  as	  isolated	   under	   the	   stoichiometric	   conditions	   outlined	   above,	   is	   unable	   to	   perform	   de	  
novo	   FeS-­‐cluster	   biogenesis	   without	   the	   addition	   of	   exogenous	   apo-­‐Isu1.	   With	  exogenous	  apo-­‐Isu1,	  however,	  SD,	  SDU,	  and	  SDUF	  are	  all	  able	  to	  produce	  FeS-­‐Isu1.	  The	  SDUF	  complex	  alone	   retains	   iron-­‐binding	   capacity	  but	   is	  unable	   to	   functionally	  utilize	  iron	   to	   complete	   FeS-­‐cluster	   formation	   at	   a	   detectable	   level.	   This	  work	   demonstrates	  that	  eukaryotic	  Isu1’s	  binding	  to	  Nfs1	  inhibits	  its	  ability	  to	  conduct	  de	  novo	  FeS-­‐cluster	  biogenesis.	  A	  model	  is	  proposed	  where	  a	  conformational	  change	  of	  Isu1	  is	  required	  for	  FeS-­‐cluster	  formation	  and	  this	  change	  can	  only	  occur	  on	  exogenous	  Isu1.	  While	  similar	  findings	   have	   been	   made	   for	   the	   bacterial	   Isu1	   ortholog,	   IscU,175-­‐177	   the	   existence	   of	  multiple	  conformers	  for	  eukaryotic	  Isu1	  has	  never	  been	  reported.	  
4.2	  Introduction	  FeS-­‐clusters	   are	   ubiquitous	   in	   biology	   and	   have	   been	   identified	   in	   all	   forms	   of	  life.178	  Over	   the	  past	  20	  years,	  FeS-­‐cluster	  metabolism	  has	  been	   the	  subject	  of	   intense	  research	   as	   dysfunctional	   FeS-­‐cluster	   biogenesis	   has	   been	   directly	   implicated	   in	   a	  variety	   of	   human	   diseases,	   including	   the	   autosomal	   recessive	   genetic	   disease	  Friedreich’s	  ataxia.179	  Proteins	  that	  bind	  FeS-­‐clusters	  (i.e.,	  “FeS-­‐proteins”)	  are	  found	  in	  a	  variety	   of	   biochemical	   pathways	   including	   the	   citric	   acid	   cycle,180	   DNA	   replication,181	  and	  the	  electron	  transport	  chain.182	  FeS-­‐proteins	  are	  synthesized	  in	  their	  apo-­‐form	  and	  receive	  their	  FeS-­‐cluster	  post	  translation.	  Considering	  the	  wide	  variety	  of	  FeS-­‐proteins,	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it	  is	  remarkable	  that	  in	  eukaryotes	  there	  are	  a	  limited	  number	  of	  pathways	  that	  provide	  FeS-­‐clusters	   to	   their	   apo-­‐protein	   partners,	   the	   primary	   assembly	   pathway	   of	   which	  occurs	   within	   the	   mitochondria.183-­‐185	   This	   primary	   pathway,	   called	   the	   iron-­‐sulfur	  cluster	   “ISC”	   pathway,	   among	   eukaryotic	   systems	   has	   been	   best	   characterized	   in	   the	  
Saccharomyces	  cerevisiae	  model.	   In	  yeast,	   reduced	  sulfur	   is	  provided	   from	  cysteine	  by	  the	   cysteine	   desulfurase	   enzyme	   “Nfs1”,186	   an	   enzyme	   that	   works	   in	   union	   with	   its	  essential	   protein	   partner	   “Isd11”.187	   The	   primary	   scaffold	   protein	   “Isu1”	   accepts	  reduced	  sulfur	  from	  Nfs1	  via	  a	  persulfide	  intermediate	  and	  utilizes	  this	  sulfur	  source	  to	  perform	  de	  novo	  FeS-­‐cluster	  formation.188	  The	  protein	  frataxin,	  “Yfh1”	  in	  yeast,	  has	  been	  identified	  as	  both	  an	  allosteric	  regulator	  of	  Nfs1189-­‐190	  and	  as	  the	  iron	  donor	  to	  Isu1.191	  A	  ferredoxin	  “Yah1”	  provides	  reducing	  equivalents	  for	  persulfide	  transfer192	  and	  possibly	  reductive	  coupling	  of	  2Fe2S-­‐clusters.188	  	  Efficient	  de	  novo	   FeS-­‐cluster	  biogenesis	   requires	   the	   coordinated	   interaction	  of	  the	   Nfs1,	   Isd11,	   Isu1,	   and	   Yfh1	   proteins.	   However,	   the	   mechanism	   by	   which	   these	  proteins	  interact	  to	  complete	  FeS-­‐cluster	  assembly	  remains	  unclear.	  These	  proteins	  can	  assemble	  under	  appropriate	  conditions	  forming	  Nfs1-­‐Isd11,	  Nfs1-­‐Isd11-­‐Isu1,	  and	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	   complexes.	   These	   respective	   complexes	   are	   abbreviated	   “SD”,	   “SDU”,	  and	  “SDUF”	  for	  their	  Nfs1	  (S),	  Isd11	  (D),	  Isu1	  (U),	  and	  Yfh1	  (F)	  components.	  Complexes	  of	   Isu1-­‐Yfh1	   have	   also	   been	   reported,	   however	   these	   were	   not	   identified	   in	   this	  study.193-­‐194	  	  Research	   characterizing	   the	   interaction	   between	   ISC	   proteins	   in	   vitro	   will	  provide	  a	  more	  detailed	  understanding	  of	  how	  the	  ISC	  proteins	  potentially	   function	   in	  
vivo.	   Few	   mechanistic	   details	   regarding	   how	   the	   eukaryotic	   ISC	   pathway	   proteins	  function	   are	   known,	   however	   recent	   NMR	   studies	   of	   the	   bacterial	   orthologs	   have	  provided	  valuable	  insight	  into	  their	  activity.175-­‐177,	  195-­‐196	  The	  bacterial	  ortholog	  of	  Isu1,	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“IscU”,	  has	  a	  particularly	  interesting	  behavior,	  as	  it	  exists	  in	  two	  states,	  ‘structured’	  and	  ‘disordered’.	   Only	   the	   structured	   state	   is	   able	   to	   bind	   to	   the	   bacterial	   Nfs1	   ortholog,	  IscS.175	   Transitioning	   between	   these	   states	   is	   important	   for	   IscU	   function,	   as	   IscU	  mutations	   that	   favor	   the	   structured	   state	   inhibit	   FeS-­‐cluster	   production.177	   Similar	  behavior	   has	   also	   been	   reported	   for	   the	   alternative	   scaffold,	   IscA.196	   For	   eukaryotic	  systems,	   recent	   reports	   from	  murine	   and	  human	   ISC	  describe	   the	   successful	   isolation	  and	   characterization	  of	   complexes	   formed	  between	  Nfs1-­‐Isd11,197-­‐198	  Nfs1-­‐Isd11-­‐Isu1,	  and	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1.199	  	  In	   this	   chapter,	   we	   describe	   similar	   characterizational	   studies	   performed	  with	  the	   yeast	   ISC	   multiprotein	   complexes.	   Since	   published	   work	   on	   SDU	   and	   SDUF	   are	  limited,	   and	   the	   molecular	   mechanism	   for	   de	   novo	   FeS-­‐cluster	   biogenesis	   by	   Isu1	   is	  unknown,	  these	  studies	  will	  provide	  a	  molecular	  understanding	  of	  how	  these	  complexes	  function.	  Isu1	  within	  the	  SDU	  and	  SDUF	  complexes	  demonstrates	  inhibited	  FeS-­‐cluster	  formation.	  Upon	  addition	  of	  exogenous	  Isu1	  to	  SDU	  or	  SDUF,	  however,	  a	  2Fe2S-­‐cluster	  signal	   immediately	  develops	   as	   assessed	  by	   circular	  dichorism	   spectroscopy.	  Utilizing	  the	   Isu1	   ortholog	   from	   Drosophila	   melanogaster,	   fIscU,	   is	   a	   unique	   approach	   to	  circumvent	   effects	   related	   to	   Isu1-­‐complexation	   because	   fIscU	   can	   fully	   complement	  yeast	  ISC	  (see	  Chapter	  3)	  but	  does	  not	  complex	  with	  yeast	  proteins	  to	  form	  a	  stable	  SD-­‐fIscU	   or	   SD-­‐fIscU-­‐F	   complex	   in	   vitro.	   In	   the	   presence	   of	   excess	   apo-­‐fIscU,	   SDUF	  demonstrates	  rapid	  FeS-­‐fIscU	  formation	  compared	  to	  SD	  and	  SDU.	  This	  stimulated	  FeS-­‐fIscU	  formation	  is	  possibly	  due	  to	  the	  high	  cysteine	  desulfurase	  activity	  observed	  with	  SDUF.	  	  
4.3	  Materials	  and	  Methods	  
4.3.1	  Expression	  and	  Purification	  of	  SD,	  SDU,	  and	  SDUF	  Complexes	  
  To	  explore	  the	  molecular	  details	  of	  the	  coordinated	  activity	  of	  yeast	  Isu1	  during	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FeS-­‐cluster	   assembly,	  we	  developed	   a	   strategy	   to	   express	   and	   isolate	   complexed	   Isu1	  within	  SDU	  and	  SDUF.	  This	  strategy	  of	  working	  with	  multiprotein	  complexes	  has	  been	  highly	   effective	  when	   studying	   the	  human	  and	  murine	   systems.200-­‐201	  Development	   of	  our	   yeast	   SDU	   and	   SDUF	   complex	   purification	   strategy	   followed	   closely	   the	   recent	  method	  employed	  to	  characterize	  SDUF	  in	  the	  murine	  system.200	  Details	  regarding	  the	  expression	   and	   purification	   of	   Saccharomyces	   cerevisiae	   Nfs1-­‐Isd11	   (SD),	   frataxin	  (Yfh1),	  and	  the	  D.	  melanogaster	  Isu1	  (fIscU)	  have	  been	  reported	  elsewhere	  (see	  Chapter	  3).	  	  	   	   Expression	  of	   SDU	  and	  SDUF	  was	  done	  using	   the	  Nfs1-­‐Isd11-­‐Isu1	   (SDU)	   genes	  placed	  in	  a	  pST39	  vector	  and	  the	  Yfh1	  gene	  placed	  in	  a	  pCOLAduet	  vector	  that	  contains	  a	   C-­‐terminal	   His-­‐tag.	   Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	   (SDUF)	   expression	   was	   performed	   by	  simultaneous	  expression	  of	   the	  untagged	  SDU	  plasmid	  with	  the	  Yfh1-­‐His6	  plasmid.	  By	  utilizing	  different	   selection	  markers,	   ampicillin	   for	   SDU	  and	  kanamycin	   for	  Yfh1,	  both	  plasmids	   could	   be	   selected	   for	   simultaneously.	   Transformation	   of	   SDU	   and	   SDUF	  constructs	  was	  done	  using	   competent	  BL21-­‐RIL	   cells	   at	   42oC	   for	  30	   seconds.	  All	   cells	  were	  grown	  in	  LB	  media	  with	  50	  μg/mL	  of	  ampicillin,	  25μg/mL	  of	  chloramphenicol,	  and	  25μg/mL	   of	   kanamycin	   (when	   applicable).	   SDU	   and	   SDUF	  were	   induced	  with	   0.8mM	  IPTG	  and	  10μM	  PLP	  at	  an	  OD	  ~0.8	  for	  3	  hours	  at	  37oC.	  After	  harvesting,	  cells	  were	  lysed	  using	   an	   AVESTIN	   Emulsiflex-­‐C3	   cell	   homogenizer.	   Lysis	   buffer	   for	   SDU/SDUF	   was	  20mM	  imidazole,	  20mM	  HEPES,	  150mM	  NaCl,	  and	  5mM	  BME.	  All	  buffers	  were	  adjusted	  to	  pH=7.5.	  Lysate	  was	  centrifuged	  at	  21,000	  rpm	  for	  45	  minutes	  and	  the	  soluble	  fraction	  was	  moved	  through	  a	  0.2μm	  filter	  before	  being	  placed	  onto	  a	  Ni-­‐column.	  The	  Ni-­‐column	  was	  washed	  with	  5	   column	  volumes	  of	   lysis	  buffer,	   followed	  by	  5	   column	  volumes	  of	  50mM	   imidazole	   lysis	   buffer.	   Elution	   of	   protein	  was	   done	  with	   5	   column	   volumes	   of	  200mM	   imidazole	   lysis	   buffer.	   The	   eluted	   fraction	   was	   treated	   with	   5mM	   EDTA	   to	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remove	  adventitious	  metal.	  	   	   After	  EDTA	  treatment,	  the	  eluted	  fraction	  was	  concentrated	  to	  ~2mL	  via	  a	  10kDa	  cutoff	   Amicon	   centricon	   and	   placed	   on	   a	   S200	   gel	   filtration	   column.	   	   Proteins	   were	  switched	  into	  the	  experimental	  buffer	  during	  the	  gel	  filtration.	  The	  experimental	  buffer	  for	  SDU	  and	  SDUF	  was	  20mM	  HEPES,	  50mM	  NaCl,	  5mM	  BME.	  Fractions	  containing	  the	  desired	   protein	  were	   pooled	   and	   concentrated	   to	  ~10mg/mL.	   Protein	   concentrations	  were	  measured	  using	  a	  millipore	  Direct	  Detect	  IR	  spectrometer	  and	  protein	  purity	  was	  estimated	   by	   SDS-­‐PAGE	   as	   >95%.	   Typical	   yields	  were	   3	  mg	   of	   SDU	   or	   SDUF	   per	   L	   of	  bacterial	  culture.	  	  Proteins	  were	  flash	  frozen	  in	  liquid	  N2	  and	  stored	  at	  -­‐80oC.	  	  	  
4.3.2	  Characterization	  of	  SDUF	  Complex	  Stability	  	   	   The	   stability	   of	   complex	   formation	   between	   the	   Nfs1,	   Isd11,	   Isu1,	   and	   Yfh1	  components	  of	  SDUF	  was	  estimated	  by	  applying	  a	  gradual	   imidazole	  gradient	  to	  SDUF	  bound	  to	  a	  Ni-­‐column.	  Frataxin-­‐His6	  binds	   to	   the	  Ni-­‐column	  and	  the	  Nfs1,	   Isd11,	   Isu1	  proteins	   bind	   to	   the	   column	   indirectly	   via	   their	   interaction	  with	   bound	   frataxin.	   The	  column	  was	  equilibrated	  with	  20mM	   imidazole,	  50mM	  NaPi,	  300mM	  NaCl,	  5mM	  BME	  buffer	  at	  pH=7.5.	  Bacterial	  lysate	  from	  SDUF-­‐expressing	  BL21-­‐RIL	  cells	  was	  placed	  on	  a	  5mL	  Ni-­‐column.	  The	  column	  was	  washed	  with	  15mL	  of	  50mM	  NaPi,	  300mM	  NaCl,	  5mM	  BME	   buffer	   at	   pH=7.5	   with	   a	   progressively	   increasing	   imidazole	   gradient	   from	   20-­‐100mM	   imidazole.	  Fractions	  were	  collected	  every	  5mL	  and	  analyzed	  via	  SDS-­‐PAGE	   to	  identify	   the	   imidazole	   concentration	   at	  which	   the	  Nfs1-­‐Isd11,	   Isu1,	   and	  Yfh1	  proteins	  elute	  from	  the	  column.	  
4.3.3	  Identification	  of	  SD,	  SDU,	  SDUF	  Complex	  Protein	  Stoichiometries	  	   Band	   densitometry	   was	   used	   to	   identify	   the	   respective	   Nfs1,	   Isd11,	   Isu1,	   and	  Yfh1	   stoichiometries	   from	   the	   isolated	   SD,	   SDU,	   and	   SDUF	   complexes.	   The	   amount	   of	  respective	  protein	  is	  taken	  as	  the	  density	  for	  each	  band	  on	  the	  SDS-­‐PAGE	  gel,	  calculated	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as	   pixel	   number	   times	   the	   average	   pixel	   intensity.	   Gels	   were	   configured	   to	   facilitate	  optimal	  band	  volume	  measurements	  with	   the	   same	   sample	  being	   run	  across	  multiple	  lanes	   to	   provide	   statistical	   relevance	   along	   with	   a	   measure	   of	   uncertainty.	   Protein	  amounts	  per	  lane	  were	  varied	  between	  0.5-­‐5μg.	  After	  de-­‐staining,	  gels	  were	  imaged	  and	  analyzed	  by	  the	  Bio-­‐Rad	  Image	  Lab	  software	  package	  to	  quantify	  band	  volumes.	  These	  band	   volumes	   were	   divided	   by	   the	   expected	   molecular	   weights	   of	   each	   respective	  protein	  to	  calculate	  a	   ‘molar	  band	  volume’.	  Molar	  band	  volumes	  were	  then	  divided	  by	  the	  molar	  band	  volume	  of	  Nfs1	  to	  provide	  a	  ‘molar	  band	  ratio’	  on	  a	  per	  Nfs1	  basis.	  	  	   Identification	   of	   the	   SaDbUcFd	   arrangement	   allowed	   the	   estimation	   of	   an	  appropriate	   molecular	   weight	   for	   the	   SD,	   SDU,	   and	   SDUF	   complexes.	   This	   molecular	  weight	  (MW)	  was	  calculated	  using	  the	  following	  formula:	  𝑀𝑊!"#$%&! = 𝒂 𝑀𝑊!"#! + 𝒃 𝑀𝑊!"#!! + 𝒄 𝑀𝑊!"#! + 𝒅 𝑀𝑊!"!! 	  It	   should	   be	   noted	   that	   the	   molar	   band	   ratio	   was	   identified	   based	   on	   the	   Nfs1	  concentration,	   which	   through	   normalization	   makes	   a	   always	   equal	   to	   1.	   Thus,	   the	  molecular	   weights	   used	   in	   subsequent	   experimentations	   were	   on	   a	   ‘per	   Nfs1’	   basis.	  Note	   this	  molecular	  weight	   is	  distinct	   from	  the	   true	  complex	  molecular	  weight,	  which	  likely	  exists	  as	  a	  dimeric	  species.	  
4.3.4	  Determination	  of	  SDUF	  Fold	  Stability	  	  	   	   Differential	   Scanning	  Calorimetry	   (DSC)	  was	  performed	   to	  assess	  any	  potential	  changes	  in	  fold-­‐stability	  of	  SDUF	  in	  comparison	  to	  its	  respective	  individual	  Nfs1,	  Isd11,	  Isu1,	   and	   Yfh1	   components.	   DSC	   was	   performed	   using	   a	   TA	   Instruments	   Nano-­‐DSC	  calorimeter,	   located	   in	   an	   anaerobic	   chamber	   for	  protein	   and	   reduced	  metal	   stability.	  The	  SDUF	  protein	  solution	  was	  diluted	  to	  4	  mg/mL	  with	  experimental	  buffer.	  A	  ~0.4	  mL	  SDUF	  solution	  was	  injected	  into	  the	  sample	  cell	  to	  accommodate	  the	  total	  cell	  volume	  of	  0.3	  mL.	  The	  reference	  cell	  was	  loaded	  with	  H2O.	  Protein	  solutions	  were	  heated	  from	  10o	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to	  90oC	  at	   a	   rate	  of	  1oC/min.	  The	  heat	   capacity	   for	   the	   sample	  was	  measured	  at	   each	  respective	   temperature	   interval.	   Melting	   curves	   for	   SDUF	   were	   compared	   to	   curves	  measured	   for	   the	   respective	   individual	   SD,	   Isu1,	   and	   Yfh1	   proteins.	   This	   process	  was	  done	  on	  multiple	  protein	  preparations	  to	  ensure	  data	  reproducibility.	  Best-­‐fit	  modeling	  parameters	   were	   identified	   by	   simulation	   with	   the	   TA	   instruments	   NanoAnalyze	  software	   package.	   Three	   separate	   two-­‐state	   scaled	   models	   were	   applied	   to	  accommodate	   the	   3	   distinct	   features	   of	   the	   SDUF	   melt	   curve.	   Best-­‐fit	   values	   were	  identified	  by	  NanoAnalyze	  via	  iteration	  of	  the	  melting	  parameters:	  melting	  temperature	  (Tm),	  heat	  of	  melting	  (ΔH),	  and	  scaling	  factor	  (Aw).	  	  
4.3.5	  FeS-­‐Isu1	  Formation	  Reaction	  Assay	  with	  Complexed	  and	  Exogenous	  Isu1	  FeS-­‐cluster	  formation	  on	  Isu1	  was	  tested	  under	  a	  variety	  of	  conditions	  and	  with	  different	   Isu1	   species	   to	  give	   insight	   into	   the	  mechanism	   for	  FeS-­‐Isu1	   formation.	  FeS-­‐Isu1	   formation	  was	   assessed	   using	   complexed	   Isu1	  within	   SDU	   and	   SDUF,	   exogenous	  Isu1,	  and	  exogenous	   fIscU	  with	  each	   Isu1	  species	  providing	  unique	   information	  about	  FeS-­‐cluster	   assembly.	   fIscU	  was	   utilized	   in	   addition	   to	   yeast	   Isu1	   because	   it	   can	   fully	  complement	   yeast	   ISC	   in	   vivo	   and	   in	   vitro	   (see	  Chapter	  3)	   but	   does	  not	   form	  a	   stable	  complex	  with	   yeast	  Nfs1.	   Therefore,	   fIscU	   can	  be	   used	  with	   yeast	   SD,	   SDU,	   and	   SDUF	  proteins	  as	  a	  strategy	   to	  minimize	  effects	  related	   to	   Isu1	  complexation	   to	  Nfs1	  on	   the	  FeS-­‐Isu1	  formation	  process.	  The	  protocol	  for	  cluster	  assembly	  is	  outlined	  in	  detail	  elsewhere	  (see	  Chapter	  3),	  however	   this	   procedure	   is	   slightly	  modified	   for	   the	   desired	   application,	   as	   described	  below.	   All	   solutions	   were	   prepared	   anaerobically	   and	   mixed	   within	   an	   aqueous	  anaerobic	  glovebox	   (Coy).	   	  FeS-­‐cluster	   formation	  was	  performed	  using	  yeast	  apo-­‐Isu1	  and	   fly	   apo-­‐IscU	   (fIscU)	   from	   purified	   apo-­‐Isu1/fIscU	   stocks.	   FeS-­‐Isu1	   formation	   on	  complexed	   Isu1,	   within	   SDU	   and	   SDUF,	   was	   measured	   using	   50µM	   SDU	   or	   SDUF	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complexes	   as	   the	   source	   of	   complexed	   Isu1.	   FeS-­‐Isu1	   formation	   on	   exogenous	  Isu1/fIscU	  was	  performed	  by	  adding	  SD,	  SDU,	  and	  SDUF	  complexes	  in	  a	  lesser	  amount	  (10µM)	   than	   the	   exogenous	   Isu1	   or	   fIscU	   (50µM).	   For	   fIscU	   experiments	   under	  stoichiometric	  conditions,	  the	  concentrations	  of	  Nfs1-­‐Isd11	  and	  Yfh1	  were	  increased	  to	  50µM,	  matching	   that	   of	   fIscU.	  A	   limiting	   amount	   of	   Fe(II)	   ammonium	   sulfate	   solution	  (75µM)	  was	   added	   to	   all	   reactions	   to	   prevent	   adverse	   FeS	  mineralization	   during	   this	  assay.202	  L-­‐cysteine	  was	  added	  in	  5-­‐fold	  excess	  to	  a	  concentration	  of	  500µM,	  making	  a	  final	  reaction	  volume	  of	  1.1mL.	  The	  reaction	  buffer	  contained	  20mM	  HEPES	  (pH	  =	  7.5),	  500mM	  NaCl,	  5mM	  BME,	  and	  5mM	  dithiothreitol	  (DTT).	  Reaction	  mixtures	  were	  sealed	  prior	  to	  removal	  from	  the	  glovebox	  to	  prevent	  oxidation	  of	  Fe2+.	  FeS-­‐Isu1	   formation	  was	  monitored	  using	  circular	  dichroism	  (CD)	  spectroscopy.	  CD	   spectra	  were	   collected	  using	   a	   Jasco	   J-­‐1500	   spectropolarimeter	  using	  1-­‐cm	  quartz	  cuvette.	  Circular	  dichroism	  has	  several	  advantages	  over	  visible	  absorption	  signals	  (see	  Chapter	  2),	  so	  this	  technique	  was	  selected	  as	  the	  preferred	  method	  for	  measuring	  FeS-­‐cluster	   assembly.	   FeS-­‐clusters	   have	   a	   characteristic	   CD	   pattern	   in	   the	   visible	   spectral	  region	   which	   can	   be	   used	   to	   quantify	   cluster	   formation.203	   For	   quantifying	   FeS-­‐fIscU	  formation,	   the	   size	  of	   the	  2Fe2S-­‐cluster	  CD	   spectral	   feature	  at	  560	  nm	  was	  measured	  every	   20	   seconds	   until	   reactions	   reached	   completion.	   The	   CD	   signal	   at	   560nm	   was	  selected	  for	  quantitation	  of	  FeS-­‐cluster	  formation,	  as	  it	  is	  sufficiently	  far	  from	  the	  PLP-­‐feature	  present	  ~420nm.	  This	  process	  was	  done	  in	  triplicate	  to	  measure	  uncertainty.	  
4.3.6	  Probing	  Complex	  Formation	  Between	  Yeast	  Nfs1-­‐Isd11,	  fIscU,	  and	  Yfh1	  Gel	   filtration	   chromatography	  was	   used	   to	   assess	  whether	   fIscU	  would	   form	   a	  stable	  complex	  with	  the	  yeast	  proteins	  Nfs1-­‐Isd11	  and	  Yfh1	  by	  screening	  for	  either	  SD-­‐fIscU	   or	   SD-­‐fIscU-­‐F	   complex	   formation.	   The	   gel	   filtration	   conditions	   selected	   for	   this	  study	  are	  identical	  to	  those	  used	  for	  SDUF	  purification:	  20mM	  HEPES,	  50mM	  NaCl,	  5mM	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BME	  at	  pH=7.5.	  Solutions	  at	  a	  total	  volume	  of	  0.6mL	  were	  prepared	  with	  200µM	  fIscU,	  200µM	  Yfh1,	  and	  100µM	  SD	  and	  were	  incubated	  overnight	  under	  anaerobic	  conditions.	  A	   0.5mL	   volume	   of	   the	   SD-­‐fIscU-­‐Yfh1	   mixture	   was	   placed	   onto	   a	   S200	   gel	   filtration	  column	  and	  eluted	   fractions	  containing	  protein	  were	  analyzed	  by	  SDS-­‐PAGE	  to	  screen	  for	   potential	   Nfs1-­‐Isd11-­‐fIscU-­‐Yfh1	   complex	   formation.	   This	   process	  was	   repeated	   in	  triplicate	  to	  measure	  data	  reproducibility.	  
4.3.7	  Measurement	  of	  Acid-­‐Labile	  Sulfide	  Content	  	  	   In	   addition	   to	   FeS-­‐Isu1	   formation,	   quantitation	   of	   acid-­‐labile	   sulfide	   (S2-­‐)	   is	  another	  valuable	  measure	  of	  ISC	  function	  by	  specifically	  measuring	  cysteine	  desulfurase	  activity.	   Nfs1	   provides	   reduced	   sulfur	   to	   Isu1	   for	   cluster	   assembly	   via	   the	   initial	  formation	   of	   a	   stable	   persulfide	   intermediate.	   	   The	   method	   used	   to	   measure	   S2-­‐	  concentrations	  were	  based	  on	  an	  original	  protocol	  first	  outlined	  for	  measuring	  sulfide	  in	  biological	  applications.204-­‐205	  In	  order	  to	  provide	  a	  valid	  comparison	  to	  results	  from	  FeS-­‐fIscU	  formation,	  reaction	  conditions	  in	  the	  cysteine	  desulfurase	  assay	  used	  were	  similar	  to	   those	   outlined	   for	   FeS-­‐fIscU	   formation	   described	   above.	   Reaction	   conditions	  employed	   in	   this	   report	  were	   10µM	   SD/SDU/SDUF,	   50µM	   fIscU,	   75µM	   Fe(II)aq,	   5mM	  DTT,	  and	  500µM	  L-­‐cysteine.	   In	  addition,	  buffer	  conditions	  were	  0.1M	  HEPES	  (pH=7.5)	  with	  10µM	  pyridoxal-­‐5’-­‐phosphate	  (PLP)	  added	  to	  the	  final	  reaction	  solution	  at	  a	  total	  volume	   of	   100µL.	   All	   proteins,	   chemicals,	   and	   buffers	   were	   allowed	   to	   equilibrate	   to	  anaerobic	   conditions	   by	   incubation	   in	   a	   glove	   box.	   A	   0.02M	   N,N-­‐diethyl-­‐p-­‐phenylenediamine	  sulfate	  (DPD)	  solution	  was	  prepared	  in	  7.2N	  HCl	  and	  a	  11.5mM	  FeCl3	  solution	  was	  prepared	  in	  1.2N	  HCl.	  Upon	  addition	  of	  cysteine,	  reactions	  were	  sealed	  and	  incubated	  for	  10	  minutes	  at	  room	  temperature.	  After	  10	  minutes,	  700µL	  of	  H2O,	  100µL	  of	  0.02M	  (DPD)	  and	  100µL	  of	  11.5mM	  FeCl3	  were	  added	  and	  the	  reaction	  mixture	  was	  
	  	  
85	  
vortexed	   for	   5	   seconds.	   The	   mixtures	   were	   then	   incubated	   at	   30oC	   for	   30	   minutes.	  Aggregated	  protein	  material	  was	  removed	  via	  centrifugation	  at	  12krpm	  for	  2	  minutes.	  Decanted	   solutions	   were	   transferred	   to	   1mL	   cuvettes.	   The	   intensity	   of	   blue	   color,	  measured	   at	   750	   nm	   by	   visible	   absorption	   spectroscopy,	   was	   used	   to	   quantitate	   the	  amount	  of	  acid-­‐labile	  sulfide	  produced.	  This	  process	  was	  done	  in	  triplicate	  to	  measure	  uncertainty.	  
4.3.8	  Estimation	  of	  Fe-­‐Binding	  via	  Quantitation	  of	  FeS-­‐Mineralization	  As	   outlined	   previously,	   adverse	   FeS-­‐mineralization	   can	   be	   estimated	   as	   the	  change	   in	   light	   scattering	   that	   develops	   during	   the	   course	   of	   the	   FeS-­‐Isu1	   formation	  reaction	  (see	  Chapter	  3).	  Light	  scattering	  was	  measured	  as	  the	  change	  in	  absorption	  at	  700nm,	  a	  wavelength	  distinct	  from	  the	  expected	  2Fe2S-­‐cluster	  chromaphore	  measured	  at	   ~456nm.	   A	   1mL	   solution	   of	   50µM	   SDUF,	   5mM	   DTT,	   75µM	   Fe2+aq	   was	   prepared	  anaerobically	   in	   a	   sealed	   1cm	   path-­‐length	   cuvette.	   Reactions	   were	   initiated	   with	  addition	  of	  cysteine	  to	  a	  final	  concentration	  of	  500µM.	  Note	  that	  the	  SDU	  and	  SDUF-­‐only	  samples	  deviate	   from	  the	   ideal	  FeS-­‐Isu1	  conditions	   identified	  previously	   in	   that	  50µM	  SDUF	   corresponds	   to	   5	   times	   more	   Nfs1,	   Isd11,	   and	   Yfh1.	   Reactions	   were	   prepared	  anaerobically	   and	  monitored	   by	  measuring	   every	   20	   seconds	   for	   40	  minutes	   using	   a	  Shimadzu	   UV-­‐1800	   UV-­‐Visible	   absorption	   spectrophotometer	   housed	   within	   the	  anaerobic	  chamber.	  All	  experiments	  were	  done	  in	  triplicate	  to	  measure	  uncertainty.	  
4.3.9	  Visible	  Absorption	  Spectroscopy	  	   Visible	  absorption	  spectroscopy	  was	  performed	  to	  study	  the	  absorption	  signal	  at	  ~420nm,	   a	   feature	  attributed	   to	   the	  pyridoxal	  5’-­‐phosphate	   (PLP)	   cofactor	  of	  Nfs1.206	  Purified	  SD,	  SDU,	  and	  SDUF	  proteins	  samples	  were	  diluted	  to	  10μM	  in	  their	  respective	  experimental	   buffer	   and	   placed	   in	   a	   1cm	   cuvette.	   Absorption	  was	  measured	   between	  300-­‐700nm	  with	  a	  1nm	  bandwidth	  on	  a	  Shimadzu	  UV-­‐1500	  spectrometer	  using	  10uM	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SD,	   SDU,	   and	  SDUF	  diluted	   in	  experimental	  buffer.	   Spectra	  used	   for	   analysis	  were	   the	  average	  of	  scans	  taken	  from	  3	  independent	  protein	  preparations	  and	  provide	  a	  valuable	  comparison	  of	  the	  PLP-­‐feature	  between	  these	  different	  complexes.	  
4.4	  Results	  and	  Discussion	  




Figure	  4.1:	  Separation	  of	  SDUF	  into	  SD,	  U,	  and	  F	  components	  using	  standard	  Ni-­‐column	  purification	   method.	   Consecutive	   column	   volumes	   are	   ordered	   from	   left	   to	   right	   at	  corresponding	  imidazole	  concentrations.	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Figure	  4.2:	  Comparison	  of	  recombinant	  SD,	  SDU,	  and	  SDUF	  complexes	  as	   isolated.	  (A)	  Gel-­‐filtration	  chromatograms	  of	  SD	  (black),	  SDU	  (red),	  and	  SDUF	  (blue).	  (B)	  SDS-­‐PAGE	  of	   SD,	   SDU,	   and	   SDUF.	   (C)	   SDS-­‐PAGE	   band	   densitometry	   of	   Nfs1	   (black),	   Isd11	   (red),	  Isu1	   (blue),	   and	   Yfh1	   (green)	   demonstrating	   complexes	   are	   in	   S2D4,	   S2D4U2,	   and	  S2D4U2F2	  arrangements.	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4.4.3	   Nfs1-­‐Isd11,	   Isu1,	   and	   Yfh1	   Complexation	   Does	   Not	   Significantly	   Effect	  




Figure	  4.3:	  Differential	  Scanning	  Calorimetric	  melt	  profile	  for	  SDUF.	  Raw	  data	  (black),	  model	  (black-­‐dashed),	  and	  individual	  fit	  features	  1	  (red),	  2	  (blue),	  and	  3	  (green).	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   Fit	  1	   Fit	  2	   Fit	  3	  
Aw	   0.13±0.01	   0.30±0.03	   0.0133±0.003	  
Tm	  (oC)	   60.1±0.1	   55.6±0.3	   43.1±0.26	  
ΔH	  (kJ/mol*K)	   710±20	   320±15	   680±90	  
Table	  4.1:	  Best-­‐fit	  model	  parameters	  for	  fits	  1,	  2,	  and	  3	  of	  SDUF	  melt	  profile	  including	  melting	  temperature	  (Tm),	  heat	  of	  melting	  (ΔH),	  and	  scaling	  factor	  (Aw).	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4.4.4	  Exogenous	  Isu1	  Required	  for	  Formation	  of	  FeS-­‐Isu1	  Through	  our	  FeS-­‐Isu1	  formation	  assay,	  we	  have	  identified	  no	  detectable	  FeS-­‐Isu1	  using	   complexed	   Isu1	   within	   the	   SDU	   or	   SDUF	   complexes.	   This	   was	   determined	   by	  attempting	  FeS-­‐Isu1	  formation	  using	  only	  complexed	  Isu1	  within	  the	  isolated	  SDU	  and	  SDUF	   complexes.	   FeS-­‐Isu1	   formation	   was	   probed	   via	   circular	   dichroism	   (CD)	  spectroscopy,	   as	   2Fe2S-­‐clusters	   produce	   a	   characteristic	   CD	   spectrum	   between	   300-­‐700nm.202,	   209-­‐210	   Applying	   findings	   from	   bacterial	   ISC,	  where	   conformational	   changes	  are	  essential	  for	  FeS-­‐IscU	  formation,175,	  177	  we	  hypothesized	  that	  complexed	  Isu1	  within	  SDU	   and	   SDUF	   would	   be	   constrained	   and	   have	   inhibited	   FeS-­‐Isu1	   formation	   ability.	  Supporting	  this	  hypothesis,	  SDU	  and	  SDUF	  alone	  produced	  no	  detectable	  2Fe2S-­‐cluster	  signal	  (Figure	  4.4A,	  blue-­‐dashed	  and	  red-­‐dashed)	  under	  assembly	  conditions.	  Addition	  of	  exogenous	  Isu1,	  however,	  results	  in	  successful	  FeS-­‐Isu1	  formation	  (Figure	  4.4A,	  blue-­‐solid	  and	  red-­‐solid).	  This	  finding	  agrees	  with	  reports	  from	  the	  human	  system,202	  where	  stoichiometric	   amounts	   of	   the	   Nfs1-­‐Isd11,	   Isu1,	   Yfh1	   human	   orthologs	   results	   in	   no	  detectable	  FeS-­‐Isu1	  formation.	  This	  behavior	  also	  explains	  why	  reported	  protocols	   for	  generating	  FeS-­‐Isu1	  have	  all	  involved	  the	  use	  of	  a	  smaller,	  catalytic	  amount	  of	  Nfs1	  with	  an	  excess	  of	  Isu1.190,	  208,	  211	  
4.4.5	  FeS-­‐cluster	  Formation	  Using	  fIscU	  with	  yeast	  Nfs1-­‐Isd11	  and	  Yfh1	  	  	   Using	   the	   Isu1	   ortholog	   from	   Drosophila	   melanogaster	   (fIscU)	   is	   a	   unique	  approach	   to	   circumvent	   Isu1-­‐complexation	   effects	   related	   to	   FeS-­‐Isu1	   formation	   and	  provides	   valuable	   insights	   into	   SD,	   SDU,	   and	   SDUF	   function.	   Attempting	   FeS-­‐Isu1	  formation	   using	   SDU	   and	   SDUF	   presents	   a	   challenge	   as	   all	   reported	   methods	   for	  converting	  apo-­‐Isu1	  to	  FeS-­‐Isu1	  have	  required	  using	  small	  amounts	  of	  Nfs1	  and	  excess	  Isu1.	  FeS-­‐Isu1	  formation	  using	  only	  SDUF,	  however,	  requires	  stoichiometric	  amounts	  of	  protein	  that	  deviates	  from	  optimal	  FeS-­‐Isu1	  conditions	  (see	  Chapter	  2).	  Therefore,	  the	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Figure	  4.4:	  Functional	  studies	  of	  SD,	  SDU,	  and	  SDUF.	  (A)	  FeS-­‐Isu1	  formation	  using	  yeast	  Isu1	  assessed	  via	  circular	  dichroism	  at	  560nm.	  5-­‐fold	  complexed	  Isu1	  within	  SDU	  (red-­‐dashed)	  and	  SDUF	  (blue-­‐dashed)	  produces	  no	  signal	  while	  addition	  of	  5-­‐fold	  exogenous	  
apo-­‐Isu1	  produces	  FeS-­‐Isu1	  signal	  using	  either	  SDU	  (red-­‐solid)	  or	  SDUF	  (blue-­‐solid).	  (B)	  SDS-­‐PAGE	  gel	  illustrating	  separation	  of	  Nfs1-­‐Isd11,	  Yfh1,	  and	  fIscU	  components	  during	  S200	  gel	  filtration.	  Lane	  1:	  Mixture	  of	  Nfs1,	  Isd11,	  fIscU,	  and	  Yfh1	  loaded	  onto	  column.	  Lane	   2:	   Isolated	   SD	   complex	   lacking	   fIscU	   or	   Yfh1.	   Lane	   3:	   Unbound	   fIscU	   and	   Yfh1	  species.	  (C)	  Successful	  FeS-­‐fIscU	  reconstitution	  using	  stoichiometric	  (50µM)	  amounts	  of	  SD,	   Yfh1,	   and	   fIscU	   (red),	   producing	   similar	   reaction	   as	   observed	   under	   optimal	   FeS-­‐Isu1	  conditions:	  10µM	  yeast	  SDUF	  with	  50µM	  exogenous	  fIscU	  (blue).	  50µM	  yeast	  SDUF	  without	  exogenous	  Isu1	  (blue-­‐dashed)	  provided	  as	  comparison.	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We	  then	  tested	  the	  ability	  of	  the	  SD,	  SDU,	  and	  SDUF	  complexes	  to	  generate	  FeS-­‐clusters	   on	   excess	   exogenous	   fIscU.	   Compared	   to	   yeast	   Isu1,	   a	   greater	   yield	   of	   FeS-­‐cluster	   formation	   is	   observed	   with	   fIscU,	   possibly	   due	   to	   instability	   and	   insolubility	  issues	   reported	   for	   yeast	   Isu1.212	   FeS-­‐fIscU	   formation	   is	   rapidly	   stimulated	   by	   SDUF	  (Figure	  4.5A,	  blue)	  compared	  to	  SD	  (black)	  and	  SDU	  (red).	  Comparing	  the	  slopes	  of	  the	  reaction	  profiles,	  the	  rate	  of	  FeS-­‐fIscU	  formation	  is	  3-­‐fold	  higher	  for	  SDUF	  (Figure	  4.5B).	  As	   SD	   and	   SDU	   produced	   similar	   rates	   of	   FeS-­‐fIscU	   formation,	   we	   hypothesized	   that	  frataxin	  was	  acting	  as	  an	  allosteric	  activator	  of	  Nfs1189-­‐190,	  208	  and	  this	  was	  the	  source	  of	  the	  stimulated	  FeS-­‐fIscU	  formation.	  
4.4.6	  High	  Cysteine	  Desulfurase	  Activity	  Identified	  in	  SDUF	  
	  	   Results	   from	   our	   cysteine	   desulfurase	   activity	   assay	   indicate	   that	   SDUF	   has	   a	  high	   cysteine	   desulfurase	   activity	   compared	   to	   SD	   and	   SDU	   .	   This	   assay	   specifically	  measures	   the	   cysteine	   desulfurase	   activity	   of	   Nfs1	   by	  measuring	   the	  methylene	   blue	  acid-­‐labile	   sulfide	   content.	   Addition	   of	   methylene	   blue	   precursors	   in	   a	   strong	   acidic	  environment	  to	  SD,	  SDU,	  and	  SDUF	  reaction	  mixtures	  results	  in	  the	  formation	  of	  a	  blue	  color,	   demonstrating	   all	   complexes	  were	   able	   to	   reduce	   sulfur	   from	   cysteine	   to	   some	  extent.	  Figure	  4.5C	  compares	  the	  amount	  of	  sulfide	  produced	  by	  SD,	  SDU,	  SDUF,	  and	  SDF	  under	   conditions	   that	   match	   those	   used	   for	   optimal	   FeS-­‐Isu1	   formation.	   SDUF	  demonstrates	  a	  dramatic	  (~6-­‐fold)	  increase	  in	  sulfide	  production	  compared	  to	  SD	  and	  SDU.	  This	  agrees	  with	  reports	  that	  frataxin	  acts	  as	  an	  allosteric	  activator	  of	  Nfs1.189-­‐190,	  
201	   This	   stimulation	   is	   possibly	   the	   source	   of	   the	   accelerated	   FeS-­‐fIscU	   formation	  observed	   in	  Figure	  4.5B.	  SD	  and	  SDU	  have	  similar	  sulfide	  production	  rates,	   consistent	  with	  the	  pattern	  observed	  for	  FeS-­‐fIscU	  formation.	  A	  possible	  alternative	  explanation	   for	   the	   lack	  of	  2Fe2S-­‐cluster	   formation	   from	  SDUF	  alone	  is	  that	  the	  active	  site	  of	  complexed	  Isu1	  is	  not	  solvent	  exposed.	  If	  the	  Isu1	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Figure	  4.5:	  FeS-­‐fIscU	  formation	  with	  excess	  fIscU.	  (A)	  FeS-­‐IscU	  formation	  using	  5-­‐fold	  
apo-­‐fIscU	  with	  SD	  (black),	  SDU	  (red),	  and	  SDUF	  (blue).	  (B)	  Rate	  of	  apo-­‐fIscU	  to	  FeS-­‐fIscU	  conversion	   for	   SD	   (black),	   SDU	   (red),	   and	   SDUF	   (blue).	   (C)	  Acid-­‐labile	   sulfide	   content	  assessed	  via	   formation	  of	  methylene	  blue	   for	   SD	   (black),	   SDU	   (red),	   SDUF	   (blue),	   and	  SDF	  (green).	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4.4.7	  SDU	  and	  SDUF	  Complexes	  Retain	  Ability	  to	  Bind	  Mononuclear	  Fe2+	  Although	  complexed	  Isu1	  does	  not	  produce	  a	  detectable	  FeS-­‐cluster,	  the	  SDU	  and	  SDUF	   complexes	   retain	   some	   ability	   to	   bind	   mononuclear	   Fe2+.	   A	   recent	   article	  demonstrated	   that	   the	   iron-­‐accepting	   site	   of	   Isu1	   is	   distinct	   from	   the	   FeS-­‐cluster	  coordination	   site.216	   In	   addition	   to	   the	   active	   site,	   therefore,	   we	   considered	   that	   the	  initial	   iron-­‐accepting	  site	  of	  Isu1	  could	  also	  be	  inaccessible	  to	  Fe	  loading.	  According	  to	  recent	   reports	   from	  the	  murine	  system,199	  however,	   this	   seemed	   less	   likely	   to	  explain	  the	  lack	  of	  observable	  2Fe2S-­‐cluster	  CD	  signal	  because	  murine	  SDUF	  is	  able	  to	  bind	  Fe2+	  in	   the	  presence	  of	   cysteine.	  The	  need	   for	   cysteine	  presents	   a	   challenge	   for	  measuring	  SDUF	   Fe-­‐binding	   because	   cysteine	   is	   a	   substrate	   for	   Nfs1.	   Addition	   of	   cysteine	   along	  with	  Fe2+,	  therefore,	  would	  result	  in	  a	  simultaneous	  chemical	  reaction	  and	  possible	  FeS	  mineral	   formation	   that	   could	   interfere	   with	   traditional	   methods	   for	   assessing	   Fe2+-­‐binding.	   In	   Chapter	   2,	   measuring	   the	   amount	   of	   light	   scattering	   during	   FeS-­‐Isu1	  formation	  was	  used	  to	  assess	  FeS	  mineralization.	  This	  work	  demonstrated	  that	  adverse	  FeS	  mineralization	  was	  linked	  to	  the	  presence	  of	  free	  Fe2+.	  The	  logical	  extension	  of	  this	  method	   is	   that	   it	   could,	   in	   some	   capacity,	   be	   used	   to	   also	   detect	   free	   Fe2+.	   This	   study	  utilized	  this	  strategy	  to	  estimate	  the	  Fe-­‐binding	  capacity	  of	  SDU	  and	  SDUF.	  This	  method	  is	  however	  experimental	  in	  nature	  and	  should	  only	  be	  used	  for	  a	  qualitative	  analysis.	  	  Even	   though	   SDU	   and	   SDUF	   cannot	   produce	   an	   appreciable	   2Fe2S-­‐cluster	   CD	  signal,	  there	  is	  only	  a	  minimal	  increase	  in	  light	  scattering	  (Figure	  4.6,	  blue)	  during	  the	  attempted	   FeS-­‐Isu1	   formation	   reaction	   that	   is	   similar	   to	   the	   feature	   observed	   under	  ideal	   FeS-­‐Isu1	   conditions	   using	   exogenous	   yeast	   Isu1	   (Figure	   4.6,	   red).	   This	   suggests	  that	  Isu1	  complexed	  to	  Nfs1	  is,	  to	  some	  extent,	  able	  to	  bind	  Fe2+.	  This	  binding	  is	  strong	  enough	   to	   prevent	   free	   Fe2+	   from	   interacting	  with	   persulfide	   from	  Nfs1,	   or	   from	   free	  sulfide	   in	   solution.	   This	   finding	   agrees	   with	   observations	   from	   FeS-­‐fIscU	   formation	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Figure	  4.6:	   FeS	  mineral	  production	  under	  various	  FeS-­‐fIscU	   formation	  conditions:	   SD	  with	   no	   Isu1	   (black),	   SD	   with	   EDTA	   and	   no	   Isu1	   (black-­‐dashed),	   optimal	   FeS-­‐Isu1	  formation	  conditions	  with	  yeast	  Isu1	  (green),	  SDU	  alone	  (red),	  and	  SDUF	  alone	  (blue).	  Reduced	   FeS	   mineralization	   observed	   using	   only	   SDU	   or	   SDUF	   demonstrates	   Fe2+	  binding	  of	  complexed	  Isu1.	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Figure	  4.7:	  Visible	  absorption	  spectra	  of	  10µM	  SD	  (black),	  SDU	  (red),	  and	  SDUF	  (blue)	  complexes	  demonstrating	  increased	  PLP-­‐feature	  at	  ~420nm	  for	  SDUF.	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4.4.9	  Proposed	  Model	  for	  SDUF	  Function	  in	  vitro	  Based	  on	  the	  results	  outlined	  above,	  we	  developed	  a	  model	  	  for	  how	  we	  believe	  SDUF	   functions	  during	   in	   vitro	   FeS-­‐cluster	  assembly.	   In	   this	  model	   (Figure	  4.8),	   SDUF	  functions	  as	  a	  highly	  active	  cysteine	  desulfurase	  and	  uncomplexed	  Isu1	  is	  the	  site	  of	  de	  
novo	   FeS-­‐cluster	   formation.	   When	   you	   consider	   the	   findings	   from	   the	   bacterial	   ISC	  system,	  which	  is	  highly	  conserved	  with	  yeast	  ISC,	  complexed	  Isu1	  is	  likely	  locked	  in	  the	  structured	   state.175	   In	   this	  model,	   Isu1’s	   transition	   from	   the	   disordered	   to	   structured	  state	  is	  essential	  for	  de	  novo	  FeS-­‐cluster	  biogenesis.177	  However,	  we	  speculate	  that	  this	  transition	  can	  only	  occur	  on	  uncomplexed	   Isu1.	  This	  model	  agrees	  with	   findings	   from	  bacterial	  ISC	  where	  IscU	  mutants	  that	  stabilize	  the	  structured	  IscU	  state	  have	  impaired	  FeS-­‐cluster	  formation.177	  	  Our	  model	  however	  does	  not	  coincide	  with	  what	  has	  recently	  been	  proposed	  in	  human	   ISC,217	   where	   FeS-­‐cluster	   formation	   occurred	   as	   an	   unstable	   intermediate	   on	  SDUF	  (“FeS-­‐SDUF”).	  For	  these	  results	  with	  yeast	  SDUF,	  we	  feel	  our	  model	  is	  favored	  for	  several	   reasons.	   First,	   no	   evidence	   has	   been	   reported	   that	   directly	   confirms	   the	  existence	   of	   an	   FeS-­‐SDUF	   intermediate.	   As	   SDUF-­‐mediated	   FeS-­‐cluster	   formation	   on	  fIscU	   reaches	   completion	   rapidly	   (~5	  minutes),	   the	   proposed	   FeS-­‐SDUF	   intermediate	  probably	  would	  be	  present	  in	  sufficient	  quantities	  to	  be	  detectable.	  Also,	  the	  similarity	  in	   SD	   and	   SDU	   function	   suggests	   that	   accelerated	   FeS-­‐cluster	   formation	   of	   SDUF	   on	  exogenous	   fIscU	   is	   not	   due	   to	   the	   complexed	   Isu1,	   but	   rather	   due	   to	   frataxin.	  Furthermore,	   SD+F	   produces	   accelerated	   FeS-­‐cluster	   formation	   similar	   to	   SDUF	   (see	  Chapter	  3).	  Lastly,	  there	  is	  also	  no	  clear	  explanation	  for	  why	  the	  FeS-­‐cluster	  produced	  by	  SDUF	  is	  unstable	  when	  it	  is	  stable	  on	  exogenous	  Isu1.	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4.4.10	  Insights	  into	  Mechanism	  for	  FeS-­‐Cluster	  Assembly	  in	  vivo	  This	   in	  vitro	  study	  of	  SD,	  SDU,	  and	  SDUF	  complexes	  may	  provide	  novel	   insights	  into	   FeS-­‐cluster	   formation	   in	   vivo.	   ISC-­‐mediated	   FeS-­‐cluster	   biogenesis	   is	   a	   tightly	  regulated	  process	   in	   vivo	   that	   requires	   the	   coordinated	   interaction	  between	   the	  Nfs1,	  Isd11,	   Isu1,	   and	   Yfh1	   proteins.218	   Complex	   formation	   between	   these	   proteins	   is,	  therefore,	  expected	  to	  be	  an	  integral	  part	  of	  the	  ISC	  pathway.219	  Unexpectedly,	  fIscU	  can	  fully	  complement	  yeast	  ISC	  in	  vivo	  but	  does	  not	  form	  an	  observable	  complex	  with	  yeast	  Nfs1-­‐Isd11	  and	  Yfh1	   in	   vitro.	  This	   suggests	   that	  SDU	  and/or	  SDUF	  complex	   formation	  may	  not	  be	  essential	  in	  vivo.	  There	  remains	  the	  possibility	  that	  fIscU	  forms	  a	  complex	  in	  




Figure	  4.8:	  Model	  for	  SDUF-­‐mediated	  FeS-­‐Isu1	  formation	  via	  uncomplexed	  apo-­‐Isu1	  in	  the	   disordered	   conformation.	   Isu1	   within	   SDUF	   is	   locked	   in	   the	   structured	  conformation.	  Black	  circles	  represent	  Fe2+	  and	  orange	  circles	  represent	  S2-­‐.	  	  	  
	   107	  
CHAPTER	  5:	  IN	  VITRO	  EFFECTS	  OF	  FRATAXIN	  ON	  DE	  NOVO	  FES-­‐CLUSTER	  
FORMATION	  	   	  
5.0	  Prelude	  While	   my	   major	   project	   goals	   did	   not	   specifically	   involve	   frataxin,	   many	   of	   my	  experiments	  led	  to	  interesting	  observations	  regarding	  this	  protein.	  As	  my	  project	  focused	  on	   the	   interaction	  between	  Nfs1-­‐Isd11,	   Isu1,	   and	  Yfh1,	   I	  utilized	   frataxin	   regularly	   in	  my	  studies.	   Most	   notably,	   demonstrating	   stimulation	   by	   frataxin	   was	   a	   critical	   goal	   for	  validating	  the	  FeS-­‐Isu1	  formation	  method.	  As	  I	  was	  studying	  both	  yeast	  and	  fly	  ISC	  proteins,	  I	  utilized	  both	  yeast	  frataxin	   ,	  “Yfh1”,	  and	  fly	  frataxin,	  “Dfh”,	   in	  my	  experiments.	  But	  aside	  from	   my	   specific	   project	   aims,	   I	   was	   innately	   curious	   about	   this	   protein	   and	   designed	  separate	   experiments	   to	   test	   its	   effects.	   This	   led	   to	   several	   interesting	   observations	  regarding	   frataxin’s	   function	   in	  vitro.	   This	   chapter	   of	  my	   dissertation	   is	   a	   compilation	   of	  side	  experiments	  related	   to	   frataxin	   that	  were	  done	  while	  working	  on	  my	  main	  project.	   I	  have	  organized	  these	  results	  into	  a	  concise	  story	  and	  I	  think	  this	  data	  might	  be	  of	  interest	  to	  future	  lab	  members.	  I	  did	  all	  the	  experiments	  and	  writing	  in	  this	  chapter.	  
5.1	  Introduction	  The	  protein	   frataxin	  has	   always	  been	  of	   prime	   interest	   to	   ISC	   researchers.	   This	   is	  because	   the	   genetic	   disease	   Friedreich’s	   ataxia	   (FRDA),	   the	   most	   obvious	   clinical	  correlation	  for	  this	  field,	  has	  been	  linked	  to	  a	  trinucleotide	  repeat	  expansion	  in	  the	  frataxin	  gene.221	   To	   illustrate	   this	   point,	   as	   of	   writing	   this	   chapter,	   on	   pubmed.gov	   there	   are	   ~5	  times	  more	  articles	  mentioning	  “frataxin”	  than	  on	  the	  scaffold	  proteins	  “Isu”/”IscU”/”ISCU”.	  Despite	  this	  increased	  focus	  on	  frataxin,	  the	  in	  vivo	  function	  of	  this	  protein	  remains	  unclear.	  Frataxin	  has	  been	  described	  as	  an	  iron	  chaperone	  that	  delivers	  iron	  to	  Isu1	  for	  de	  novo	  FeS-­‐
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cluster	   synthesis222-­‐226	   and	   to	   ferrochelatase	   for	   the	   biosynthesis	   of	   heme.227	   Structural	  data	  in	  particular	  has	  supported	  the	  role	  of	  frataxin	  in	  Fe	  binding	  and	  transport.225,	  228	  But	  in	  recent	  years,	  there	  have	  been	  a	  significant	  amount	  of	  reports	  that	  frataxin	  interacts	  with	  Nfs1	  and	  acts	  as	  an	  allosteric	  regulator.229-­‐231	  To	  this	  effect,	  reviewing	  literature	  on	  frataxin	  is	   challenging	   because	   there	   is	   such	   a	  wide	   variety	   of	   conflicting	   results	   that	   have	   been	  published	   in	   different	   systems.	   This	   suggests	   that	   the	   role	   of	   frataxin	   is	   likely	   more	  complicated	  than	  was	  initially	  thought.232	  	  The	  following	  chapter	  describes	  the	  in	  vitro	  effects	  of	  frataxin	  related	  to	  binding	  to	  fIscU	  and	  to	  FeS-­‐cluster	  assembly.	  Utilizing	  a	  reaction	  system	  with	  yeast	  Nfs1-­‐Isd11	  and	  fly	  IscU,	   “fIscU”,	   both	   yeast	   frataxin,	   “Yfh1”,	   and	   fly	   frataxin,	   “Dfh”,	   were	   used	   in	   these	  experiments.	   These	   results	   suggest	   that	   frataxin	   can	   function	   as	   an	   activator	   of	   cysteine	  desulfurase	   in	  vitro.	  Frataxin	  demonstrates	  significant	  stimulation	  on	  FeS-­‐fIscU	  formation	  when	  present	  in	  small	  amounts	  (<	  10μM),	  consistent	  with	  its	  role	  as	  an	  allosteric	  regulator.	  	  Frataxin’s	   allosteric	   effects	   are	   possibly	   related	   to	   stimulation	   of	   cysteine	   desulfurase	   as	  assessed	  by	  measuring	  acid-­‐labile	  sulfide	  production	  (see	  Chapter	  4).	  In	  a	  reaction	  system	  consisting	  of	  yeast	  Nfs1-­‐Isd11	  and	  fly	  IscU,	  Yfh1	  demonstrates	  a	  larger	  stimulation	  than	  Dfh	  on	  FeS-­‐fIscU	  formation.	  Testing	  Fe-­‐delivery	  to	  Isu1	  via	  frataxin	  in	  vitro	  was	  not	  successful	  because	  Fe-­‐transfer	  steps	  may	  occur	  too	  quickly	  to	  be	  assessed	  via	  the	  FeS-­‐fIscU	  formation	  method.	  	  
5.2	  Methods	  
5.2.1	  Protein	  Expression	  and	  Isolation	  Yeast	  frataxin	  (Yfh1),	  Drosophila	  IscU	  (fIscU),	  and	  yeast	  Nfs1-­‐Isd11	  were	  grown	  and	  purified	   as	   described	   in	   Chapter	   3.	   This	   chapter	   also	   utilizes	   the	   frataxin	   ortholog	   from	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Drosophila	  melanogaster,	  “Dfh”.	  Dfh	  was	  purified	  as	  described	  in	  Kondapalli	  et	  al.223	  Briefly,	  the	   Dfh	   gene	   was	   purchased	   from	   the	   Drosophila	   Genomics	   Resource	   Center	   (Clone	   ID:	  AT09528).	  The	  Dfh	  cDNA	  was	  cloned	  by	  Kalyan	  Kondapalli	  into	  a	  pET101/D-­‐TOPO	  vector.	  Recombinant	   expression	  was	   done	   via	   transformation	   into	   BL21(DE3)	  E.	   coli	   competent	  cells.	  	   Dfh	   growth	   and	   purification	   was	   done	   following	   the	   same	   protocol	   used	   for	  untagged	  Yfh1.	  Cells	  expressing	  Dfh	  were	  grown	  in	  LB	  broth	  and	  induced	  with	  1mM	  IPTG	  at	  an	  OD600	  ~0.6.	  After	  induction,	  cells	  were	  induced	  at	  37oC	  for	  4	  hours.	  Cells	  were	  isolated	  from	   broth	   via	   centrifugation	   and	   resuspended	   in	   the	   purification	   buffer:	   25mM	   Tris,	  10mM	  EDTA,	  5mM	  BME	  buffer	  at	  pH=8.0.	  Cells	  were	  lysed	  using	  an	  AVESTIN	  Emulsiflex-­‐C3	  homogenizer.	  Soluble	  and	  insoluble	  cellular	  materials	  were	  separated	  via	  centrifugation	  for	  45	  minutes	   at	   21,000rpm.	   The	   soluble	   fraction	  was	   run	   through	   a	   0.2μm	   filter	   and	   two	  steps	   of	   ammonium	   sulfate	   precipitation	  were	   used	   to	   isolate	   Dfh.	   Salting-­‐in	   (protein	   in	  solution)	   was	   done	   by	   adding	   ammonium	   sulfate	   to	   40%	   saturation,	   and	   salting	   out	  (protein	  in	  precipitate)	  was	  done	  by	  increasing	  the	  ammonium	  sulfate	  to	  65%	  saturation.	  Salted-­‐out	   precipitate	   containing	   Dfh	   was	   dissolved	   in	   purification	   buffer	   and	   dialyzed	  twice	  into	  2L	  of	  fresh	  purification	  buffer	  for	  3	  hours	  to	  remove	  the	  ammonium	  sulfate.	  This	  protein	  solution	  was	  run	  through	  a	  Q-­‐sepharose	  column	  and	  eluted	  using	  an	  NaCl	  gradient,	  increasing	  from	  0	  to	  1M	  NaCl.	  Fractions	  containing	  protein	  were	  pooled	  and	  salt	  was	  again	  removed	   via	   two	   rounds	   of	   dialysis	   into	   2L	   of	   purification	   buffer	   for	   3	   hours.	   Next,	  ammonium	   sulfate	  was	   added	   to	   the	   protein	   solution	   to	   a	   concentration	   of	   1M	   and	   run	  through	  a	  phenyl-­‐sepharose	  column.	  Protein	  was	  eluted	  using	  a	  decreasing	  gradient	  (from	  1M	   down	   to	   0)	   of	   ammonium	   sulfate	   concentration.	   Lastly,	   fractions	   containing	   protein	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were	   pooled,	   concentrated	   using	   an	   Amicon	   10kDa	   cutoff	   centricon	   to	   ~2mL,	   and	   run	  through	   a	   S75	   size-­‐exclusion	   column.	   Frataxin	   was	   switched	   into	   the	   final	   experimental	  buffer	   during	   size-­‐exclusion	   chromatography:	   20mM	  HEPES,	   150mM	  NaCl,	   5mM	  BME	   at	  pH=7.5.	   Protein	   quality	   was	   estimated	   via	   SDS-­‐PAGE	   and	   concentration	   was	   measured	  using	  a	  Millipore	  Direct-­‐Detect	  IR	  spectrometer.	  
5.2.2	  Effect	  of	  Frataxin	  on	  FeS-­‐Isu1	  Formation	  	   FeS-­‐fIscU	   formation	   was	   examined	   under	   the	   “optimal	   FeS-­‐Isu1	   formation”	  conditions	  described	  in	  Chapter	  2	  and	  using	  apo-­‐fIscU	  to	  test	  the	  effect	  of	  frataxin	  on	  FeS-­‐cluster	   assembly.	   In	   this	   chapter,	   conditions	  used	   for	   these	   studies	   are	   identical	   to	   those	  described	   in	   Chapter	   2	   (50μM	   fIscU,	   10μM	   Nfs1-­‐Isd11,	   75μM	   Fe,	   500μM	   cysteine,	   5mM	  DTT)	   but	   with	   the	   addition	   of	   frataxin.	   Frataxin	   was	   utilized	   in	   a	   different	   manner	  depending	  on	  the	  particular	  application.	  Frataxin	  concentration	  dependence	  studies	  were	  performed	  where	  the	  apo-­‐frataxin	  concentration	  was	  varied	  between	  0-­‐100μM	  (as	  noted)	  in	   the	   following	   experimental	   buffer:	   20mM	   HEPES,	   5mM	   BME	   at	   pH=7.5	   at	   room	  temperature	  with	  either	  150mM	  or	  500mM	  NaCl	   (as	  noted).	  holo-­‐Dfh	   (with	  Fe)	  and	  apo-­‐Dfh	  (No	  Fe)	  were	  prepared	  as	  follows.	  holo-­‐Dfh	  was	  produced	  by	  incubating	  stoichiometric	  amounts	  of	  Fe2+	  and	  Dfh	  for	  30	  minutes.	  For	  holo-­‐Dfh	  reactions,	  the	  only	  source	  of	  Fe2+	  was	  via	   addition	   of	   75μM	   holo-­‐Dfh.	   Reactions	   utilizing	   apo-­‐Dfh	   involved	   adding	   equimolar	  (75μM)	  amounts	  of	   Fe2+	   and	  apo-­‐Dfh	   to	   the	   reaction	  mixture	   separately,	  with	  Fe2+	   being	  added	  to	  the	  Isu1	  reaction	  mixture	  5	  minutes	  before	  addition	  of	  apo-­‐Dfh.	  The	  buffer	  used	  in	  
apo	   vs.	   holo-­‐Dfh	   experiments	   was	   20mM	   HEPES,	   150mM	   NaCl,	   5mM	   BME	   at	   pH=7.5	   at	  room	  temperature.	  Conditions	  were,	  otherwise,	  identical	  to	  the	  optimal	  FeS-­‐Isu1	  formation	  conditions	  described	  in	  Chapter	  2.	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5.2.3	  Pull-­‐Down	  Assay	  For	  Measuring	  Dfh-­‐fIscU	  Binding	  	   A	   simple	   pull-­‐down	   assay	   was	   employed	   to	   test	   the	   effects	   of	   Fe	   on	   Dfh-­‐fIscU	  complex	  stability.	  This	  pull-­‐down	  assay	  was	  done	  using	  Ni-­‐column	  affinity	  chromatography	  with	   untagged	   Dfh	   and	   N-­‐terminal	   His6-­‐tagged	   fIscU.	   All	   experiments	   were	   done	   in	   an	  anaerobic	   glovebox	   (Coy),	   regulated	   to	   room	   temperature.	   Conditions	   were	   selected	   for	  pull-­‐down	   assays	   were	   matched	   as	   well	   as	   possible	   to	   conditions	   used	   in	   the	   Dfh:fiscU	  isothermal	  titration	  calorimetry	  (ITC)	  studies	  within	  Dr.	  Swati	  Rawat’s	  dissertation.	  A	  Dfh-­‐fIscU	   protein	  mixture	  was	   prepared	   in	   20mM	  HEPES,	   150mM	  NaCl,	   5mM	  BME	   buffer	   at	  pH=7.5.	  Concentrated	  Dfh	  (~400μM)	  was	  incubated	  with	  1xFe	  equivalent	  for	  30	  minutes	  to	  produce	  holo-­‐Dfh,	  while	  apo-­‐Dfh	  was	  produced	  adding	  equal	  volume	  of	  buffer	  instead	  of	  Fe.	  Either	   holo-­‐	   or	   apo-­‐Dfh	   was	   then	   mixed	   with	   concentrated	   fIscU	   to	   create	   100μM	  fIscU:200μM	  holo-­‐Dfh	  (200μM	  	  Fe)	  and	  100μM	  fIscU:200μM	  apo-­‐Dfh	  mixtures,	  respectively	  and	  samples	  were	  prepared	  at	  a	  final	  volume	  of	  0.3mL.	  A	  0.25mL	  volume	  of	  the	  fIscU:apo-­‐Dfh	   mixture	   was	   loaded	   on	   to	   a	   5-­‐mL	   Ni-­‐column	   as	   a	   stable	   base	   for	   testing	   complex	  formation,	  with	  the	  His	  rich	  attachment	  site	  located	  on	  the	  N-­‐terminus	  of	  fIscU.	  The	  column	  was	  washed	  with	  either	  25mL	  or	  50mL	  of	  20mM	  HEPES,	  20mM	   Imidazole,	  150mM	  NaCl	  buffer	   at	   pH=7.5.	   Proteins	  were	   eluted	   using	   25mL	  of	   the	   same	  washing	   buffer	  with	   the	  imidazole	   concentration	   increased	   to	   250mM.	  After	   elution	   of	   the	   fIscU:apo-­‐Dfh	  mixture,	  the	  column	  was	  re-­‐requilibrated	  with	  50mL	  of	  binding	  buffer	  and	  all	  steps	  were	  repeated	  identically	  for	  the	  fIscU:holo-­‐Dfh	  mixture.	  The	  eluted	  fractions	  were	  concentrated	  to	  1mL.	  All	  fractions	  were	  analyzed	  via	  SDS-­‐PAGE	  to	  estimate	  the	  amount	  of	  Dfh-­‐binding	  to	  fIscU.	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5.3	  Results	  
5.3.1	  Effect	  of	  Frataxin	  is	  Concentration	  Dependent	  Under	  Physiologic	  Salt	  Levels	  	   Under	  a	  near-­‐physiologic	  salt	  concentration	  (150mM),	  frataxin’s	  effect	  on	  FeS-­‐fIscU	  formation	  depends	  on	  its	  concentration.	  Lower	  concentrations	  of	  frataxin	  (0-­‐20μM)	  result	  in	   stimulation,	   and	   higher	   concentrations	   (>50μM)	   result	   in	   inhibition.	   Intermediate	  concentrations	  (20-­‐50μM)	  have	  little	  effect.	  This	  pattern	  was	  observed	  for	  Yfh1	  (Figure	  5.1	  A	  and	  B)	   and	  Dfh	   (not	   shown).	  This	   concentration-­‐dependence	  was	  minimized	  when	   the	  salt	  concentration	  is	  increased	  to	  500mM	  for	  both	  Yfh1	  and	  Dfh	  (Figure	  5.1C).	  Under	  either	  salt	   condition,	   however,	   frataxin	   stimulation	   was	   profound	   even	   when	   present	   in	   small	  amounts.	   In	   fact,	   concentrations	   as	   low	   as	   1μM	   result	   in	   80%	   of	   the	   maximal	   frataxin	  stimulation	  (Figure	  5.1C).	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Figure	   5.1:	   (A)	   FeS-­‐fIscU	   transformation	   over	   time	   under	   differing	   Yfh1	   concentrations	  with	  150mM	  NaCl,	  50μM	  fIscU,	  and	  75μM	  Fe:	  no	  Yfh1	  (black),	  5μM	  Yfh1	  (blue),	  10μM	  Yfh1	  (red),	  15μM	  (gray),	  25μM	  Yfh1	  (pink),	  50μM	  Yfh1	  (cyan),	  100μM	  Yfh1	  (yellow).	  (B)	  Initial	  rate	   of	   FeS-­‐fIscU	   formation	   under	   differing	   Yfh1	   concentrations.	   Gray	   line	   indicates	  transition	   from	   stimulation	   to	   inhibition.	   (C)	   Inhibitory	   effect	   from	   increasing	   frataxin	  concentration	   is	  dramatically	   reduced	  under	  high	  salt	   (500mM	  NaCl)	   conditions	   for	  both	  Yfh1	  (blue)	  and	  Dfh	  (red).	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5.3.2	  Testing	  Dfh	  as	  Fe-­‐Donor	  for	  FeS-­‐fIscU	  Formation	  	   In	   order	   to	   test	   the	   ability	   of	   Dfh	   to	   function	   as	   an	   Fe-­‐donor	   during	   FeS-­‐cluster	  formation,	  FeS-­‐fIscU	  formation	  was	  assessed	  by	  either	  adding	  holo-­‐Dfh	  to	  apo-­‐fIscU	  or	  by	  adding	   apo-­‐Dfh	   to	   Fe-­‐fIscU	   during	   reaction	   mixture	   preparation.	   Under	   the	   conditions	  described	   in	   section	   5.2.2,	   use	   of	   apo-­‐	   vs	   holo-­‐Dfh	   demonstrates	   no	   effect	   on	   FeS-­‐fIscU	  formation	   (Figure	   5.2).	   Considering	   that	   reaction	   mixtures	   are	   incubated	   for	   5	   minutes	  prior	   to	   reaction	   initiation	   with	   cysteine,	   this	   suggests	   that	   Fe-­‐transfer	   has	   reached	  completion	  prior	  to	  reaction	  initiation.	  An	  assay	  requiring	  ~40	  minutes	  may	  be	  too	  slow	  to	  provide	  information	  about	  Fe-­‐delivery.	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Figure	  5.2:	  Effects	  of	  75μM	  apo-­‐	  (blue)	  vs	  holo-­‐	  (red)	  Dfh	  compared	  to	  no	  frataxin	  (black)	  on	   FeS-­‐fIscU	   formation.	   Inhibitory	   effect	   is	   observed	   at	   75μM	   Dfh	   under	   150mM	   NaCl	  buffer	   conditions.	   Dfh-­‐mediated	   effects	   on	   FeS-­‐fIscU	   formation	   do	   not	   depend	   on	   Fe-­‐binding	  status	  (apo	  vs	  holo)	  of	  Dfh	  under	  the	  described	  conditions.	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Figure	   5.3:	  FeS-­‐IscU	   transformation	  with	  no	   frataxin	   (red),	  Yfh1	  (blue),	  and	  Dfh	  (green).	  10μM	  frataxin	  stimulates	  FeS-­‐fIscU	  formation	  using	  10μM	  yeast	  Nfs1-­‐Isd11	  and	  50μM	  apo-­‐fIscU	  in	  500mM	  NaCl	  solution.	  Stimulation	  is	  ~30%	  greater	  using	  Yfh1	  than	  Dfh.	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5.3.3	  Both	  Dfh	  and	  Yfh1	  Stimulate	  FeS-­‐fIscU	  Formation	  Using	  Yeast	  Nfs1-­‐Isd11	  	   Using	  either	  10μM	  Yfh1	  or	  Dfh	  with	  yeast	  Nfs1-­‐Isd11	  results	  in	  stimulated	  FeS-­‐fIscU	  formation.	   This	   agrees	   with	   the	   finding	   from	   Chapter	   3	   that	   ISC	   is	   highly	   conserved	  between	  S.	  cerevesiae	  and	  D.	  melanogaster	  and	  agrees	  with	  previous	  reports	   that	  Dfh	  can	  complement	  yeast	  ISC	  (unpublished	  data).	  A	  concentration	  of	  10μM	  frataxin	  was	  selected	  for	   this	   study	   as	   experimental	   results	   show	   stimulation	   had	   reached	   maximum	   at	   this	  concentration	   (Figure	   5.1C).	   In	   500mM	   NaCl	   reaction	   buffer,	   Yfh1	   demonstrates	   a	  significantly	  greater	  stimulation	  (3.0x)	  than	  observed	  for	  Dfh	  (2.2x).	  Assuming	  that	   intra-­‐species	  reactivity	  is	  complete,	  and	  inter-­‐species	  reactivity	  is	  partial,	  this	  data	  suggests	  that	  frataxin	   stimulation	   is	   more	   associated	   with	   Nfs1	   than	   with	   Isu1.	   There	   are	   potential	  complications	   and	   alternative	   explanations	   for	   this	   pattern,	   however.	   There	   may	   be	  differences	   in	   stability	   or	   activity	   of	   the	   recombinant	   Yfh1	   and	   Dfh	   proteins	   that	   affects	  their	  stimulatory	  behavior	  or	  there	  may	  be	  incomplete	  cross-­‐reactivity	  between	  the	  fly	  IscU	  and	  yeast	  Nfs1-­‐Isd11.	  
5.3.4	  Dfh-­‐fIscU	  Binding	  Not	  Significantly	  Affected	  by	  Fe2+	  	  Utilizing	   a	   Ni-­‐column	   pull-­‐down	   assay,	   binding	   of	   Dfh	   to	   His6-­‐fIscU	   is	   not	  significantly	  affected	  by	  the	  use	  of	  apo-­‐	  or	  holo-­‐Dfh	  (Figure	  5.4A).	  Repeating	  this	  assay	  with	  an	  additional	  washing	   step	  produces	  a	   similar	  pattern	   (Figure	  5.4B).	  With	  either	  apo-­‐	   or	  
holo-­‐Dfh,	  relatively	  small	  amounts	  of	  Dfh	  remain	  bound	  to	  fIscU.	  This	  could	  possibly	  have	  been	   prevented	   if	   non-­‐specific	   interactions	  were	   screened	   by	  washing	  with	   lysate.	   	   This	  step	   was	   not	   included	   because	   of	   concerns	   that	   bacterial	   lysate	   was	   not	   completely	  anaerobic,	   which	   could	   introduce	   potential	   oxidation	   of	   Fe2+.	   Therefore,	   conclusions	  regarding	  the	  presence	  or	  absence	  of	  specific	  Dfh-­‐fIscU	  binding	  cannot	  be	  made,	  only	  that	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this	   binding	   is	   not	   significantly	   affected	   by	   the	   presence	   of	   Fe	   under	   these	   binding	  conditions.	  This	  small	  amount	  of	  Dfh:fIscU	  binding,	  however,	  is	  quite	  similar	  to	  similar	  pull-­‐down	  studies	  done	  on	  Yfh1:Isu1	  binding	  in	  mitochondrial	  lysate.233	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Figure	   5.4:	   SDS-­‐PAGE	   of	   various	   protein	   mixtures	   from	   Ni-­‐column	   pull	   down	   assay	  measuring	   His6-­‐fIscU	   binding	   to	   untagged	   Dfh.	   Dfh-­‐fIscU	   binding	   is	   not	   significantly	  affected	  by	  using	  apo-­‐Dfh	  (no	  Fe)	  in	  place	  of	  holo-­‐Dfh	  (with	  Fe).	  Labels	  in	  black	  correspond	  to	  apo-­‐Dfh	  and	  in	  red	  to	  holo-­‐Dfh.	  Lanes:	  L	  (ladder),	  1	  (2xapo/holo-­‐Dfh:1xfIscU	  mixture),	  2	  (flow-­‐through),	  3	  (Wash),	  and	  4	  (eluted).	  After	  addition	  of	  protein	  mixtures,	  columns	  were	  washed	  with	  either	  25mL	  (panel	  A)	  or	  50mL	  (panel	  B)	  of	  binding	  buffer.	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5.4	  Discussion	  
5.4.1	  Frataxin’s	  Inhibition	  of	  FeS-­‐Cluster	  Formation	  Related	  to	  Protein	  Instability	  in	  
vitro	   The	   concentration	   dependent	   stimulatory	   vs.	   inhibitory	   effect	   of	   frataxin	   on	   FeS-­‐fIscU	   formation	  may	   be	   an	   artifact	   related	   to	   protein	   instability	   in	  vitro.	   As	   described	   in	  section	   5.3.1,	   in	   150mM	  NaCl	   solution,	   frataxin	   concentrations	   0-­‐20μM	  were	   stimulatory	  while	  frataxin	  concentrations	  >50μM	  were	  inhibitory	  for	  FeS-­‐fIscU	  formation.	  Under	  higher	  salt	  conditions	  (500mM	  NaCl),	  however,	  frataxin	  only	  caused	  stimulation	  under	  all	  frataxin	  concentrations	  tested	  (0-­‐100μM).	  This	  dependence	  on	  salt	  concentration	  suggests	  that	  the	  inhibition	  caused	  by	  frataxin	  is	  an	  artifact	  related	  to	  protein	  instability.	  While	   it	  has	  been	  reported	  that	  frataxin	  orthologs	  have	  different	  effects	  in	  different	  systems,229	  it	  has	  never	  been	   reported	   that	   frataxin	   stimulation	   vs.	   inhibition	   can	   be	   modulated	   under	   differing	  reaction	  conditions.	   It	   is	  not	   clear	  what	   is	   creating	   this	   frataxin	  concentration-­‐dependent	  stimulatory	   vs.	   inhibitory	   effect	   but	   one	   theory	   is	   that	   frataxin	   is	   oligomerizing	   with	   Fe	  under	   lower	   salt	   conditions,	   as	   there	   have	   been	   several	   reports	   noting	   that	   frataxin	  oligomerizes	   in	   the	   presence	   of	   Fe.234-­‐236	   This	   could	   also	   explain	   why	   in	   addition	   to	  inhibiting	   FeS-­‐fIscU	   formation,	   large	   amounts	   of	   frataxin	   (>50μM)	   also	   reduce	   the	   yield	  FeS-­‐clusters.	   As	   these	   findings	   are	   highly	   dependent	   on	   in	   vitro	   reaction	   conditions,	   this	  frataxin	  concentration	  dependent	  stimulatory	  vs.	  inhibitory	  effect	  on	  FeS-­‐cluster	  formation	  may	  not	  have	  physiologic	  relevance.	  
5.4.2	  Frataxin	  as	  an	  Allosteric	  Activator	  of	  Nfs1	  	  	   Small	  amounts	  (<10μM)	  of	  either	  Dfh	  and	  Yfh1	  demonstrate	  a	  profound	  stimulation	  on	  FeS-­‐cluster	  formation	  and	  this	  supports	  the	  role	  of	  frataxin	  as	  an	  allosteric	  activator	  in	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vitro.	  This	  finding	  agrees	  with	  various	  reports	  on	  the	  topic.229-­‐230,	  237-­‐238	  Frataxin’s	  allosteric	  activation	  may	  be	  of	  the	  cysteine	  desulfurase	  enzyme	  Nfs1	  as	  frataxin	  increases	  acid-­‐labile	  sulfide	  production	  in	  a	  pattern	  consistent	  with	  observed	  FeS-­‐fIscU	  formation	  (see	  Chapter	  4).	  Visible	  absorption	  spectroscopic	  analyses	  of	  as-­‐purified	  SD,	  SDU,	  and	  SDUF	  complexes	  suggest	  that	  frataxin	  affects	  the	  PLP-­‐binding	  of	  Nfs1	  (see	  Chapter	  4)	  and	  this	  may	  indicate	  a	  possible	  mechanism	  for	   frataxin-­‐mediated	  stimulation	  of	   the	  cysteine	  desulfurase	  activity	  of	  Nfs1.	  An	  important	  consideration,	  however,	  is	  that	  FeS-­‐fIscU	  formation	  could	  potentially	  be	   complicated	   by	   frataxin’s	   combined	   effects	   on	   Fe-­‐delivery	   and	   cysteine	   desulfurase	  activation.	   Using	   sodium	   sulfide	   in	   place	   of	   Nfs1-­‐Isd11	   and	   cysteine	   is	   a	   strategy	   to	  uniquely	   consider	   frataxin’s	   role	   in	   Fe-­‐delivery	   because	   it	   circumvents	   effects	   related	   to	  cysteine	  desulfurase.	  	  
5.4.3	  The	  FeS-­‐Isu1	  Formation	  Method	  Unable	  to	  Assess	  Fe-­‐Delivery	  by	  Dfh	  to	  fIscU	  	   Studies	  comparing	   the	  effects	  of	  apo-­‐Dfh	  with	  Fe-­‐fIscU	  vs.	  holo-­‐Dfh	  with	  apo-­‐fIscU	  on	  FeS-­‐fIscU	   formation	   suggest	   that	   this	  method	   is	   too	   slow	   to	   adequately	   assess	   effects	  related	   to	   Fe-­‐transfer.	   Possibly	   Fe-­‐delivery	   to	   fIscU	   occurs	   very	   fast	   and	   starts	   prior	   to	  reaction	  initiation	  with	  cysteine.	  This	  would	  agree	  with	  previous	  findings	  that	  Fe-­‐transfer	  from	  frataxin	  to	  Isu1	  does	  not	  require	  cysteine.222	  Reaction	  activation	  with	  Fe2+	  instead	  of	  cysteine	   is	   a	   potential	   approach	   to	   study	   Fe-­‐transfer	   effects,	   however	   this	  may	   facilitate	  FeS-­‐mineralization	  that	  could	  complicate	  the	  experiment.	  
5.4.4	  Dfh-­‐fIscU	  Binding	  is	  Not	  Significantly	  Affected	  by	  Iron	  The	   pull-­‐down	   assay	   studies	   (Figure	   5.4)	   using	  D.	  melanogaster	   proteins	   suggest	  that	  Dfh-­‐fIscU	  binding	   is	  not	  affected	  by	  the	  presence	  of	  Fe.	  This	  disagrees	  with	  previous	  findings	   from	  both	  S.	  cerevesiae	   and	  D.	  melanogaster.	   It	   is	  unclear,	  however,	   if	   ITC	  curves	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from	   Cook	   et	   al.222	   (yeast)	   and	   Dr.	   Swati	   Rawat’s	   dissertation	   (fly)	   were	   measuring	   Fe-­‐transfer	   from	   frataxin	   to	   Isu1	  or	  a	  direct	  protein-­‐protein	   interaction.	  To	  support	   that	   the	  ITC	   curves	   were	   actually	   measuring	   Fe-­‐transfer,	   however,	   binding	   parameters	   for	   holo-­‐Yfh1	   to	   Isu1	   are	   similar	   to	   the	   parameters	   of	   free	   Fe2+	   into	   Isu1.222	   Also,	   the	   binding	  parameters	   for	  holo-­‐Dfh	   into	   fIscU	   are	   comparable	   to	   free	   Fe2+	   into	   fIscU	   (see	   Dr.	   Swati	  Rawat’s	   dissertation).	   The	   described	   pull-­‐down	   studies	   using	   apo/holo-­‐Dfh	   were	   an	  attempt	  to	  estimate	  protein-­‐protein	  binding	  specifically	  in	  a	  way	  that	  would	  not	  be	  affected	  by	  potential	  Fe-­‐transfer.	  These	  pull-­‐down	  studies	  have	  potential	   complications,	  however.	  One	  possibility	  to	  note	  is	  that	  the	  Ni	  ions	  of	  the	  Ni-­‐column	  could	  functionally	  bind	  to	  apo-­‐Dfh,	   removing	  any	  differences	   from	  the	  holo-­‐Dfh	  binding	  studies.	  Alternatively,	   imidazole	  used	  in	  the	  experimental	  buffer	  could	  interfere	  with	  Dfh-­‐fIscU	  binding	  or	  could	  adversely	  affect	   the	   Fe-­‐binding	   capacity	   of	   these	   proteins.	   Lastly,	   the	   binding	   interaction	   between	  
holo-­‐Dfh	  and	  fIscU	  may	  interfere	  with	  the	  Ni-­‐column	  binding	  of	  His6-­‐fIscU.	  
5.4.5	  Frataxin	  as	  Allosteric	  Activator	  of	  Nfs1	  in	  vivo	  	   In	   vitro	   results	   suggesting	   that	   frataxin	   is	   an	   allosteric	   activator	   of	   cysteine	  desulfurase	  may	  provide	  insights	  into	  frataxin’s	  function	  in	  vivo.	  The	  role	  of	  frataxin	  in	  vivo	  has	   a	   direct	   clinical	   significance,	   as	   this	   protein	   is	   under-­‐expressed	   in	   patients	   suffering	  from	   Friedreich’s	   Ataxia	   (FRDA).221	   	   This	   suggests	   a	   novel	   treatment	   strategy	   for	   FRDA,	  such	  as	  a	  small	  molecule	  that	  functions,	  like	  frataxin,	  to	  stimulate	  Nfs1	  activity.	  A	  structure	  for	   a	   human	   ISCS-­‐ISD11-­‐ACP1	   complex	   has	   recently	   been	   solved	   (still	   unpublished)	   and	  hopefully	  simulated	  small-­‐molecule	  design	  will	  be	  possible	  in	  the	  near	  future.	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CHAPTER	  6:	  CONCLUSIONS	  AND	  FUTURE	  DIRECTIONS	  
	  
6.0	  Prelude	  This	  final	  chapter	  of	  my	  dissertation	  will	  summarize	  results	  from	  Chapter	  2-­‐5,	  draw	  conclusions	  from	  them,	  and	  propose	  additional	  work	  for	  future	  studies.	   	  I	  will	  also	  reflect	  on	  the	  strengths	  and	  weaknesses	  of	  this	  research	  and	  describe	  its	  significance	  to	  the	  field	  of	  Fe-­‐S	  cluster	  biogenesis.	  I	  did	  all	  the	  writing	  in	  this	  chapter.	  
6.1	  Introduction	  This	  chapter	  will	  summarize	  the	  in	  vitro	  findings	  outlined	  previously	  and	  attempt	  to	  draw	  in	  vivo	  conclusions	  from	  them.	  Up	  to	  this	  point,	  this	  dissertation	  has	  been	  hesitant	  to	  take	   this	   step	   because	  many	   of	   these	   described	   results	  were	   highly	   dependent	   on	   the	   in	  
vitro	   conditions	   selected.	   This	   was	   particularly	   true	   for	   the	   FeS-­‐Isu1	   formation	  method,	  where	   a	   wide	   variety	   of	   results	   could	   be	   observed	   by	   simply	   manipulating	   reaction	  conditions.	  Unexplored	  changes	  to	  pH,	  temperature,	  or	  salt/protein/buffer	  concentrations	  could	   lead	   to	   completely	   opposite	   results	   from	   what	   was	   reported	   here.	   Similarly,	  discrepancies	   between	   this	   work	   and	   past	   findings	   could	   be	   merely	   a	   result	   of	   using	  different	  conditions.	  Therefore,	   it	   seems	   like	  a	  gigantic	   leap	   to	   take	   these	   findings,	  which	  were	  made	  in	  a	  dish	  under	  very	  specific	  conditions,	  and	  apply	  them	  to	  a	  living	  cell.	  A	  logical	  strategy	  to	  combat	  this	  problem	  is	  to	  try	  to	  use	  conditions	  that	  match	  those	  found	  in	  vivo.	  While	   this	   can	   be	   attempted,	   truly	   matching	   in	   vivo	   conditions	   may	   be	   impossible	   in	  
vitro.239	  In	  vivo,	  cells	  utilize	  a	  huge	  number	  of	  proteins,	  nucleic	  acids,	  lipids,	  and	  other	  small	  molecules.	  Various	  cellular	  environments	  are	  compartmentalized	  into	  micro-­‐environments	  where	  conditions	  are	  unique	  and	  continuously	  changing.240	  Please	  keep	  this	  in	  mind	  while	  considering	  the	  in	  vivo	  conclusions	  and	  correlations	  made	  in	  this	  chapter.	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6.2	  Summary	  of	  Results	  The	   findings	   discussed	   in	   Chapters	   2-­‐5	   will	   be	   summarized	   in	   this	   section.	   One	  consistent	   feature	   found	   throughout	   this	   dissertation	   is	   a	   heavy	   reliance	   on	   in	   vitro	  functional	  studies.	  In	  particular,	  much	  of	  this	  work	  focused	  on	  developing	  and	  validating	  an	  appropriate	  method	   to	  conduct	  a	   functional	  assay	  of	   recombinant	   Isu1	   in	  vitro.	  Once	   this	  method,	   called	   the	   “FeS-­‐Isu1	   formation	  method”,	   had	   been	   validated	   it	  was	   applied	   to	   a	  wide	  variety	  of	  situations	  in	  attempt	  to	  answer	  specific	  questions.	  While	  these	  studies	  have	  some	  utility,	  the	  lack	  of	  prominent	  structural	  techniques	  in	  this	  dissertation,	  such	  as	  X-­‐ray	  crystallography	   and	   Nuclear	   Magnetic	   Resonance	   Spectroscopy,	   limits	   our	   ability	   to	  generate	  structural	  models	  and	  mechanisms.	  	  
6.2.1	  Optimal	  Method	  for	  Forming	  FeS-­‐Isu1	  in	  vitro	  Replicating	  Isu1’s	  role	  in	  vivo	  can	  be	  done	  in	  vitro	  via	  a	  FeS-­‐Isu1	  formation	  assay.	  In	  order	   to	  obtain	  optimal	   results,	  however,	   this	  assay	  must	  be	  done	  under	  a	   specific	   set	  of	  conditions.	  These	  conditions	  require	  excess	  Isu1	  and	  a	  limiting	  amount	  of	  Nfs1-­‐Isd11	  and	  Fe2+.	   Excess	   Fe2+	   leads	   to	   an	   adverse	   side	   reaction,	   termed	   “FeS-­‐mineralization”,	   that	  inhibits	  Fe-­‐S	  cluster	  formation.	  Circular	  dichroism	  is	  the	  optimal	  method	  for	  assessing	  Fe-­‐S	  cluster	   formation	   on	   Isu1	   as	   it	   is	   insensitive	   to	   FeS-­‐mineralization.	  While	   these	   optimal	  conditions	  may	   facilitate	   study	   of	   Isu1	   in	   vitro,	   it	   remains	   unclear	   how	   these	   conditions	  relate	  to	  ISC	  function	  in	  vivo.	  
6.2.2	  Characterization	  of	  Isu1	  Ortholog	  from	  D.	  melanogaster,	  fIscU	  The	  Isu1	  ortholog	  from	  D.	  melanogaster,	  “fIscU”,	  is	  a	  scaffold	  for	  de	  novo	  Fe-­‐S	  cluster	  biogenesis	  that	  has	  similar	  characteristics	  as	  its	  yeast	  ortholog.	  fIscU	  binds	  2	  mononuclear	  iron	  atoms	  and	  can	  assemble	  these	  atoms	  into	  an	  Fe-­‐S	  cluster.	  This	  protein	  is	  dimeric	  and	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assembles	  one	  2Fe2S-­‐cluster	  per	  monomer.	  fIscU	  can	  fully	  complement	  yeast	  ISC	  in	  vivo	  as	  fIscU	  can	  rescue	  the	  Isu1/2	  deletion	  phenotype	  in	  yeast.	  Use	  of	  fIscU	  is	  a	  viable	  alternative	  to	   the	  unstable	  yeast	   Isu1	   in	   the	   in	  vitro	  and	   in	  vivo	  study	  of	  yeast	   ISC.	  This	  strategy	  may	  facilitate	   novel	   experimentation	   of	   the	   yeast	   ISC	   pathway	   in	   the	   future.	   Challenging	  experimental	  techniques	  such	  as	  X-­‐ray	  crystallography	  and	  NMR	  spectroscopy,	  for	  example,	  may	   be	   possible	   with	   more	   stable	   Isu1	   orthologs	   and	   this	   could	   provide	   important	  structural	  information	  and	  identify	  mechanistic	  details	  of	  ISC.	  
6.2.3	  Isolation	  and	  Characterization	  of	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	  (“SDUF”)	  Complex	  	   The	  proteins	  of	  upstream	  Saccharomyces	  cerevesiae	  ISC	  (Nfs1,	  Isd11,	  Isu1,	  and	  Yfh1)	  form	  a	  complex	  that	  can	  be	  isolated	  in	  vitro.	  This	  complex,	  sometimes	  referred	  to	  the	  “Fe-­‐S	  cluster	   assembly	   complex”	   or	   “SDUF”,	   is	   a	   result	   of	   relatively	  weak	   interactions	  between	  Nfs1-­‐Isd11	   (“SD”),	   Isu1	   (“U”),	   and	  Yfh1	   (“F”)	   that	   requires	   the	   use	   of	   low-­‐salt	   conditions	  (~50mM	  NaCl)	   that	  prevent	   complex	  dissociation.	  Despite	  being	  named	   the	   “Fe-­‐S	  cluster	  assembly	   complex”,	   complexed	   Isu1	   within	   SDU	   and	   SDUF	   demonstrates	   inhibited	   Fe-­‐S	  cluster	   formation	   as	   assessed	   via	   circular	   dichroism	   spectroscopy.	   Exogenous	   apo-­‐Isu1,	  however,	   is	   able	   to	   produce	   FeS-­‐Isu1	   in	   the	   presence	   of	   SD,	   SDU,	   or	   SDUF.	   FeS-­‐fIscU	  formation	  is	  accelerated	  3-­‐fold	  by	  the	  use	  of	  SDUF	  over	  SD	  or	  SDU.	  SDUF	  demonstrates	  high	  cysteine	  desulfurase	  activity	   that	   is	  possibly	   the	  source	  of	   its	  ability	   to	   rapidly	   form	  FeS-­‐fIscU.	   Despite	   demonstrating	   complete	   complementation	   with	   yeast	   ISC,	   fIscU	   does	   not	  form	  a	  stable	  complex	  with	  yeast	  SD	  under	  conditions	  that	  allow	  SDU	  and	  SDUF	  complex	  isolation.	  While	   stoichiometric	   conditions	   of	  Nfs1-­‐Isd11,	   Isu1,	   and	  Yfh1	  proteins	   prevent	  observable	   FeS-­‐Isu1	   formation,	   using	   fIscU	  under	   these	   conditions	   in	   place	   of	   yeast	   Isu1	  results	  in	  unhindered	  Fe-­‐S	  cluster	  production.	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6.2.4	  Frataxin	  Functions	  as	  an	  Allosteric	  Activator	  of	  Cysteine	  Desulfurase	  in	  vitro	   	  Lastly,	   my	   activity	   studies	   validate	   that	   frataxin	   is	   an	   allosteric	   activator	   of	   the	  cysteine	  desulfurase	  enzyme	  Nfs1-­‐Isd11.	  Under	  500mM	  NaCl	  conditions,	  small	  amounts	  of	  frataxin	   (<1μM)	   produce	   a	   dramatic	   stimulation	   (3x)	   in	   FeS-­‐Isu1	   formation	   when	   using	  10μM	  Nfs1-­‐Isd11,	  consistent	  with	  frataxin’s	  role	  as	  an	  allosteric	  regulator.	  Frataxin	  affects	  the	  PLP-­‐binding	  of	  Nfs1	  in	  as-­‐purified	  SDUF,	  suggesting	  a	  possible	  mechanism	  for	  frataxin-­‐mediated	  stimulation	  of	   ISC.	  Frataxin’s	   role	   in	  Fe-­‐delivery	   to	   Isu1	  could	  not	  be	  evaluated	  using	  the	  described	   in	  vitro	  methods.	  Using	  apo-­‐frataxin	  vs.	  holo-­‐frataxin	  has	  no	  effect	  on	  FeS-­‐fIscU	  formation,	  as	  Fe-­‐S	  cluster	  assembly	  is	  likely	  too	  slow	  to	  assess	  rapid	  Fe-­‐transfer	  behavior.	   Using	   a	   simple	   pull-­‐down	   assay	   with	   D.	   melanogaster	   proteins,	   Isu1-­‐frataxin	  binding	  is	  not	  affected	  by	  the	  use	  of	  apo-­‐	  vs	  holo-­‐	  frataxin.	  This	  work	  suggests	  that	  frataxin	  and	   Isu1	   binding	   requires	   the	   presence	   of	   Nfs1-­‐Isd11.	   These	   results	   are	   consistent	  with	  similar	  pull-­‐down	  studies	  from	  yeast	  mitochondrial	  lysate.241-­‐242	  
6.3	  Correlations	  to	  ISC	  Function	  in	  vivo	  
6.3.1	  Regulation	  of	  Iron	  Critical	  for	  Efficient	  Fe-­‐S	  cluster	  Formation	  in	  vivo	  	   In	  vitro	  FeS-­‐Isu1	  formation	  studies	  demonstrate	  that	  excess	  Fe	  can	  inhibit	  FeS-­‐Isu1	  formation	  and	  we	  propose	   that	   regulation	  of	  Fe	   levels	  may	  be	   important	   for	   in	  vivo	   Fe-­‐S	  cluster	  biogenesis.	  Outside	  of	  the	  ROS-­‐mediated	  effects	  of	  free	  Fe,	  it	  is	  possible	  that	  adverse	  FeS-­‐mineralization	   via	   free	   Fe	   could	   also	   occur	   in	   vivo.	   This	   insoluble	   mineral	   may	   be	  difficult	  for	  cells	  to	  remove	  and	  could	  be	  a	  source	  of	  toxicity.	  This	  agrees	  with	  direct	  in	  vivo	  evidence	  that	  Fe-­‐level	  control	  is	  important	  for	  efficient	  ISC	  function	  in	  yeast.243-­‐244	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6.3.2	  Nfs1-­‐Isu1	  Binding	  Studies	  Suggests	  Model	  for	  ISC	  Function	  in	  vivo	  Studies	  of	  SDUF	  are	  particularly	  interesting	  for	  describing	  in	  vivo	  ISC	  and	  suggest	  a	  model	  where	   the	  Nfs1-­‐Isu1	   interaction	   is	   transient	   in	  vivo.	   In	  vitro	  studies	  of	  SDUF	  agree	  with	  recent	  reports	  that	  complexed	  Isu1	  is	  unable	  to	  produce	  an	  observable	  Fe-­‐S	  cluster.245	  This	  suggests	  that	  something	  is	  ‘missing’	  from	  the	  complex	  for	  it	  to	  complete	  this	  essential	  function.	  While	  we	  don’t	  know	  precisely	  what	  this	  is,	  the	  requirement	  for	  exogenous	  Isu1	  provides	  an	  interesting	  clue.	  Perhaps	  the	  missing	  component	  is	  an	  event	  (or	  molecule)	  that	  triggers	  (or	  modulates)	  SDUF	  dissociation	  (possibly	  Ssq1	  or	  Jac1	  binding)246	  and	  facilitates	  exogenous	  Isu1	  formation.	  In	  this	  model,	  complex	  formation	  would	  be	  important	  for	  Fe-­‐	  or	  S-­‐	   transfer	   but	   the	   Fe-­‐S	   cluster	   assembly	   actually	   occurs	   after	   complex	   dissociation.	   The	  SDUF	  complex	  association,	  would	   therefore,	  be	   transient	   in	  vivo	  and	   its	  dissociation	   is	  an	  essential	  step	  for	  FeS-­‐Isu1	  formation.	  There	  also	  could	  be	  another	  required	  component	  for	  SDUF-­‐mediated	  Fe-­‐S	  cluster	  formation	  that	  has	  yet	  to	  be	  identified.	  Lastly,	  it	  is	  possible	  that	  SDUF	   complexation	   is	   not	   essential	   in	   vivo.	   fIscU	   is	   able	   to	   fully	   complement	   yeast	   ISC	  despite	  the	  fact	  that	  it	  has	  not	  been	  observed	  to	  form	  a	  stable	  complex	  with	  yeast	  SD	  and	  Yfh1	   (although	   there	  may	   be	   an	   fIscU-­‐Nfs1	   interaction	   in	   vivo	   that	   cannot	   be	   isolated	   in	  
vitro).	  	  
6.3.3	  Frataxin	  Can	  Activate	  Cysteine	  Desulfurase	  Enzyme	  Nfs1	  in	  vivo	  	   In	  vitro	   functional	   studies	  described	   in	  Chapters	  4	  and	  5	   suggest	   that	   frataxin	   can	  stimulate	   the	   cysteine	   desulfurase	   activity	   of	   Nfs1	   and	   we	   propose	   that	   frataxin	   may	  demonstrate	  similar	  behavior	  in	  vivo.	  The	  role	  of	  frataxin	  has	  a	  direct	  clinical	  significance,	  as	  this	  protein	  is	  under-­‐expressed	  in	  patients	  suffering	  from	  Friedreich’s	  Ataxia	  (FRDA).247	  	  This	  suggests	  a	  novel	  treatment	  strategy	  for	  FRDA,	  such	  as	  a	  small	  molecule	  that	  functions,	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like	  frataxin,	  to	  stimulate	  Nfs1	  activity.	  A	  structure	  for	  a	  human	  ISCS-­‐ISD11-­‐ACP1	  complex	  has	  recently	  been	  solved	  (still	  unpublished)	  and	  hopefully	  simulated	  small-­‐molecule	  design	  will	  be	  possible	  in	  the	  near	  future.	  
6.4	  Future	  Directions	  	   Although	   the	   time	   for	   me	   to	   collect	   data	   has	   ended,	   I	   continue	   to	   think	   up	   new	  experiments	   that	  might	   answer	  many	  of	   the	  questions	   raised	  by	   this	  work.	   I	   am	  hopeful	  that	   future	   students,	   either	   from	   Dr.	   Stemmler’s	   lab	   or	   elsewhere,	   will	   try	   to	   reproduce	  these	  findings	  and/or	  expand	  on	  them.	  This	  section	  will	  list	  several	  ideas	  to	  further	  develop	  this	  work.	  Perhaps	  if	  you	  are	  struggling	  with	  your	  project	  and	  are	  looking	  for	  new	  ideas	  you	  may	  find	  these	  useful.	  	  
6.4.1	  Structural	  Characterization	  of	  apo-­‐	  vs	  FeS-­‐Isu1	  	   Structural	  characterization	  of	  eukaryotic	   Isu1	  holds	  enormous	  potential	   that	  could	  suggest	  a	  mechanism	  for	  Isu1-­‐mediated	  Fe-­‐S	  cluster	  formation	  and	  Isu1’s	  interaction	  with	  Nfs1	  and	  Yfh1.	  NMR	  studies	  of	   the	  bacterial	   Isu1	  ortholog,	   “IscU”,	  have	  revealed	  multiple	  conformations	  for	  IscU,	  “structured”	  (S)	  and	  “disordered”	  (D).248	  IscU	  inherently	  exists	  as	  a	  mixture	   of	   these	   conformers,	   typically	   in	   a	   ~80%	   S/20%	   D	   arrangement.249	   The	   best	  explanation	   for	  SDUF’s	  behavior	  stems	   from	  this	  work,	  and	  possibly	  eukaryotic	   Isu1	  also	  demonstrates	   similar	   behavior.	   No	   structural	   information	   for	   eukaryotic	   Isu1	   is	   known,	  however,	  and	  there	  is	  huge	  potential	  in	  researching	  this	  topic.	  NMR	  studies	  comparing	  apo-­‐Isu1	   to	  FeS-­‐Isu1	  may	  be	   the	  best	  choice	   for	  probing	   these	  conformations.249-­‐250	  Labs	   that	  have	  expertise	  in	  NMR	  have	  not	  reported	  eukaryotic	  Isu1	  structural	  information,	  however,	  so	   one	   could	   deduce	   that	   this	  would	   be	   difficult.	   Circular	   dichroism	   secondary	   structure	  estimation	  may	   also	   be	   useful,	   but	   this	   is	   a	   qualitative	   technique	   at	   best	   and	   it	   could	   be	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difficult	   to	   identify	   differences	   in	   a	   species	   that,	   at	   most,	   makes	   up	   20%	   of	   the	   sample.	  Using	  fIscU	  may	  be	  a	  novel	  approach	  for	  structural	  characterization	  of	  Isu1	  as	   it	   is	  highly	  conserved	  with	  yeast	  Isu1	  but	  has	  increased	  stability	  and	  solubility.	  
6.4.2	  Investigation	  of	  Direct	  Sulfur	  Transfer	  from	  Nfs1	  to	  Isu1	  	   Despite	   all	   the	   FeS-­‐Isu1	   studies	   reported	   here,	   very	   little	   has	   been	   identified	  regarding	   how	   Isu1	   gets	   reduced	   sulfur.	   Possible	   mechanisms	   include	   direct	   persulfide	  transfer	  from	  Nfs1	  to	  Isu1	  or,	  a	  free	  hydrogen-­‐sulfide	  intermediate	  produced	  by	  Nfs1	  that	  interacts	  with	   Isu1.	   Seeing	  as	   fIscU	  possibly	  does	  not	   complex	  with	  Nfs1	   (although	   there	  may	  be	  a	  weak	   transient	   interaction	  that	  cannot	  be	   isolated),	   it	   is	  unclear	  how	  fIscU	  gets	  reduced	   sulfur	   during	   the	   in	   vitro	   FeS-­‐fIscU	   formation	   reaction.	   Persulfide	   identification	  using	  radioactive	  S35-­‐labeled	  cysteine	  could	  be	  very	  useful	  to	  answer	  these	  questions.251-­‐252	  Dr.	   Dancis	   and	   Dr.	   Pain	   have	   familiarity	   with	   this	   method	   and	   could	   be	   a	   tremendous	  resource.	  But	  before	  persulfide	  studies	  of	  Isu1	  can	  be	  done,	  successful	  persulfide	  formation	  on	  Nfs1	  must	  be	  demonstrated.	  	  	  
6.4.3	  Functional	  Assays	  Incorporating	  Downstream	  ISC	  While	   Yah1	   was	   utilized	   as	   a	   2Fe2S-­‐cluster	   standard	   in	   Chapter	   3,	   further	  experimentation	   could	   investigate	   this	   protein	   with	   respect	   to	   its	   in	   vivo	   function	   as	   a	  source	  of	  electrons	  for	  FeS-­‐Isu1	  formation.	  Excess	  reduced	  Yah1	  could	  potentially	  be	  used	  in	  place	  of	  DTT	  for	  this	  reaction.253	  This	  would	  likely	  require	  either	  an	  excess	  of	  Yah1	  (>100	  μM	   for	   50	   μM	   Isu),	   or	   use	   of	   the	   Yah1	   reductase	   enzyme	   “Arh1”	   and	   excess	  NADPH.	   An	  important	  note	  is	  that	  this	  work	  should	  utilize	  a	  near-­‐limiting	  amount	  of	  cysteine,	  as	  excess	  cysteine	  can	  be	  used	  in	  place	  of	  DTT	  for	  reducing	  equivalents.	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Although	   little	   is	   known	   regarding	   the	   early	   stages	   of	   ISC,	   perhaps	   even	   less	   is	  known	   regarding	   downstream	  processes.	   Grx5	   is	   the	   in	  vivo	   acceptor	   of	   the	   Fe-­‐S	   cluster	  from	   Isu1	   and	   this	   has	   been	   demonstrated	   in	   vitro.254-­‐256	   Efficient	   transfer	   from	   Isu1	   to	  Grx5,	   however,	   requires	   Ssq1	   and	   Jac1,257	  which	  would	   increase	   the	   number	   of	   proteins	  needed	   for	   this	   reaction	   to	   7.	   With	   these	   additional	   proteins,	   stoichiometries	   could	   be	  appropriately	   adjusted	   and	   the	   FeS-­‐Isu1	   formation	   reaction	   could	   be	   re-­‐designed	   to	  incorporate	  an	  entire	  additional	  step	  of	  ISC.	  Likely	  this	  would	  involve	  an	  enzymatic	  amount	  of	  Nfs1-­‐Isd11,	  apo-­‐Isu1,	  Yfh1,	  Ssq1,	  and	  Jac1	  and	  excess	  apo-­‐Grx5.257	  
6.4.4	  Additional	  Characterization	  of	  SDUF	  	   This	  dissertation	  only	  provides	  a	  limited	  study	  on	  SDUF	  and	  there	  is	  much	  more	  that	  needs	   to	  be	  done	   to	   characterize	   this	   complex.	  One	   challenge	  posed	  by	   this	  work	   is	   that	  many	   of	   the	   typical	  methods	   used	   for	   recombinant	   protein	   are	   difficult	   to	   perform	  with	  SDUF	  because	  SDUF	  is	  a	  mixture	  of	  proteins	  that,	  by	  mass,	  is	  predominantly	  Nfs1-­‐Isd11.258	  The	   melting	   behavior	   of	   SDUF,	   for	   example,	   is	   very	   similar	   to	   Nfs1-­‐Isd11.	   Circular	  dichroism	   secondary	   structure	   estimation	   would	   likely	   produce	   a	   spectrum	   that	   looks	  similar	  to	  Nfs1-­‐Isd11.	  A	  crystallographic	  structure	  for	  SDUF	  would	  be	  immensely	  useful,	  or	  for	  any	  yeast	  ISC	  component	  for	  that	  matter,	  but	  this	  may	  be	  difficult.	  The	  work	  described	  in	  Chapter	  4	  did	  not	  adequately	  investigate	  SDUF’s	  inability	  to	  make	   a	   CD-­‐active	   Fe-­‐S	   cluster.	   The	  model	   described	   in	   Chapter	   4	   suggests	   that	   no	   Fe-­‐S	  cluster	   formation	   is	   occurring	   with	   complexed	   Isu1,	   but	   perhaps	   complexed	   Isu1	   is	  producing	  a	  non	  CD-­‐active	  or	  transient	  Fe-­‐S	  cluster	  that	  could	  be	  detected	  by	  other	  means.	  XAS	   studies	   were	   attempted	   on	   this	   topic	   but	   these	   studies	   were	   unsuccessful.	   As	  attempted	  FeS-­‐Isu1	  formation	  with	  SDUF	  did	  not	  produce	  a	  significant	  FeS-­‐mineral	  signal,	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it	  appears	  as	  though	  complexed	  Isu1	  still	  binds	  Fe	  to	  some	  extent.	  Much	  more	  work	  could	  be	   done	   to	   estimate	   SDUF	   Fe-­‐binding,	   however.	   Fluorescence	   quenching	   studies	   via	  competition	  with	  the	  Fura-­‐FF	  ligand	  may	  be	  a	  good	  choice	  for	  this	  application	  (see	  Chapter	  3).	   The	   reported	   requirement	   for	   cysteine	   presents	   a	   potential	   complication	   for	   these	  studies,	  as	  cysteine	  is	  a	  substrate	  for	  the	  cysteine	  desulfurase	  enzyme.	  	  
6.4.5	  Expanding	  ISC	  Studies	  to	  Other	  Organisms	  	   This	   work	   utilized	   ISC	   proteins	   from	   yeast	   (Saccharomyces	   cerevesiae)	   and	   fly	  (Drosophila	  melanogaster)	   systems.	  Mixing	   and	  matching	   these	   proteins	  was	   essential	   to	  perform	   these	   experiments.	   For	   example,	   fIscU	   is	  much	  more	   stable/soluble/active	   than	  yeast	   Isu1,	   but	   I	   have	   observed	   that	  Drosophila	   Nfs1-­‐Isd11	   is	   less	   stable/soluble/active	  than	   its	   yeast	   counterpart.	   Considering	   that	   the	   last	   common	   ancestor	   of	   flies	   and	   yeast	  lived	   ~1	   billion	   years	   ago,259	   there	   are	   probably	   many,	   many	   other	   organisms	   that	  demonstrate	   similar	   complementation	  between	   their	   ISC	  proteins	   and	  many	   ISC	   systems	  remain	  unexplored.	  For	  the	  purposes	  of	  this	  work,	  yeast	  Nfs1-­‐Isd11,	  Yfh1,	  and	  fIscU	  were	  sufficient	  but	  for	  more	  challenging	  methods	  such	  as	  crystallography,	  NMR,	  ITC,	  etc.,	   there	  may	  be	  highly	  stable	  proteins	  found	  in	  other	  systems	  that	  could	  facilitate	  these	  methods.	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ABSTRACT	  	  
INSIGHTS	  INTO	  DE	  NOVO	  FES-­‐CLUSTER	  BIOGENESIS	  VIA	  THE	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Degree:	  Doctor	  of	  Philosophy	  FeS-­‐clusters	   are	   iron-­‐containing	   cofactors	   utilized	   by	   numerous	   proteins	   within	  several	  biological	  pathways	  essential	   to	   life.	   In	  eukaryotes,	   the	  primary	  pathway	   for	  FeS-­‐cluster	   production	   is	   the	   iron-­‐sulfur	   cluster	   (ISC)	   pathway.	   The	   eukaryotic	   ISC	   pathway,	  localized	   primarily	   within	   the	   mitochondria,	   has	   been	   best	   characterized	   within	  
Saccharomyces	  cerevisiae.	  In	  yeast,	  de	  novo	  FeS-­‐cluster	  formation	  is	  accomplished	  through	  coordinated	  assembly	  of	   the	  substrates	   iron	  and	  sulfur	  on	   the	  primary	  scaffold	  assembly	  protein	  “Isu1”.	  The	  sulfur	  used	  for	  cluster	  assembly	  is	  provided	  by	  the	  cysteine	  desulfurase	  “Nfs1”,	   a	   protein	   that	  works	   in	   union	  with	   its	   accessory	   protein	   “Isd11”.	   Frataxin	   “Yfh1”	  helps	  direct	  cluster	  assembly	  by	  serving	  as	  a	  modulator	  of	  Nfs1	  activity,	  by	  assisting	  in	  the	  delivery	  of	  Fe(II)	  to	  Isu1,	  or	  through	  a	  combination	  of	  roles.	  	  This	  work	  describes	  and	  optimizes	  an	  in	  vitro	  method	  for	  generating	  an	  FeS-­‐cluster	  on	   the	   scaffold	   Isu1.	   Further	   in	  vitro	   studies	   on	   the	   yeast	   ISC	   system	   have	   been	   limited,	  however,	   due	   to	   the	   inherent	   instability	   of	   recombinant	   Isu1,	   a	   molecule	   prone	   to	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degradation	   and	   aggregation.	   To	   circumvent	   Isu1	   stability	   issues,	   this	   research	  demonstrates	  successful	   cross-­‐reactivity	  between	   the	   fly	   Isu1	  ortholog,	   “fIscU”,	  and	  yeast	  ISC	  in	  vitro	  and	  in	  vivo.	  This	  strategy	  could	  facilitate	  novel	  experimentation	  of	  the	  yeast	  ISC	  pathway	   in	   the	   future.	   This	   work	   also	   isolates	   complexes	   formed	   between	   recombinant	  yeast	   Nfs1-­‐Isd11,	   Nfs1-­‐Isd11-­‐Isu1,	   and	   Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1,	   and	   characterizes	   their	  activity	   related	   to	   substrate	   binding	   and	   cluster	   assembly.	   Complexed	   Isu1,	   as	   isolated	  within	  Nfs1-­‐Isd11-­‐Isu1	  and	  Nfs1-­‐Isd11-­‐Isu1-­‐Yfh1	  complexes,	  demonstrates	  inhibited	  FeS-­‐cluster	  biogenesis	  without	  the	  addition	  of	  exogenous	  apo-­‐Isu1.	  This	  suggests	  a	  mechanism	  for	   de	   novo	   FeS-­‐cluster	   formation	   on	   Isu1	   that	   is	   similar	   to	   recent	   observations	   from	  bacterial	   ISC.	   Lastly,	   evidence	   is	   provided	   that	   suggests	   that	   frataxin	   can	   function	   as	   an	  allosteric	  activator	  of	  Nfs1	  in	  vitro.	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